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A B S T R A C T  
Background 
Hypertension is a global public health problem. It is the number one risk factor for 
mortality and the third leading cause of disability-adjusted life-years (DALYs) 
worldwide. The burden of the disease is more severe in low- and middle-income 
countries, where prevalence estimates are projected to increase by 30% over the 
next decade. This is not surprising owing to the on-going epidemiological transition 
taking place in these countries, where the interplay between social factors and 
disease is highly pertinent. However, evidence on the burden of hypertension and its 
determinants in low- and middle-income countries are limited. The overall aim of this 
research is to examine the prevalence and status of hypertension in low- and middle-
income countries. The definition of hypertension used in this research is blood 
pressure measurement of ≥140 /90 mmHg (SBP/DBP), the use of antihypertensive 
medication, or self-reported physician diagnosis of hypertension. 
Objectives 
 To estimate the overall prevalence of hypertension in low- and middle-income 
countries. 
 To examine the socio-demographic determinants of hypertension in low- and 
middle-income settings.  
 To examine the geographic variation of hypertension prevalence in selected 
low-and middle-income countries. 
 To interpret the findings and discuss their implications for practice/policy and 
future research.    
Methods 
A systematic review and meta-analysis was conducted to provide overall and regional 
estimates of hypertension prevalence across low- and middle-income countries, and 
to examine patterns of the disease across different socio-demographic characteristics 
in these settings. Studies reporting hypertension prevalence in low- and middle-
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income countries were sought from electronic databases and grey literature. The 
data from these studies were analyzed using random-effects meta-analyses and sub-
group analyses. 
Secondary data analyses of DHS datasets were also conducted to estimate 
hypertension prevalence and examine its geographic variation in selected low- and 
middle-income countries with hypertension data, while accounting for a number 
socio-demographic characteristics. The secondary data analyses entailed logistic 
regression and Bayesian geo-additive analyses. Odds ratios with 95% confidence 
intervals were reported for the logistic regression analyses, whereas posterior odds 
ratios with 95% credible intervals were reported for the Bayesian geo-additive 
analyses.     
Results 
The systematic review included 242 studies, comprising 1,494,609 adults from 45 
countries. The overall prevalence of hypertension was 32.3% (95% confidence 
interval [CI] 29.4–35.3) with the Latin America and Caribbean region reporting the 
highest prevalence (39.1%, 95% CI 33.1–45.2). Prevalence was also highest in upper-
middle income countries (37.8%, 95% CI 35.0–40.6) and lowest in low-income 
countries (23.1%, 95% CI 20.1–26.2). Prevalence among adults ≥65 years was 
substantially higher than adults <65 years; however, there was no significant sex-
difference overall (31.9% vs 30.8%, p=0.6). Prevalence was generally higher among 
the non-educated compared to educated people (49.0% vs. 24.9%, p<0.05), among 
overweight/obese persons compared to normal weight (46.4% vs. 26.3%, p<0.05), 
and among urban settlers compared to rural (32.7% vs 25.2%, p=0.0005). Meta-
regression showed that combined overweight/obesity (p<0.05) and being 
uneducated (p<0.05) significantly accounted for between-study heterogeneity in 
hypertension rates 
The secondary analysis comprised data on 93,247 respondents in 10 selected 
countries (Albania, Armenia, Azerbaijan, Ukraine, Uzbekistan, Egypt, Morocco, 
Lesotho, Senegal and Maldives). The prevalence of hypertension was lowest in 
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Morocco (5.4%) and highest in Albania (22.7%). Age was the most consistent 
predictor of hypertension. Being employed was protective in the Eastern European 
countries (Albania, Armenia, Azerbaijan, Ukraine and Uzbekistan) (p<0.05 for each) 
and in African countries such as Egypt and Senegal (p<0.05 for each). Education was 
protective in Egypt, Senegal and Maldives (p<0.05 for each), but may be a strong 
determinant in Lesotho given the extremely high literacy rates in the country.  
Examining the geographic variation of hypertension revealed that Tirana and Elbasan 
districts had the highest burden of hypertension compared to other districts in 
Albania; Sharkia and Kalyoubia districts had the highest burden of hypertension 
compared to other districts in Egypt; while Quthing and Maseru districts had the 
highest burden of hypertension in Lesotho. 
Conclusion 
Overall, the findings provide contemporary and up-to-date estimates that reflect the 
significant burden of hypertension in low- and middle-income countries and evidence 
that hypertension remains a major public health issue in these settings. The findings 
also suggest that addressing the wider social determinants of hypertension, such as 
illiteracy and unemployment, may reduce overall prevalence of the disease in low- 
and middle-income countries.   
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CHAPTER ONE:  INTRODUCTION 
1.1 INTRODUCTION 
The major causes of mortality in the world today are non-communicable diseases 
(NCDs), and collectively, these health conditions are responsible for more than 36 
million deaths annually [World Health Organisation (WHO), 2014]. They are 
characterised by their long duration and slow progression (WHO, 2011a), examples 
include; cardiovascular diseases (CVDs), chronic respiratory diseases, cancers, and 
diabetes (WHO, 2014). 
NCDs pose a global threat, and the burden of death and disability attributable to 
these diseases are rising in almost every country of the globe due to the changing 
patterns in lifestyle, negative effects of globalization, poor dietary habits, rapid 
urbanization, and trends of ageing in populations (Beaglehole et al., 2011; 
Hosseinpoor et al., 2012). Despite being thought of as diseases of the most affluent 
nations, approximately 4 out of every 5 NCD deaths occur in low- and middle-income 
countries (LMICs) (WHO, 2014). 
The encumbrance of NCDs in LMICs goes beyond a global health issue to an economic 
and developmental issue as they lead to increase in poverty, increase in healthcare 
expenditure, and loss of productivity (Suhrcke et al., 2007; Lee et al., 2010; Mahal et 
al., 2010; Beaglehole et al., 2011). In relation to the economic impact of NCDs, the 
World Economic Forum and the Harvard School of Public health in late 2011 
forecasted that the global economic burden of NCDs over the next 2 decades would 
be approximately US$47 trillion (Bloom et al., 2011; Moolani et al., 2012) unless all 
stakeholders around the world act together towards combatting these diseases.   
NCDs share common risk factors (Suhrcke et al., 2007). However, the scope of this 
research is limited to CVDs and more specifically hypertension, given that the latter is 
one of the most important risk factors for mortality and burden of disease globally, 
with very high prevalence in LMICs (WHO, 2014). 
Page | 2  
 
 
CVDs are referred to as a group of diseases of the heart and blood vessels (Bloomfield 
et al., 2006; Newby et al., 2010) and are reported to be the leading cause of disease, 
disability, and death globally (Mathers & Loncar, 2006; Gaziano, 2008; WHO, 2014). 
CVDs account for the most NCD deaths with a mortality rate of approximately 17 
million people every year while cancers are responsible for the death of over 7 
million people annually, chronic respiratory diseases on the other hand claim 4.2 
million lives yearly, whereas 1.3 million people die annually as a result of diabetes 
(Lim et al., 2012; WHO, 2014). 
Furthermore, WHO (2005) highlighted that CVDs transcend socioeconomic, gender, 
and geographical boundaries. It has been reported that ≥80% of CVD deaths occur in 
low-and-middle-income countries and the distribution is almost equal in men and 
women (WHO, 2013b). For instance, the incidence of ischemic heart disease (IHD) in 
the Western World is rapidly declining but in Eastern Europe and the Indian 
subcontinent, incidence of the disease is rising (Bloomfield et al., 2006). In the work 
of Deaton et al., (2011), the authors highlighted that even in developing countries 
where the prevalence of CVDs is high, greater burden of the diseases occur in the 
lower socio-economic group. This signals a shift in the epidemic of CVDs, hence, 
prompting the need for reliable, cost-effective, and innovative approaches to apply 
what is already known about these diseases in the developed countries to the 
developing countries.  
The key risk factors of CVDs include: hypertension (high blood pressure), physical 
inactivity, tobacco smoking, diabetes mellitus, unhealthy diet, family history of CVDs, 
hyperlipidaemia (high blood lipids), obesity, poverty, hereditary factors, demographic 
characteristics, age, sex, and haemostatic factors (Zipes et al., 2005; Bloomfield et al., 
2006; Longmore et al., 2010; Newby et al., 2010; Neylon et al., 2013; WHO, 2013b; 
World Heart Federation, 2015).  
Significant gaps exist in what is known about CVDs and their risk factors in LMICs 
either due to inadequate data or paucity of information on regional variations in 
cardiovascular diseases incidence, prevalence and/or mortality in these countries 
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(Gupta, 2011; Kandala et al., 2013). There is therefore a need to conduct 
epidemiological studies that will provide an insight into the geographic variation of 
the risk factors of CVDs in LMICs. These studies will enable researchers to identify the 
primordial determinants of the risk factors of CVDs in these countries and also inform 
resource allocation and public health interventions. In addition, the studies would 
provide a basis for replicating studies/surveys that are conducted elsewhere, such as 
the British Regional Heart Study (BRHS) (Walker et al., 2004), Cardiovascular Risk 
Factor Multiple Evaluation in Latin America Study (CARMELA) (Schargrodsky et al., 
2008), International collaborative study of cardiovascular disease in Asia (InterASIA) 
(He et al., 2004), the Prospective Urban-Rural Epidemiological Study (PURE) (Teo et 
al., 2009) in many of the LMICs.  
This research will focus on examining the geographical variation of the major risk 
factor for CVDs (hypertension) and its associated determinants in selected low-and 
middle-income countries which are spread across Sub-Saharan Africa, Eastern 
Europe, and the Indian sub-continent. 
1.2 BACKGROUND 
1.2.1 DEFINITION OF THE HEALTH PROBLEM - HYPERTENSION 
Hypertension (high blood pressure) is a chronic condition in which blood vessels 
(arteries) have persistent raised pressure generated by the force of blood pushing 
against the artery walls as it is pumped by the heart (Newby et al., 2010; WHO, 
2013a). High blood pressure increases the risk of damage to the heart and blood 
vessels in organs such as the kidneys and brain, which leads to heart diseases, stroke, 
kidney failure, cognitive impairment and other co-morbidities (Kearney et al., 2005; 
Addo et al., 2007). 
Blood pressure occurs within a continuous range, therefore cut off levels are usually 
defined according to the amount of risk they pose to patients (Newby et al., 2010). 
According to the National Institute for Health and Care Excellence (NICE) (2011a), 
there is no natural cut off point above or below which hypertension exists. Newby et 
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al., (2010) further postulated that high blood pressure is not a specific disease, but 
rather a trait that represents quantitative rather than qualitative deviation from the 
norm, therefore any definition of hypertension is arbitrary. 
However, in this research many definitions and classifications of hypertension have 
been considered including that of the British Hypertension Society (BHS), World 
Health Organisation-International Society of Hypertension (1999), European Society 
of Hypertension-European Society of Cardiology (2003), and the Sixth and Seventh 
report of the United States of Americas’ Joint National Committee on Prevention, 
Detection, Evaluation, and treatment of High Blood Pressure (JNC) in 1997 and 2003 
respectively (Chobanian et al., 2003) which are presented in the table below: 
Table 1.1: Classification of blood pressure levels 
Category Systolic Blood 
Pressure (SBP) 
(mmHg) 
Diastolic Blood 
Pressure (DBP 
(mmHg) 
Blood Pressure 
Optimal                     <120           and        <80 
Normal                      <130          and        <85 
High-normal                    130-139        or         85-89 
Hypertension 
Level 1 (mild)                    140-159        or         90-99 
Level 2 (moderate)                    160-179        or       100-109 
Level 3 (severe)                      ≥180          and         ≥110 
Isolated Systolic hypertension 
Level 1                    140-159      and          <90 
Level 2                      ≥160          and          <90 
Source: Williams, et al., (2004)  
For the purpose of this research, the definition of hypertension adopted is blood 
pressure of ≥140 /90 mmHg (SBP/DBP), self-reported physician diagnosis of 
hypertension, or being on anti-hypertensive medication- which is also in line with the 
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definitions adopted by Carretero & Oparil (2000), Kearney et al., (2005) and WHO 
(2013a).  
1.2.2 THE GLOBAL EPIDEMIOLOGY AND ASSOCIATED BURDEN OF 
HYPERTENSION 
WHO (2013a) reported that 1 in 3 adults around the world have high blood pressure. 
However, extensive diagnosis and cost-effective treatments have led to better 
management and prevention of hypertension sequels in developed countries which 
also contributed significantly to the reduction of deaths from heart diseases and 
disability from stroke (WHO, 2011a). On the contrary, a lot of people with 
hypertension in developing countries are undiagnosed and therefore risk missing out 
on treatments that could reduce death from heart diseases and disability from stroke 
and other form of cardiovascular morbidities (Ibrahim & Damasceno, 2012) 
Hypertension is widely recognized as a chronic non-communicable disease and it is 
dubbed by many researchers as a ‘silent killer’ partly due to its associated high 
mortality rates and its asymptomatic presentation (Kearney et al., 2005; Ma et al., 
2013). It has been established that hypertension is the major risk factor for mortality 
and the third leading cause of disability-adjusted life-years (DALYs) worldwide (Ezzati 
et al., 2002; Hendricks et al., 2012).  
Specifically, hypertension is estimated to cause over 7 million premature deaths, 
about 12.8% of all deaths globally and this accounts for 57 million disability adjusted 
life years (DALYs) (WHO, 2016a). In other words, hypertension accounts for the loss 
of the equivalent of 57 million years of full health. 
Hypertension may portend a considerable impact on the global incidence of 
cardiovascular disease, given that the disease it is the single most important risk 
factor for stroke and coronary heart disease, accounting for about 54% and 47% of 
cases respectively (Lawes et al., 2008; WHO, 2016a). Hence, hypertension is 
potentially among the major drivers of cardiovascular diseases- the major cause of 
mortality worldwide (WHO, 2016a). Few studies have explored the relationship 
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between elevated blood pressure and life expectancy in adults. Of note, Franco et al. 
(2005), in a secondary data analysis examined the life expectancy at 50 years of 3128 
men and women with high blood pressure, as compared to normotensive men and 
women from the Framingham Heart Study. The findings revealed that the 
normotensives lived slightly longer than the hypertensives (5.1 years versus 4.9 
years). 
In the past two decades, the prevalence of hypertension has been higher in low-and 
middle-income countries compared to high-income countries, and continue to 
increase rapidly. For instance, in the year 2000, there were approximately twice as 
many people with hypertension in low-and middle-income countries, compared to 
high-income countries (639 million versus 333 million) (Kearney et al., 2005). 
Projections at that time estimated a 60% increase in global hypertension prevalence 
by the year 2025, which would be driven by a considerably larger increase in 
hypertension prevalence in low-and middle-income countries (80% versus 24%) 
(Kearney et al., 2005). Figure 1.1 below is a graphical illustration of the prevalence of 
hypertension across country income groups and geographical regions based on 
estimates for the year 2008. In addition, about one billion people were living with 
hypertension worldwide during this time, which represented a 40% increase from 
600 million affected people in the year 1980 (WHO, 2013d). As shown, the increase in 
hypertension prevalence during this period was driven by estimates from low-and 
middle-income countries. 
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Figure 1.1: Prevalence of hypertension in WHO regions. Source: World Health 
Organisation (2013b) 
With regards to the prevalence of high blood pressure across the WHO regions, the 
African region (AFR) had the highest prevalence with 46% for both sexes, followed by 
the Eastern Mediterranean (EMR) and European (EUR) regions with prevalence 
slightly above 40% for both sexes, whereas the Americas (AMR) region had the 
lowest prevalence of 35% for both sexes. Of note, the prevalence of hypertension 
higher among men than women across all the regions, however caution must be 
applied in interpreting these figures, given that the observed sex differences in 
hypertension prevalence were only statistically significant in the European and 
American regions (WHO, 2013d). 
The WHO in its 2014 Global Status Report on non-communicable Diseases stipulated 
that the global prevalence of hypertension in adults 18 years and above was 
estimated at 22%. Furthermore, the WHO highlighted that, the prevalence of 
hypertension remained highest in the African region at 30% for all adults and lowest 
in the Americas at 18%. In addition, the prevalence of high blood pressure by country 
income group was highest in low-income countries compared to the middle-income 
and high-income countries (WHO, 2014). These variations in estimate from 2008 to 
2014 indicate a shift in prevalence among WHO regions and World Bank income 
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group in which the African region and low-income countries have the highest 
prevalence estimates of hypertension.  
1.2.3 RISK FACTORS FOR HYPERTENSION AND THEIR RELEVANCE TO LOW-
AND MIDDLE-INCOME COUNTRIES 
Findings from several literature sources have ascribed the increase of the 
hypertension epidemic in low-and middle-income countries to the following factors: 
ageing of the population, lifestyle factors (such as smoking, alcohol, physical 
inactivity, poor dietary habits), socioeconomic determinants (which include wealth, 
education, household income, and occupational grade), psychosocial factors (such as 
stress and job strain), medication adherence, and environmental factors (such as 
urbanisation, pollution, and overcrowding e.t.c). (Messerli et al., 1981; Koplan & 
Dietz, 1999; Lewington et al., 2002; Gascon et al., 2004; Stranges et al., 2004; Ezzati 
et al., 2006; WHO, 2013d;2013e; Murphy et al., 2016; UNFPA, 2016; World Heart 
Federation, 2016).  
1.2.3.1 AGEING POPULATIONS 
Blood pressure increases with age, and the age-related changes in blood pressure are 
associated with a temporal relationship between ageing and hypertension. For 
instance, Vasan et al. (2002), in a population-based cohort study, revealed a 90% 
incidence of hypertension in middle-aged men and women who were previously 
normotensive. One of the biological mechanisms for the age-related increase in 
blood pressure is explained by the progressive loss of the elastic properties of blood 
vessels with ageing, which lead to stiffening of the blood vessels and loss of blood 
pressure regulation. 
For more than three decades, it has been widely documented that increasing age is 
the most consistent independent predictor of hypertension prevalence in low-and 
middle-income countries (Messerli et al., 1981; Landahl et al., 1986).  The average 
life-expectancy in low-and middle-income countries increased from 47 years in 1960 
to 70 years in 2014 (World Bank, 2016). In other words, the resident populations in 
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low-and middle-income countries are, on the average, 23 years older today than they 
were five decades ago. Of note, this increase in average life-expectancy (in low-and 
middle-income countries) is much steeper than the 13-year increase (68 years to 81 
years) observed in high-income countries during the same period (World Bank, 2016). 
Therefore, ageing populations may play an important role in the on-going epidemic 
of hypertension in low-and middle-income countries. 
1.2.3.2 LIFESTYLE FACTORS 
Lifestyle or behavioural factors increase the risk of developing hypertension. Of note, 
these factors include unhealthy dietary patterns, physical inactivity, tobacco use, and 
harmful use of alcohol (WHO, 2013d). Lifestyle factors may interact with ageing in 
improving the prediction of hypertension, as the latter often accompanies a more 
prolonged exposure to the former.  
Poor dietary behaviours may reflect patterns influenced by social and physical 
environments (Reddy & Katan, 2004). For instance, the nutritional transition that has 
accompanied the urbanization of low- and middle-income countries presents an 
increased substitution of plant-based foods for fast foods that tend to be 
disproportionately high in sodium and saturated fats. Sodium increases blood 
pressure by causing the body to retain fluids while constricting the arteries (Zheng et 
al. 2014). Consumption of saturated fats increases the formation of atheromatous 
plaques, which reduces the calibre of blood vessels, so that the pressure of blood 
flow along affected vessels is increased. Furthermore, the WHO (2016) affirms that 
low- and middle-income countries are witnessing the fastest rise in childhood obesity 
across the world. And although based on evidence from high-income populations, 
26% of obese children develop hypertension as adults compared to 6% of normal-
weight children (Watson et al., 2013). This piece of evidence is important within the 
context of developing economies, which grow at faster rates than developed 
countries, and provide an enabling environment for the aggressive marketing of fast 
foods (World Heart Federation, 2016).  
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Physical inactivity is an independent risk factor for cardiovascular diseases (Koplan & 
Dietz, 1999). Generally, physical activity increases blood flow to the endocrine 
organs, which leads to the release of natural hormones and cytokines that relax 
blood vessels and lower blood pressure (Koplan & Dietz, 1999).  The WHO (2016b) 
reports that an estimated 3.2 million deaths each year are attributable to insufficient 
physical activity as nearly one-third of adults aged 15 and above are insufficiently 
active (28% of males and 34% of females). Interestingly, rapid dramatic reductions in 
physical activity are also occurring in low- and middle-income countries (Swinburn et 
al. 2004). The current levels of physical inactivity in low- and middle-income countries 
are partly due to increasing sedentary lifestyle in occupational activities, given rapid 
technological changes and industrialization that potentially transform the various 
sectors of developing economies. The current levels of physical activity in low- and 
middle-income countries may also be explained by increasing motorisation of 
transportation, which continue to replace walking and bicycle riding in urban cities. In 
China, for instance, car owners were 80% more likely to be hypertensive, compared 
to people who walk or use bicycles (Hu & Willet, 2002).  
Tobacco use is the most preventable cause of cardiovascular mortality worldwide 
with majority of the world’s cigarette smokers (1.3 billion about a decade ago) 
resident in low- and middle-income countries (Teo et al. 2006). The relationship 
between tobacco use and hypertension has been widely documented. The harmful 
effects of tobacco on health include fatty build-ups in arteries (atherosclerosis), 
impairment of endothelial function, arterial stiffness, increasing heart rate, and 
increasing myocardial contractility, all of which increase blood pressure (Najem et al. 
2006; Rosen et al. 2006; Jatoi et al. 2007; Virdis et al. 2010). In a study conducted to 
evaluate the association between cigarette smoking and hypertension among 28,000 
normotensive women, Browan et al. (2007) found that cigarette smoking was 
modestly associated with an increased risk of developing hypertension, and the 
association was strongest among women who smoked 15 cigarettes per day or more. 
Harmful consumption of alcohol increases blood pressure and significantly increases 
the risk of developing hypertension in the future (Alcohol Concern, 2015). Essentially, 
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alcohol consumption is associated with weight gain, which in turn, is associated with 
increased blood pressure. Several epidemiological studies have demonstrated a 
plausible dose-response relationship between the amount of alcohol consumed and 
the risk of hypertension. For instance, in a meta-analysis of observational studies, the 
pooled risk of developing hypertension was higher among men who consumed more 
than 50g/day of alcohol (RR 1.61, 95% CI 1.38-1.87), compared to men who 
consumed less (RR 1.03, 95% CI 0.94-1.13) (Briasoulis et al., 2012). Similarly, the 
pooled risk of hypertension was slightly increased among women who consumed 
more than 30g/day of alcohol (RR 1.19, 95% CI 1.07-1.32), but not among women 
who consumed less (RR 0.87, 95% CI 0.82-0.92) (Briasoulis et al., 2012). In addition, 
Stranges et al. (2004) found that the odds of developing hypertension were 
significantly higher among persons who consumed more than 2 drinks per day, 
compared to those who consumed less than 2 drinks per day (OR 1.75, 95% CI 1.13-
2.72). Unfortunately, these findings are based on evidence from high-income 
countries, given the dearth of published data on the dose-response relationship 
between alcohol consumption and hypertension risk in low- and middle-income 
countries. Nonetheless, harmful alcohol consumption remains a public health 
problem in low- and middle-income countries. A considerable proportion of people 
resident in low- and middle-income countries live in poverty with reduced social 
support, which have consequences for mental health issues, and invite alcohol abuse 
as a coping mechanism for stress relief. In Brazil, for instance, more than three-
quarters of street children are heavy drinkers (WHO, 2004). This portends a greater 
risk of developing hypertension and cardiovascular health outcomes in their later 
adulthood. 
1.2.3.3 PSYCHOSOCIAL FACTORS 
Psychosocial factors comprise of stress and strain among populations. Stress and 
strain are plausible causes of hypertension when combined with other factors 
(Sparrenberger et al. 2009). The most common psychosocial factors in low-and 
middle-income countries are job strain (Babu et al. 2013) and emotional distress 
(Brosschot et al. 2005). The mechanism underlying the stress-hypertension 
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relationship involves stimulation of the nervous system to produce large amounts of 
catecholamines that leads to increased blood pressure (Kulkarni et al. 1998; McEwen, 
1998; Spruill, 2010). However, the process by which stress contribute to sustained 
raised blood pressure over time is still being investigated, possible reasons include 
the repeated activation of this system, failure to return to resting levels following 
stressful events, and failure to adapt to repeated stressors for the development of 
hypertension (McEwen, 1998).  
Job strain on the other hand is characterised by a combination of high workload and 
few decision-making opportunities in the workplace. Babu et al. (2013) conducted a 
systematic review and meta-analysis comprising over 25,000 workers to determine 
the relationship between job strain and hypertension and found a statistically 
significant association (OR 1.29 95% CI 1.14 – 1.47). Again, the included studies were 
largely from high-income countries, given the dearth of relevant studies from low- 
and middle-income countries. Nonetheless, high strain jobs are typically associated 
with lower occupational grades, which are speculated to be more prevalent in low- 
and middle-income countries, compared to high-income countries. 
1.2.3.4 MEDICATION ADHERENCE 
Given the chronicity of hypertension, it is not unexpected that sub-optimal 
adherence to antihypertensive medication constitutes an important public health 
problem in the treatment and control of hypertension, especially in low- and middle-
income countries, where access to these medications are limited by health systems in 
which patients finance the costs of their health care. A recent systematic review and 
meta-analysis comprising 92,443 adults in low- and middle-income countries 
revealed that approximately two-thirds of hypertensive patients do not adhere to 
their medications (pooled percentage 63.35%; 95% CI 38.78 - 87.91) (Nielsen et al. 
2016). It is worthy to note that, factors contributing to non-adherence in the study 
were largely related to socio-economic factors. 
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1.2.3.5 ENVIRONMENTAL FACTORS 
Environmental factors that affect the development of hypertension in low- and 
middle-income countries include overcrowding and pollution: common aftermaths of 
rapid urbanisation. 
Rapid urbanisation refers to the accelerated increase in the proportion of people 
living in urban areas and the ways in which societies cope (Godfrey & Julien, 2005). 
The United Nations projected that by the year 2050, about 64% of populations in the 
developing regions of the world would be living in urban areas, with many cities in 
this region such as Jakarta (Indonesia), Manila (Philippines), Mumbai (India), Cairo 
(Egypt), and Lagos (Nigeria) already having an estimated population of 20 million 
each (UNFPA, 2016). In low- and middle-income countries, rapid urbanisation does 
not necessarily translate to increase in life expectancy (Eckert & Kohler, 2014), but 
contributes to shifts in disease burden (Godfrey & Julien, 2005; Allender et al. 2008; 
Eckert & Kohler, 2014). In these countries, the negative effects of urbanisation are 
more common among the urban poor as they grapple with health inequalities, 
extreme poverty, vulnerability, and marginalization (UNFPA, 2016).  
Overcrowding or housing instability on the hand is a plausible independent 
environmental risk factor for hypertension (D’Atri & Ostfeld, 1975; Seedat et al., 
1982). An explanation of the link between overcrowding and hypertension is that the 
latter leads to psychological distress, and strained relationships even within 
households (emotional distress) among other factors which eventually lead to 
hypertension (Kopko, 2016). 
Another important environmental risk factor that affects the development of 
hypertension is pollution. Several types of pollution have been linked with 
hypertension particularly noise pollution (Zawilla et al. 2014), air pollution (Chan et 
al. 2015), and oil pollution (Ezejimofor et al. 2016). There are a number of 
epidemiological studies that have shown an association between occupational and 
environmental noise exposure and hypertension. van Kempen et al. (2002) 
conducted a meta-analysis of 43 epidemiologic studies published between 1970 and 
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1999 that investigated the relation between occupational and community noise 
exposure and blood pressure and/or ischemic heart disease. They found a significant 
associations of occupational (RR 1.14; 95% CI: 1.01–1.29) and traffic noise exposure 
(RR 1.26; 95% CI: 1.14–1.39) with increased hypertension risk (van Kempen et al., 
2002). Regarding oil pollution, Ezejimofor et al. (2016) conducted a comparative 
cross-sectional study among over 2,000 residents of the Niger-Delta oil-producing 
region of Nigeria, stratified by areas of residence (polluted and non-polluted 
communities). The findings of the study revealed that the adjusted odds of 
developing hypertension were approximately five-folds higher among participants 
living in oil-polluted communities, compared to participants living in non-oil polluted 
communities (aOR 4.85, 95% CI 1.84-12.82). 
1.2.3.6 SOCIAL DETERMINANTS 
Social determinants of health are characterised by wealth, education, household 
income, social support, culture, accessibility to health care, psychosocial factors, and 
residential environments (Clark et al. 2009; Havranek et al. 2015). These factors 
determine the conditions in which individuals are born, raised, live, work, and age, as 
well as the mechanisms put in place to deal with their ill health (Marmot et al. 2008). 
Disparities in these living conditions lead to varying health status among individuals 
or populations - health inequalities (Arcaya et al. 2015). At the centre of these 
differences lies an individual’s socioeconomic status (SES) where ― in its most 
simplistic definition ― refers to the standing of an individual in a community with 
respect to education, wealth, and profession. Hence, a person of low SES is described 
as one with little or no formal education, belonging to a lower wealth quintile, or 
having lower occupational grades. In all countries, individuals of low SES suffer health 
disadvantage while persons with higher SES tend to have better health (Marmot, 
2005). In other words, there is a social gradient in health across and within 
populations. 
Although the mechanisms involved are not clear-cut, they are speculated to include 
poorer lifestyle, adverse living conditions, psychosocial stress, occupational strain, 
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and limited access to health care resources. The latter is particularly important within 
the context of low- and middle-income countries where people living in these 
settings tend to pay out of-pocket for health care (Murphy et al. 2016).  
Epidemiological studies conducted in low- and middle-income countries have 
consistently demonstrated the graded association between socioeconomic factors 
and hypertension risk. For instance, studies show inverse associations of the number 
of years of formal education completed (Albert et al. 2006; Wen-Hui et al. 2013), 
occupational grade (Clark et al. 2009) and house-hold income (Harhay et al. 2013) 
with hypertension prevalence. 
In addition, there is epidemiological evidence of the impact of urbanisation on the 
rising prevalence of hypertension across low- and middle-income countries. For 
example, studies show higher prevalence estimates of hypertension among urban 
settlers in low- and middle-income countries, compared to rural settlers (Midha et al. 
2009). Similarly, prevalence estimates of hypertension tend to be higher in upper 
middle-income countries, compared to the less advanced lower middle-income and 
low income countries (Addo et al. 2007).  
The hypothesized mechanisms of the association between social determinants and 
hypertension and their relationships with other risk factors of hypertension are 
illustrated in Figure 1.2 (page 19). 
1.3 EPIDEMIOLOGICAL TRANSITION 
This is a theory proposed by Omran in 1971 that focuses on the complex changes in 
the pattern of health and diseases and their interactions with economic, social, and 
demographic determinants as they affect populations (Omran, 1971; 1979). In 
essence, the theory is concerned with the constant patterns of changes in the 
primary causes of morbidity and mortality as societies develop. Omran (2005) posits 
that in many high-income countries, epidemiological transition has paralleled 
demographic and technological transitions and it is advancing in many low-and 
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middle-income countries because degenerative and man-made diseases are gradually 
displacing communicable diseases as the primary causes of deaths.  
It is also imperative to highlight that epidemiological transition is associated with 
demographic and nutritional transitions (Popkin & Gordon-Larsen, 2004; Amuna & 
Zotor, 2008). The demographic transition describes a change in population dynamics 
highlighting the relationship between mortality and birth rate (Amuna & Zotor, 
2008). On the other hand, nutritional transition implies a shift in pattern of diet and 
physical activity by populations which includes consumption of unhealthy foods 
(containing high levels of salt, sugar, and fat, with large intakes of “empty calories”) 
as well as lack of regular physical activities (Popkin & Gordon-Larsen, 2004). 
As stated earlier, the focus of this research is on examining the major primary risk 
factor for CVDs (hypertension) and its determinants in some selected low-and 
middle-income countries. Therefore, it will be important to underline the stages of 
epidemiological transition as they relate to CVDs so as to determine where LMICs lie. 
A summary can be found on the following page. 
Table 1.1: Modified model of the stages of epidemiologic transition in relation to 
cardiovascular diseases 
Stages of Development Deaths from CVD, 
% of Total Deaths 
Predominant CVDs and 
Risk Factors 
Regional Examples 
 
Age of pestilence and 
famine 
 
5-10 
Rheumatic heart disease, 
infections, and 
nutritional 
cardiomyopathies 
Sub-Saharan Africa, rural 
India, South America 
 
Age of receding 
pandemics 
 
10-35 
Same as above and 
hypertensive heart 
disease and 
haemorrhagic strokes 
 
China 
 
Age of degenerative 
diseases 
 
35-65 
All forms of strokes, 
ischemic heart disease at 
young ages, increasing 
obesity and diabetes 
Urban India, former 
socialist economies, 
aboriginal communities 
Age of delayed 
degenerative diseases 
 
<50 
Stroke and ischemic 
heart disease at old age 
Western Europe, North 
America, Australia, New 
Zealand 
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Age of health regression 
and social upheaval 
 
35-55 
Re-emergence of deaths 
from rheumatic heart 
disease, infections, 
increased alcoholism, 
and violence; increase in 
ischemic and 
hypertensive diseases in 
the young 
 
Russia 
Source: Yusuf et al., (2001) 
From the table above, it can be understood that most of the countries of interest to 
this research (Albania, Armenia, Azerbaijan, Egypt, Lesotho, Maldives, Morocco, 
Senegal, Ukraine, and Uzbekistan) are within the first three stages of the 
epidemiological transition of CVDs. 
1.4 STUDY JUSTIFICATION 
Hypertension is chosen as the health outcome of interest in this research because of 
its increasing prevalence in almost every part of the world particularly in low-and 
middle-income countries. Furthermore, the on-going epidemiological transition 
which is accompanied by demographic and nutritional transitions in these settings 
added to the interest of undertaking this research.   
As highlighted in many research articles, low-and middle-income countries have weak 
health infrastructure and limited resources allocated to health care, while they are 
still struggling with the burden of infectious diseases such as HIV/AIDS, tuberculosis, 
measles, cholera, polio, and haemorrhagic viral infections. Therefore, with high 
prevalence of chronic non-communicable diseases such as ‘hypertension’, the health 
settings in these countries will have to deal with multiple burdens of diseases and 
health outcomes.  
In many of these countries, though, infectious diseases are to a larger extent under 
control through the concerted effort and support from the global community, 
particularly developed countries such as USA, UK, Canada, Germany, Netherlands, 
Japan and international organisations such as WHO, UNICEF, World Bank, Global 
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Fund as well as other philanthropic organisations such as the Bill & Melinda Gates 
Foundation and MacArthur Foundation.  
However, unless the social determinants and primordial risk factors of chronic 
diseases such as ‘hypertension’ are understood, identified, and acted upon within the 
context of low-resource settings, economic and social development in these 
countries will be hampered, and indirectly, the burden is going to shift to developed 
countries which at present are also facing economic challenges. Another important 
issue of concern, is that many governments and public health planners of developing 
countries still remain largely unaware of the current magnitude of certain conditions 
such as ‘hypertension’ and its serious complications in their own countries. 
It is on this note that research on chronic diseases prevention and control need to 
focus on generating country-specific information about risk factors of chronic 
diseases such as ‘hypertension’, the burden of these diseases, as well as impact of 
globalization and urbanization on behaviours of the population so as to make 
compelling arguments to leaders of the low-and middle-income settings for 
prioritizing chronic diseases prevention and control on their development agenda. 
This study will play a major role towards understanding the prevalence and 
identifying the leading risk factors of hypertension in the countries investigated as 
well as enabling cross-comparisons of the findings between countries in the same 
region (e.g. Lesotho and Senegal- which are all located in sub-Saharan Africa) or 
between countries in different regions (e.g. Albania and Maldives- which are located 
in Eastern Europe and the Indian sub-continent respectively) so as to provide 
evidence that will inform potential interventions in these countries. 
The study will also inform public health policy, resource allocation, and provide 
platforms for cost-effective monitoring of trends of hypertension as they occur even 
at smaller geographic scales within the countries explored and other low-and middle-
income countries sharing similar geographical characteristics. The study might also 
help inform the design of cost-effective interventions to address the burden of 
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hypertension across these countries, which will be tailored to the specific needs of 
the selected populations. 
1.5 RESEARCH QUESTIONS 
a) What is the status of hypertension in low-and middle-income countries? 
b) What is the prevalence and geographic variation of hypertension in Albania, 
Armenia, Azerbaijan, Egypt, Lesotho, Maldives, Morocco, Senegal, Ukraine, 
and Uzbekistan? 
c) What are the risk-factors underlying the geographic variation of hypertension 
in these countries? 
1.6 RESEARCH HYPOTHESES 
I. There is a significant geographical variation in hypertension prevalence across 
selected low- and middle-income countries. 
II. There is a significant difference in hypertension prevalence among 
populations residing in low- and middle-income countries with respect to: 
a) Ageing of the population (Messerli et al., 1981; Lewington et al., 2002) 
b) Environmental factors (urbanisation, overcrowding, and pollution) 
(D’Atri & Ostfeld, 1975; Seedat et al., 1982; Zawilla et al. 2014) 
c) Lifestyle factors [Smoking status (current smokers vs non-smokers); 
Alcohol drinking status (current drinkers vs non-drinkers), physical 
inactivity, and unhealthy dietary patterns] (Reddy & Katan, 2004; Teo 
et al. 2006; Mungal-Singh, 2012; Baan et al. 2007) 
d) Socioeconomic factors (educational attainment, wealth status, and 
household income) (Clark et al. 2009; Wen-Hui et al. 2013; Murphy et 
al. 2016) 
e) Psychosocial factors (stress, job strain) (Sparrenberger et al. 2009; 
Babu et al. 2013)  
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f) Medication adherence (optimal vs sub-optimal) (Gascon et al., 2004; 
Krousel-Wood et al., 2009; Nielsen et al. 2016) 
The mechanisms in which these hypotheses are related with hypertension as well as 
their interrelationships are illustrated in Figure 1.2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dotted lines represents interrelationships between the factors; solid lines represents relationships 
between the risk factors and hypertension 
Figure 1.2: The hypothesized mechanisms of the relationship between hypertension 
and its risk factors 
From Figure 1.2 above, it can be observed that all the factors (age, medication 
adherence, socio-economic, lifestyle, psychosocial, and environmental factors) are 
directly associated with hypertension. In addition, socio-economic factors are related 
to other factors including lifestyle factors, psychosocial factors, environmental 
factors, and medication adherence. Similarly, psychosocial factors and lifestyle 
factors are associated. This is due to the explanation provided on page 11 that 
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individuals that are exposed to emotional stress or job strain often tend to use 
smoking or alcohol as coping mechanisms as opposed to seeking medical 
interventions. Likewise, environmental factors which result from the aftermath of 
urbanisation such as overcrowding and pollution are associated with psychosocial 
factors as explained in pages 11-12. 
1.7 AIM OF THE RESEARCH 
The overall aim of this research is to examine the prevalence and status of 
hypertension in low- and middle-income countries.  
1.7.1 OBJECTIVES 
The objectives for this research are: 
 To conduct a systematic review and meta-analysis on the prevalence of 
hypertension in low-and middle-income countries  
 To examine the geographic variation of hypertension in low-and middle-
income countries by analysing geographical patterns in hypertension 
prevalence across and within these countries using existing data from the 
Demographic and Health Surveys (DHS) datasets.  
 To determine the potential influence of a wide range of traditional and 
emerging risk factors for hypertension in these countries, including socio-
demographic and major lifestyle characteristics. 
 To discuss the findings and their implications for practice/policy and future 
research.  
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1.8 STUDY SETTING 
The study settings for this research are a number of low-and-middle income 
countries (LMICs). The World Bank (2015a) often refers to LMICs as developing 
economies or developing countries, however, the Bank cautioned that countries that 
fall under this category are not necessary on the same pace of development nor have 
they reached their final stage of development, hence, the need to understand the 
term and its application. 
The International Monetary Fund (IMF) (2009) in its country composition of the 
regions highlighted that countries belonging to this category span from many regions 
of the world, including sub-Saharan and North Africa, South, West, and Central Asia, 
North and South America, the Caribbean, North and Eastern Europe. 
In terms of the economics, World Bank (2015a) stated that countries are divided 
according to Gross National Income (GNI) per capita, calculated using the World Bank 
Atlas Method. The groups are: low income, $1,045 or less; lower middle income, 
>$1,046 - $4,125; upper middle income, >$4,126 - $12,745; and high income, $12,746 
or more.  
As stated above, this research seeks to examine the geographical variation of 
hypertension and its associated risk factors in some selected LMICs (i.e. Albania, 
Armenia, Azerbaijan, Egypt, Lesotho, Maldives, Morocco, Senegal, Ukraine, and 
Uzbekistan).  
1.9 RATIONALE FOR SELECTING THE COUNTRIES INCLUDED IN ANALYSIS 
Selection of these countries is driven mainly by the availability of data on 
hypertension in the Demographic Health Survey datasets and fortuitously the 
countries selected spread across North, South, and West Africa, Eastern Europe, and 
the Indian sub-continent. It is worthy to note that these countries reflect a range of 
different socio-cultural and economic contexts and they also have different patterns 
of diseases and risk factors. Furthermore, these countries are at different stages of 
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the on-going epidemiological transition; therefore, applying the novel techniques of 
disease mapping will help us understand the different patterns of hypertension 
burden and aetiology as well as the geographical variation of the disease in these 
countries. 
1.10 OVERVIEW OF THE THESIS STRUCTURE 
This thesis comprises six chapters. 
Chapter One sets the stage for the thesis by providing the background of NCDs, 
hypertension (its epidemiology and risk factors), epidemiological transition, study 
justification, research questions, aims & objectives, study settings, the rationale for 
selecting the countries explored in the thesis. 
Chapter Two discusses the socio-demographic profile of the ten countries included in 
the thesis (Albania, Armenia, Azerbaijan, Egypt, Lesotho, Maldives, Morocco, Senegal, 
Ukraine, and Uzbekistan). 
Chapter Three presents the methods employed in producing the thesis, including a 
systematic review and meta-analysis and secondary data analyses of DHS datasets.  
Chapter Four presents the results of the systematic review and meta-analysis and 
secondary data analyses. 
Chapter Five discusses the findings of the systematic review and secondary analyses, 
their limitations and strengths, and their implications for practice, policy and future 
research.  
Chapter Six summarizes the findings and provides concluding remarks. 
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CHAPTER TWO: SOCIO-DEMOGRAPHIC 
PROFILE OF INCLUDED COUNTRIES 
This chapter will present the socio-demographic profile of the ten countries (Albania, 
Armenia, Azerbaijan, Egypt, Lesotho, Maldives, Morocco, Senegal, Ukraine, and 
Uzbekistan) which will be explored in this research. The socio-demographic profiles of 
these countries will provide information on the geography, population, age structure, 
birth and death rates, under-five mortality, maternal mortality, top causes of 
mortality, disability adjusted life years (DALYs) and economic indices. The socio-
demographic differences across the selected countries and their implications for 
hypertension prevalence will also be highlighted. 
2.1 ALBANIA  
The Republic of Albania is a country located on the Balkan Peninsula in South-Eastern 
Europe. It has a surface area of 28,748 square kilometres (km2). It shares a border 
with Montenegro to the North-West, Kosovo to the North-East, Macedonia to the 
North and East, and Greece to the South and South-East. The country’s coastline is 
487 km long.  The climate is considered a continental climate characterized by cold 
winters and hot summers (Central Intelligence Agency, 2016a). Albania has 12 
counties, including its capital Tirana. Below is a map of Albania and its neighbouring 
countries. 
 
Figure 2.1: Map of Albania, showing the countries it shares borders with. Source: 
Operation World (2015) 
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Albania has a population of 3,038,594 (2016 estimate) with a density of about 110 
people per km2. The annual population growth rate is 0.3% (2016 estimate) (World 
Bank, 2015b). The average life expectancy at birth is 78.3 years (male 75.7 years; 
female 81.2 years) (2016 estimate) (Central Intelligence Agency, 2016a). Life 
expectancy is higher in urban areas than in rural areas: men and women in urban 
areas live approximately 3 years longer than their counterparts in rural areas. More 
than 98% of the resident population are ethnic Albanians with small groups of 
Greeks, Macedonians, Vlachs, Bulgarians and Serbs (Institute of Statistics, 2008). 
The birth and death rates for Albanians is 13.1 births/1,000 population and 6.7 
deaths/1,000 population respectively (2016 estimate). The Infant mortality rate is 
estimated at 12.3 deaths/1,000 live births. Maternal mortality rate is at 29 
deaths/100,000 live births (WHO, 2015a). Albanians have a median age of 32.5 years 
(male 31.2 years; female 33.8 years) (2016 estimate). The age structure of the 
country is presented in the population pyramid in Figure 2.2. 
 
Figure 2.1.2: Albania population pyramid (2016 estimate). Source: Central Intelligence 
Agency, (2016a) 
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From the population pyramid above, the age structure of Albania is as follows; 0-14 
years, 18.4% (male 295,022; female 263,141); 15-24 years, 18.1% (male 284,201; 
female 265,530); 25-54 years, 40.7% (male 589,707; female 648,021); 55-64 years 
11.2% (male 168,500; female 172,587); 65 years and over 11.6% (male 165,076; 
female 186,809). From the age structure, it can be understood that the 25-54-year 
age group represents the highest population in the country. Overall, men and women 
aged 0-54 years make up more than three-quarters of the total population. Table 2.1 
summarises the top causes of mortality and DALYs in Albania from the latest available 
estimates.  
Table 2.1: Summary of top causes of mortality and DALYs for Albania 
Health Outcome Top causes 
Mortality Ischaemic heart disease (25.4%); stroke (25.2%); pulmonary cancers 
(3.5%); chronic obstructive pulmonary disease (2.8%); stomach cancer 
(2.4%); hypertensive heart disease (1.8%); kidney disease (1.5%); heart 
disease of other origins (1.4%); and road traffic accidents (1.4%) 
DALYs Cardiovascular diseases and diabetes; neuro-psychiatric conditions; 
cancers; endocrine, blood and immune disorders; gastrointestinal 
diseases; genitourinary diseases; skin diseases; and congenital 
anomalies 
Source: WHO, 2016c. 
The Gross Domestic Product (GDP) of Albania (2015 estimate) is US $32.6 billion, and 
the GDP per capita is approximately US $11,900 (2015 estimate). In 2014, 
approximately 6% of the GDP was spent on health care. The income gap between the 
rich and the poor is relatively small, with Gini index of 29% (2012 estimate) (a Gini 
index of 0% represents perfect equality, whereas a Gini index of 100% represents 
perfect inequality) (World Bank, 2015b). In 2015, about 17% of the resident 
population was unemployed, and the population living below poverty line was 14%. 
The percentage of people living in urban areas is 57.4% (with an annual rate of 
urbanisation of 2.2%) (Central Intelligence Agency, 2016a). Albania is classified by the 
World Bank as an upper middle-income country (World Bank, 2015b). 
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2.2 ARMENIA 
Armenia is a landlocked mountainous country situated in the southern Caucasus 
Mountains in southwestern Asia. The country borders Georgia to the North, Iran to 
the South, Turkey to the West, and Azerbaijan to the East. The area of the country is 
29,743 km2, with more than two-thirds used for agricultural purposes. Armenia has a 
highland continental climate with cold winters and hot summers. The country is 
subdivided into 11 regions, including the region of Yerevan, which is the capital city of 
Armenia (National Statistical Service, 2011). The map of Armenia showing its 11 
regions and neighbouring countries is presented below. 
 
Figure 2.3: Map of Armenia showing 11 regions and surrounding countries. Source: 
Maps Open Source (2015a) 
Armenia has a population of 3,051,250 (2016 estimate). The average life expectancy 
at birth is 74.6 years (male 71.4 years; female 78.3 years) (2016 estimate) (Central 
Intelligence Agency, 2016b), and the resident population comprises Armenians 
(98.1%), Kurds (1.1%), and other ethnic groups (0.7%) The birth and death rates in 
Armenia is 13.3 births/1,000 population and 9.4 deaths/1,000 population respectively 
(2016 estimate). The Infant mortality rate is estimated at 13.1 deaths/1,000 live 
births, and maternal mortality rate is approximately 25 deaths/100,000 live births 
Page | 28  
 
 
(Central Intelligence Agency, 2016b; WHO, 2015b; World Bank, 2015c). Armenians 
have a median age of 34.6 years (male 32.8 years; female 36.5 years) (2016 
estimate). The age structure of Armenia is presented in the population pyramid in 
Figure 2.4. 
 
Figure 2.4: Armenia population pyramid (2016 estimate). Source: Central Intelligence 
Agency, (2016b) 
From the population pyramid above, the age structure of Armenia is as follows; 0-14 
years, 19.0% (male 308,701; female 271,028); 15-24 years, 13.6% (male 213,203; 
female 201,291); 25-54 years, 43.5% (male 640,070; female 685,958); 55-64 years 
13.0% (male 180,700; female 214,834); 65 years and over 11.0% (male 134,330; 
female 201,135). Table 2.2 summarises the top causes of mortality and DALYs in 
Armenia from the latest available estimates. 
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Table 2.2: Summary of top causes of mortality and DALYs for Armenia 
Health Outcome Top causes 
Mortality Ischaemic heart disease (36%); stroke (15%); pulmonary cancers (4.5%); 
chronic obstructive pulmonary disease (4.2%); diabetes mellitus (3.4%); 
liver cirrhosis (2.3%); hypertensive heart disease (2%); breast cancer 
(1.9%); stomach cancer (1.9%); colon and rectum cancers (1.7%) 
DALYs Cardiovascular diseases and diabetes; neuro-psychiatric conditions; 
cancers; endocrine, blood and immune disorders; and congenital 
anomalies 
Source: WHO, 2016d. 
The GDP of Armenia (2014 estimate) is US $25.3 billion, the GDP per capita is 
approximately US $8,500. In 2014, approximately 4.5% of GDP was spent on health 
care. The distribution of family income (Gini index) is 30.3 (2012 estimate), 
unemployment rate was 17.8% (2014 estimate) and the population living below 
poverty is 32% (2013 estimate). The percentage of people living in urban areas are 
estimated at 62.7% (Central Intelligence Agency, 2016b). Armenia is classified by the 
World Bank as a lower middle-income country (World Bank, 2015c). 
2.3 AZERBAIJAN 
Azerbaijan is located in the Asian part of the Eurasian continent and has a favourable 
geographic position between the Black Sea and the Caspian Sea. Historically, 
Azerbaijan extends 210,000 km2 from the Caucasus Mountains in Asia to the 
mountainous area south and southeast of Lake Urmiya. Nine of the world’s 11 
climate zones are represented in Azerbaijan; these include dry and semi-arid steppes 
in the east, subtropical climate in the Southeast, cold climate in the mountains of the 
North, and temperate climate along the shores of the Caspian Sea (Ministry of 
Education, 2006; Central Intelligence Agency, 2016c).  
The country is rich in oil and gas, iron ore, bauxite, molybdenum, mineral water, and 
other natural resources. The country consists of 66 administrative regions (Rayons), 
13 urban districts, and the Autonomous Republic of Nakhichevan. There are 70 
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towns, 239 settlements, and 4,272 rural settlements (State Statistical Committee, 
2007a). Since the early 1990s, as a result of the conflict with Armenia over Dagligh 
Garabakh, about 20 % of the land area of the country has been occupied and 
controlled by Armenia (Central Intelligence Agency, 2016c; Ministry of Education, 
2006). The map of Azerbaijan showing the 66 Rayons is presented below. 
 
Figure 2.5: Map of Azerbaijan showing its 66 Rayons. Source: Maps Open Source 
(2015b)  
Azerbaijan has a population of 9,872,765 (2016 estimate) with annual population 
growth rate of 0.92%. Approximately 54.6% of the population reside in urban areas. 
The average life expectancy at birth is 72.5 years (male 69.5 years; female 75.8 years) 
(2016 estimate) (Central Intelligence Agency, 2016c). Azerbaijan is constituted by 
91.6% Azerbaijanis, 2% Lezgians, 1.3% Russians, 1.3% Armenians (that live 
predominantly in the Nagorno-Karabakh region), 1.3% Talysh, and 2.4% of other 
ethnicities (Central Intelligence Agency, 2016c). The birth and death rates for 
Azerbaijan is 16.2 births/1,000 population and 7.1 deaths/1,000 population 
respectively (2016 estimate). The Infant mortality rate is estimated at 24.7 
deaths/1,000 live births (2016 estimate), maternal mortality rate on the other hand is 
approximately at 25 deaths/100,000 live births (2015 estimate) (WHO, 2015c; Central 
Intelligence Agency, 2016c). Azerbaijanis have a median age of 30.9 years (male 29.3 
years; female 32.6 years) (2016 estimate). The age structure of Azerbaijan as 
highlighted on the country’s population pyramid is presented below. 
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Figure 2.6: Azerbaijan population pyramid (2016 estimate). Source: Central 
Intelligence Agency, (2016c) 
From the population pyramid above, the age structure of Azerbaijan is as follows; 0-
14 years, 22.8% (male 1,204,976; female 1,047,737); 15-24 years, 15.8% 566(male 
812,537; female 744,538); 25-54 years, 45.3% (male 2,188,683; female 2,281,242); 
55-64 years 9.6% (male 439,566; female 512,118); 65 years and over 6.5% (male 
245,144; female 396,224). Table 2.3 summarises the cause of death and DALYs in 
Azerbaijan from the latest available estimates.  
Table 2.3: Summary of top causes of mortality and DALYs for Azerbaijan 
Health Outcome Top causes 
Mortality Ischaemic heart disease (32.9%); stroke (14.9%); cirrhosis of the liver 
(3.3%); lower respiratory infections (3%); hypertensive heart disease 
(2.2%); road injury (2%); preterm birth complications (2%); chronic 
obstructive pulmonary disease (1.9%); diabetes mellitus (1.9%); 
stomach cancer (1.9%) 
DALYs Cardiovascular diseases and diabetes; neuro-psychiatric conditions; 
cancers; genitourinary, and skin diseases; oral conditions; and 
congenital anomalies 
Source: WHO 2016e. 
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The GDP of Azerbaijan (2015 estimate) is US $169.4 billion, the GDP per capita is 
approximately US $18,000. Approximately 6.0% of GDP. The distribution of family 
income (Gini index) is 33.7 (2008 estimate), unemployment rate as at 2015 estimate 
was 5.3% and the population living below poverty is 6% (2012 estimate) The 
percentage of people living in urban areas are estimated to be 54.6% (Central 
Intelligence Agency, 2016c). Azerbaijan is classified by the World Bank as an upper 
middle-income country (World Bank, 2015d). 
The GDP of Armenia (2014 estimate) is US $25.3 billion, the GDP per capita is 
approximately US $8,500. In 2014, approximately 4.5% of GDP was spent on health 
care. The distribution of family income (Gini index) is 30.3 (2012 estimate), 
unemployment rate was 17.8% (2014 estimate) and the population living below 
poverty is 32% (2013 estimate). The percentage of people living in urban areas are 
estimated at 62.7% (Central Intelligence Agency, 2016b). Armenia is classified by the 
World Bank as a lower middle-income country (World Bank, 2015c). 
2.4 EGYPT 
The Arab Republic of Egypt is a country located in Northern Africa. It shares a border 
with the Mediterranean Sea to the north, Sudan to the South, the Red Sea to the 
East, and Libya to the West. Among the Arab countries in the world, Egypt has the 
largest and most densely settled population, with a total area of approximately 
1,000,000 km2 (Central Intelligence Agency, 2016d). Egypt has 27 governorates 
(administrative divisions) in which 4 governorates (Alexandria, Cairo, Suez and Port 
Said) have no rural population. The capital of Egypt is Cairo.  Egypt operates a 
republic type of government with a bicameral parliament that consists of a Shura 
Council sometimes referred to as ‘Majlis al-Shura’. This council, however functions 
mostly in a consultative role to the executive arm of government (Central Intelligence 
Agency, 2016d). 
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Figure 2.7: Map of Egypt showing the 27 Governorates. Source: FAO (2015) 
Egypt has a population of 94,666,993 (2016 estimate) with a density of about 110 
people per sq. km. The annual population growth rate is 2.51% (2016 estimate) 
(Central Intelligence Agency, 2016d). The average life expectancy at birth is 72.7 
years (male 71.4 years; female 74.2 years) (2016 estimate) (WHO, 2015d). More than 
99.6% of the population are ethnic Egyptians with other inhabitants making up the 
0.4% (Central Intelligence Agency, 2016d). The birth and death rates for Egyptians is 
30.3 births/1,000 population and 4.7 deaths/1,000 population respectively (2016 
estimate). The Infant mortality rate is estimated at 19.7 deaths/1,000 live births, 
maternal mortality rate on the other hand is approximately 33 deaths/100,000 live 
births. Egyptians have a median age of 23.8 years (male 23.5 years; female 24.1 
years) (2016 estimate) (WHO, 2015d). The age structure of Egypt is presented below. 
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Figure 2.8: Population pyramid of Egypt (2016 estimate). Source: Central Intelligence 
Agency, (2016d) 
The age structure of Egypt is as follows; 0-14 years, 33.2% (male 16,268,862; female 
15,169,039); 15-24 years, 19.2% (male 9,371,819; female 8,839,999); 25-54 years, 
37.5% (male 18,020,332; female 17,448,871); 55-64 years 5.9% (male 2,771,399; 
female 2,826,094); 65 years and over 4.2% (male 1,937,119; female 2,013,459). The 
age structure of Egypt reveals that the 25-54 years age-group has the highest 
population in the country, followed by the 0-14 years of the total population. It also 
highlights that the population aged 55 years and over make up only 11.7% of the 
total population. The top 10 causes of death and DALYs in Egypt from the latest 
available estimates (2012) are presented in Table 2.4. 
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Table 2.4: Summary of top causes of mortality and DALYs for Egypt 
Health Outcome Top causes 
Mortality Ischaemic heart disease (20.5%); stroke (13.3%); cirrhosis of the liver 
(7.9%); hypertensive heart disease (4.1%); cardiomyopathy, myocarditis 
(3.3%); liver cancer (3.2%); kidney disease (3%); chronic obstructive 
pulmonary disease (2.8%); lower respiratory infections (2.7%); 
endocrine, blood, immune disorders (2.4%) 
DALYs Cardiovascular diseases and diabetes; non-malignant neoplasms; 
endocrine, blood and immune disorders; oral conditions; congenital 
anomalies; maternal, neonatal, and nutritional illnesses. 
Source: WHO, 2016f 
The GDP of Egypt (2016 estimate) is US $1.1 trillion, the GDP per capita is 
approximately US $11,800. The health expenditure of the country is 5.6% of GDP 
(2014 estimate). The distribution of family income (Gini index) is 30.8 (2008 
estimate), unemployment rate was 12.8% (2015 estimate) and the population living 
below poverty is 25.2% (2011 estimate). The percentage of people living in urban 
areas are estimated to be 43.1% of the total population (2015 estimate) (World Bank, 
2015e). Egypt is classified by the World Bank as a lower middle-income country. 
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2.5 LESOTHO 
Lesotho is a mountainous kingdom situated in the Southern Africa. The country is 
divided into 10 administrative districts with a total area of about 30,355 km2. Less 
than 10% of the land mass is reserved for agricultural purposes. The map of Lesotho 
showing its 10 administrative districts is presented in Figure 2.9. 
 
Figure 2.9: Political map of Lesotho showing its 10 administrative districts. Source: 
Ezilon (2015a) 
Lesotho has a population of 1,953,070 people (2016 estimate), the country has a 
population growth rate of about 0.34% (2014 estimate) (Central Intelligence Agency, 
2016e). The average life expectancy at birth is 53 years (male 52.9 years; female 53.1 
years) (2016 estimate) (WHO, 2015e; World Bank, 2015f). Sothos comprise 99.7% of 
the country’s population, whereas Europeans, Asians, and others make up the 
remaining 0.3%. The birth and death rates in Lesotho is 25.1 births/1,000 population 
and 14.9 deaths/1,000 population respectively (2016 estimate). The Infant mortality 
rate is estimated at 47.6 deaths/1,000 live births (2016 estimate), and maternal 
mortality rate is about 487 deaths/100,000 live births (2015 estimate). The excess 
mortality due to AIDS may account for lower life expectancy, and the high infant 
mortality and overall mortality rates in Lesotho. About one in four people in the 
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country are affected by HIV (UNAIDS, 2014). The age structure of Lesotho is 
presented on the population pyramid below. 
 
Figure 2.10: Population pyramid of Lesotho (2016 estimate). Source: Central 
Intelligence Agency, (2016e) 
From the population pyramid above, the age structure of Lesotho is as follows; 0-14 
years, 32.4% (male 317,933; female 314,849); 15-24 years, 19.6% (male 181,907; 
female 200,113); 25-54 years, 37.6% (male 358,643; female 375,313); 55-64 years 
5.0% (male 52,016; female 45,549); 65 years and over 5.5% (male 54,466; female 
52,281). The median age of Lesotho’s population is 24 years, with no difference 
between males and females (Central Intelligence Agency, 2016e).  
The top causes of mortality and DALYs in Lesotho based on the most recent available 
estimates (2012) are summarised in Table 2.5.  Although cardiovascular disease is the 
second leading cause of death in the country, the disease accounts for a significantly 
smaller proportion of all-cause mortality, compared to HIV/AIDS-related deaths. The 
majority of the resident population are young (median age 24 years), suggesting high 
levels of high-risk social behaviours and increased risk of HIV transmission. However, 
one cannot rule out the potential for reverse causation: people in Lesotho are less 
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likely to live beyond middle age because of the high rates of HIV/AIDS-related deaths 
in the country. The younger age demographic profile of Lesotho may account for 
lower rates of hypertension and other cardiovascular conditions. While it may be 
more important to address HIV in Lesotho than to address hypertension risk, Lesotho 
is not spared the effects of the ongoing epidemiological transition in sub-Saharan 
Africa. In a national survey conducted in Lesotho in 2001, the prevalence of 
hypertension was estimated to be 37.6% overall (Ministry of Health and Social 
Welfare, 2001). More recently, in a cross-sectional study investigating hypertension 
in a primary-care setting in Lesotho, hypertension prevalence was estimated to be 
84.2% overall, with 74.3% of patients using anti-hypertensive medications (Thinyane 
et al., 2015). Nonetheless, it is important to acknowledge the small size and hospital-
based setting of this study, which may partly explain these estimates (Thinyane et al. 
2015).  
Table 2.5: Summary of top causes of mortality and DALYs for Lesotho 
Health Outcome Top causes 
Mortality HIV/AIDS (41.4%); cardiovascular disease (12%); lower respiratory 
infections (6%); diarrhoeal disease (3.3%); preterm birth complications 
(3.2%); birth asphyxia and birth trauma (2.9%); diabetes mellitus (2.8%); 
interpersonal violence (2.8%) 
DALYs HIV/AIDS; maternal, neonatal, and nutritional; and other infectious 
diseases (excluding acute respiratory diseases, HIV, tuberculosis, and 
malaria) 
Source: WHO, 2016g 
The GDP of Lesotho (2014 estimate) is US $5.77 billion, the GDP per capita is 
approximately US $3,000. The health expenditure of the country is 10.9% of GDP 
(2016 estimate). The distribution of family income (Gini index) is 63.2 (1995 
estimate), unemployment rate as at 2014 estimate was 28.1% and the population 
living below poverty is 57.1% (2010 estimate) The percentage of people living in 
urban areas is estimated to be 27.3% which translates to 71.7% of the population 
living in either rural or semi-urban areas. Lesotho is classified by the World Bank as 
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lower middle-income country (Central Intelligence Agency 2016e; World Bank, 
2015f). 
2.6 MALDIVES 
The Republic of Maldives is an archipelago in the Indian Ocean located 600 
kilometres south of India. It consists of 1,192 small islands that form a chain, about 
820 km long and 120 km wide, within an area of 90,000 km2. Only 196 of the islands 
are officially inhabited, although another 84 islands are used as resorts, and 14 
islands serve industrial purposes. The capital of Malé, with an area of about 2 km2, 
accommodates one-third of the country's population of about 300,000. The total land 
area is estimated to be 300 km2, of which only 10% are suitable for agriculture 
(Ministry of Economic Development, 2010; Central Intelligence Agency, 2016f).  
For administrative purposes, the 26 natural atolls of the Maldives are classified into 
20 groups, each of which is referred to as an administrative atoll. The islands are low 
lying, with an average elevation of 1.6 meters above sea level. Only a few islands 
have a land area in excess of 1 km2. (Ministry of Economic Development, 2010). The 
map of Maldives showing its Atolls (administrative regions) is presented on the next 
page. 
 
Figure 2.11: Map of Maldives showing its Atolls. Source: World Atlas (2015a) 
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Maldives has a population of 392,960 people (2016 estimate). The country is 
characterized by a population growth rate of about -0.07% (2016 estimate) (Central 
Intelligence Agency, 2016f). The average life expectancy at birth is 75.6 years (male 
73.3 years; female 78 years) (2016 estimate) (WHO, 2015f; World Bank, 2015g). The 
country’s composition is made up of South Indians, Sinhalese, and Arabs. The birth 
and death rates for Maldives is 16 births/1,000 population and 3.9 deaths/1,000 
population respectively (2016 estimate). The Infant mortality rate is estimated at 
22.9 deaths/1,000 live births (2016 estimate), maternal mortality rate on the other 
hand is approximately 68 deaths/100,000 live births (2015 estimate) (WHO, 2015f). 
The median age of Maldivians is 27.8 years (male 27.8 years; female 27.8 years) 
(Central Intelligence Agency, 2016f). The population pyramid on the next page 
presents the age structure of the country. 
 
Figure 2.12: Population pyramid of Maldives (2016 estimate). Source: Central 
Intelligence Agency, (2016f) 
From the population pyramid above, the age structure of Egypt is as follows; 0-14 
years, 21.2% (male 42,513; female 40,824); 15-24 years, 21.3% (male 48,319; female 
35,360); 25-54 years, 47.6% (male 107,152; female 80,031); 55-64 years 5.5% (male 
10,749; female 10,799); 65 years and over 4.4% (male 8,012; female 9,201).  It also 
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highlights that the population aged 55 years and over make up only 9.9% of the total 
population. The top 10 causes of death and DALYs in Maldives from the latest 
available estimates (2012) are presented in Table 2.6. 
Table 2.6: Summary of top causes of mortality and DALYs for Maldives 
Health Outcome Top causes 
Mortality Ischaemic heart disease (15.2%); stroke (13.8%); chronic obstructive 
pulmonary disease (4.8%); lower respiratory infections (4.4%); kidney 
diseases (3.5%); endocrine, blood, immune disorders (2.6%); congenital 
anomalies (2.3%); diabetes mellitus (2.1%); asthma (2%); preterm birth 
complications (1.6%) 
DALYs Non-malignant neoplasms; endocrine, blood and immune disorders; 
neuro-psychiatric conditions; cardiovascular disease and diabetes 
Source: WHO, 2016h 
The GDP of Maldives (2015 estimate) is US $5.19 billion, the GDP per capita is 
approximately US $14,900. The health expenditure of the country is 13.7% of GDP 
(2014 estimate). The distribution of family income (Gini index) is 37.4 (2004 
estimate), unemployment rate as at 2013 estimate was 11.6% and the population 
living below poverty is 16% (2008 estimate). The percentage of people living in urban 
areas are estimated to be 45.5% (Central Intelligence Agency, 2016f). Maldives is 
classified by the World Bank as an upper middle-income country (World Bank, 
2015g). 
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2.7 MOROCCO 
Morocco, officially the Kingdom of Morocco, is the most westbound of the North 
African countries. It is one of three countries (Spain, France) to have both Atlantic 
and Mediterranean coastlines. The Arabic name Al-Mamlakat Al-Maghribiyyah, 
which translates to "The Western Kingdom", and Al-Maghrib, or the Maghreb, 
meaning "The West", are commonly used as alternate names. Morocco is 
a constitutional monarchy with an elected parliament. The political capital is Rabat, 
although the largest city is Casablanca, other bigger cities include Marrakech, Tangier, 
Salé, Agadir, Fes, Tetouan, Oujda, Kenitra, Nador, and Meknes (Central Intelligence 
Agency, 2016g). Below is the political map of Morocco. 
 
Figure 2.13: Political map of Morocco showing its regions. Source: Maps of World 
(2015a) 
The country has a population of 33,655,786 (2016 estimate). The annual population 
growth rate is 0.99% (2016 estimate) (World Bank, 2015h). The average life 
expectancy at birth is 76.9 years (male 73.8 years; female 80.1 years) (2016 estimate) 
(WHO, 2015g). Morocco is made up of 99% Arab-Berbers, while other ethnicities 
make up 1% of the country. The birth and death rates for Moroccans is 18 
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births/1,000 population and 4.8 deaths/1,000 population respectively (2016 
estimate). The Infant mortality rate is estimated at 22.7 deaths/1,000 live births 
(2016 estimate), maternal mortality rate on the other hand is approximately at 121 
deaths/100,000 live births (2015 estimate) (WHO, 2015g). The median age of 
Morocco is 28.9 years (male 28.3 years; female 29.5 years) (2016 estimate) (Central 
Intelligence Agency, 2016g). The age structure of Morocco is presented in the 
population pyramid below. 
 
Figure 2.14: Population pyramid of Morocco (2016 estimate). Source: Central 
Intelligence Agency, (2016g) 
From the population pyramid above, the age structure of Morocco is as follows; 0-14 
years, 26.1% (male 4,459,511; female 4,319,538); 15-24 years, 17.2% (male 
2,882,145; female 2,913,917); 25-54 years, 42.2% (male 6,874,144; female 
7,341,892); 55-64 years 7.9% (male 1,318,302; female 1,337,192); 65 years and over 
6.6% (male 995,620; female 1,213,525). The top 10 causes of death and DALYs in 
Morocco from the latest available estimates (2012) are presented in Table 2.7. 
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Table 2.7: Summary of top causes of mortality and DALYs for Morocco 
Health Outcome Top causes 
Mortality Stroke (12.8%); diabetes mellitus (11.9%); ischaemic heart disease 
(11.7%);  lower respiratory infections (5.5%); hypertensive heart disease 
(3.2%); road injury (2.9%); preterm birth complications (2.5%); asthma 
(2.1%); liver cirrhosis (2.1%); kidney disease (1.9%) 
DALYs Non-malignant neoplasms; endocrine, blood and immune disorders; 
maternal, neonatal, and nutritional illnesses. 
Source: WHO, 2016i 
The GDP of Morocco (2014 estimate) is US $254.4 billion, the GDP per capita is 
approximately US $7,700. The health expenditure of the country is 6.4% of GDP (2012 
estimate). The distribution of family income (Gini index) is 40.9 (2007 estimate), 
unemployment rate as at 2015 estimate was 9.7% and the population living below 
poverty is 15% (2007 estimate) The percentage of people living in urban areas are 
estimated to be 59.7% of the total population (2014 estimate). Morocco is classified 
by the World Bank as a lower middle-income country (World Bank, 2015h). 
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2.8 SENEGAL 
Senegal is located in the extreme West of the African continent. The country shares 
its borders with the Republic of Mauritania to the North, Mali to the East, Guinea and 
Guinea Bissau to the South, and the North Atlantic Ocean to the West. Senegal has 14 
administrative regions, 117 districts, and 353 rural communities (Central Intelligence 
Agency, 2016h). The map of Senegal is shown in Figure 2.15. 
 
Figure 2.15: Map of Senegal. Source: World Atlas (2015b) 
The country has a population of 14,320,055 with an annual population growth rate of 
2.4% (2016 estimates) (Central Intelligence Agency, 2016h). The average life 
expectancy at birth is 61.7 years (male 59.7 years; female 63.8 years) (2016 estimate) 
(Central Intelligence Agency, 2016h). The composition of the country is made up of 
many ethnic groups including Wolof 43.3%, Pular 23.8%, Serer 14.7%, Jola 3.7%, 
Mandinka 3%, Soninke 1.1%, European and Lebanese 1%, and others 9.4% (Central 
Intelligence Agency, 2016h). 
The birth and death rates in Senegal are 34 births/1,000 population and 8.3 
deaths/1,000 population respectively (2016 estimate). The Infant mortality rate is 
estimated at 50.3 deaths/1,000 live births (2016 estimate) and maternal mortality 
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rate is 315 deaths/100,000 live births (2015 estimate). The median age of Senegal is 
18.7 years (male 17.8 years; female 19.6 years) (2016 estimate) (Central Intelligence 
Agency, 2016h; WHO, 2015h). The age structure of Senegal is presented in the 
population pyramid in Figure 2.16. 
  
Figure 2.16: Population pyramid of Senegal. Source: Central Intelligence Agency, 
(2016h) 
From the population pyramid, the age structure of Senegal is as follows; 0-14 years, 
41.8% (male 3,011,233; female 2,981,128); 15-24 years, 20.4% (male 1,452,415; 
female 1,462,989); 25-54 years, 30.9% (male 2,031,035; female 2,398,788); 55-64 
years 3.9% (male 242,429; female 317,439); 65 years and over 2.9% (male 189,201; 
female 233,398).  
The top causes of death in Senegal based on the most recent available estimates 
(2012) are presented in Table 2.8. Although it may be more worthwhile to address 
respiratory infections in Senegal than to address hypertension and its complications, 
Senegal (like Lesotho) is not exempt from the effects of the ongoing epidemiological 
transition in sub-Saharan Africa. In addition, the prevalence of hypertension the 
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country has been increasing over the years from 29.5% in 1988 (Lang et al., 1988) to 
43.7% in 2011 (Mbaye et al., 2011). 
Table 2.8: Summary of top causes of mortality and DALYs for Senegal 
Health Outcome Top causes 
Mortality Lower respiratory infections (16.1%); malaria (8%); diarrhoeal diseases 
(6.3%); preterm birth complications (4.5%); stroke (4.4%); birth asphyxia 
and birth trauma (3.9%); ischaemic heart disease (3.3%); diabetes 
mellitus (3.1%); meningitis (2.8%); tuberculosis (2.7%) 
DALYs Maternal, neonatal, and nutritional; other infectious diseases (other 
than acute respiratory diseases, HIV, TB, and malaria); HIV, TB, malaria 
Source: WHO, 2016j 
The GDP of Senegal (2015 estimate) is US $36.7 billion, the GDP per capita is 
approximately US $2,500 while the health expenditure of the country is 4.7% of GDP 
(2014 estimate). The distribution of family income (Gini index) is 40.3 (2011 
estimate), unemployment rate as at 2007 estimate was 48% and the population living 
below poverty is 46.7% (2011 estimate). The percentage of people living in urban 
areas are estimated to be 43.7% of the total population (2015 estimate) (World Bank, 
2015i; Central Intelligence Agency, 2016h). Senegal is classified by the World Bank as 
a lower middle-income country. 
2.9 UKRAINE  
Ukraine is located in Eastern Europe and is bordered by the Black Sea and the Sea of 
Azov in the south, by Russia on the east and north, by Belarus on the north; by 
Poland, Slovakia, Hungary and Romania on the west, and by Moldova to the south. 
The territory of Ukraine is 603.5 thousand square kilometres (State Statistical 
Committee 2007b; Central Intelligence Agency, 2016i). 
Ukraine has 27 administrative divisions: 24 regions (oblasts), the Autonomous 
Republic of Crimea (which is disputed between Russia and Ukraine), and two cities 
with special status: Kyiv and Sevastopol. The capital of Ukraine is Kyiv. Ukraine 
extends across the Eastern European plain and includes three vegetation zones: pine 
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and mixed forest, forest-steppe, and steppe (Central Intelligence Agency, 2016i). The 
political map of Ukraine showing and its neighbouring countries (Poland, Belarus, 
Russia, Moldova, Romania, Hungary, and Slovakia) is shown on the next page.  
 
Figure 2.17: Political map of Ukraine. Source: Maps of World (2015b) 
Ukraine has a population of 44,209,733 (2016 estimate) and an annual population 
growth rate is -0.4% (2016 estimate) (Central Intelligence Agency, 2016i). The 
average life expectancy at birth is 71.8 years (male 67.1 years; female 76.9 years) 
(2016 estimate) (Central Intelligence Agency, 2016i). Ukrainians make up the largest 
part of the population (77.8 %); Russians are the second largest group (17.3 %); and 
other ethnic/linguistic groups, each constitute 1% or less of the population (State 
Statistical Committee, 2003).  
The birth and death rates in Ukraine are 10.5 births/1,000 population and 14.4 
deaths/1,000 population respectively (2016 estimate). Infant mortality rate is 
estimated at 8 deaths/1,000 live births (2016 estimate), maternal mortality rate on 
the other hand is approximately at 24 deaths/100,000 live births (2015 estimate) 
(WHO, 2015i; Central Intelligence Agency, 2016i). The median age of Ukraine is 40.4 
years (male 37.2 years; female 43.5 years) (Central Intelligence Agency, 2016i). The 
age structure and distribution is presented on the next page. 
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Figure 2.18: Population pyramid of Ukraine. Source: Central Intelligence Agency, 
(2016i) 
Looking at the population pyramid above, the age structure of Ukraine is as follows; 
0-14 years, 15.5% (male 3,528,821; female 3,326,405); 15-24 years, 10.3% (male 
2,334,454; female 2,218,718); 25-54 years, 44.5% (male 9,639,404; female 
10,020,385); 55-64 years 13.7% (male 2,587,898; female 3,458,016); 65 years and 
over 16.0% (male 2,375,904; female 4,719,728). Table 2.9 summarises the top causes 
of mortality and DALYs in Ukraine. 
Table 2.9: Summary of top causes of mortality and DALYs for Ukraine 
Health Outcome Top causes 
Mortality Ischaemic heart disease (48%); stroke (17.1%); HIV/AIDS (3%); cirrhosis 
of the liver (2.5%); pulmonary cancers (2.1%); colon and rectum cancers 
(1.8%); chronic obstructive pulmonary disease (1.6%) 
DALYs Cardiovascular diseases and diabetes; cancers 
Source: WHO, 2016k 
The GDP [Purchasing Power Parity (PPP)] of Ukraine (2014 estimate) is US $339.5 
billion, the GDP per capita is approximately US $7,500 while the health expenditure 
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of the country is 7.1% of GDP (2014 estimate). The distribution of family income (Gini 
index) is 24.6 (2013 estimate), unemployment rate as at 2015 estimate was 9.5% and 
the population living below poverty is 24.1% (2010 estimate). The percentage of 
people living in urban areas are estimated to be 69.7% of the total population (2015 
estimate). Ukraine is classified by the World Bank as a lower middle-income country 
(World Bank, 2015j). 
2.10 UZBEKISTAN 
Uzbekistan is a landlocked country located in Central Asia between two major rivers, 
the Amudarya and the Syrdarya. The territory of Uzbekistan covers 448,900 square 
kilometres and is bordered by Kazakhstan to the north, Kyrgyzstan and Tajikistan to 
the south and east, Afghanistan to the south, and Turkmenistan to the west 
Uzbekistan consists of 12 administrative regions (oblasts), the Autonomous Republic 
of Karakalpakstan, and Tashkent City. Each region is further broken down into 
administrative areas called ‘Rayons’. There are 162 rayons, and 118 cities and towns 
in Uzbekistan (Central Intelligence Agency, 2016j). Below is the political map of 
Uzbekistan showing its administrative regions. 
 
Figure 2.19: Political map of Uzbekistan showing its administrative regions. Source: 
Ezilon (2015b) 
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With a population of 24,473,614 (2016 estimate), Uzbekistan is the third most 
populous country of the former Soviet Union after Russia and the Ukraine (Central 
Intelligence Agency, 2016j). Approximately 64% of the population reside in rural 
areas with only 36.4% of the total population living in urban areas (World Bank, 
2015k).  The average life expectancy in the country is 73.8 years (male 70.7 years; 
female 77 years) (2016 estimate). The population density of Uzbekistan is 56 
persons/km2. However, the population is unevenly distributed among the regions. 
Uzbekistan is a multinational country. It has been estimated that people of more than 
130 nationalities live in Uzbekistan. The majority is Uzbeks, constituting more than 80 
% of the population, Russians 5.5%, Tajiks 5%, Kazakhs 3%, Tatars 1.5%, and others 
2.5% (Central Intelligence Agency, 2016j). The birth and death rates in Uzbekistan are 
16.9 births/1,000 population and 5.3 deaths/1,000 population respectively (2016 
estimate). The Infant mortality rate is estimated at 18.6 deaths/1,000 live births, 
maternal mortality rate on the other hand is approximately 36 deaths/100,000 live 
births (WHO, 2015j; Central Intelligence Agency, 2016j). The median age of 
Uzbekistan is 28.1 years (male 27.6 years; female 28.7 years) (2016 estimate) (Central 
Intelligence Agency, 2016j). The age structure of Uzbekistan is presented in the 
population pyramid below. 
 
Figure 2.20: Population pyramid of Uzbekistan. Source: Central Intelligence Agency 
(2016j) 
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From the population pyramid above, the age structure of Uzbekistan is as follows; 0-
14 years, 24.2% (male 3,658,960; female 3,480,659); 15-24 years, 19.2% (male 
2,874,982; female 2,790,128); 25-54 years, 43.5% (male 6,444,288; female 
6,510,741); 55-64 years 7.5% (male 1,049,876; female 1,171,369); 65 years and over 
5.1% (male 637,408; female 855,203). The major causes of mortality and DALYs are 
presented in Table 2.10. 
Table 2.10: Summary of top causes of mortality and DALYs for Uzbekistan 
Health Outcome Top causes 
Mortality Ischaemic heart disease (34.2%); stroke (15.9%); liver cirrhosis (4.5%); 
lower respiratory infections (4.1%); diabetes (2.2%); chronic obstructive 
pulmonary disease (2%); preterm birth complications (1.9%) 
DALYs Cardiovascular diseases and diabetes; neuro-psychiatric conditions; 
non-malignant neoplasms; endocrine, blood and immune disorders; 
genitourinary and skin diseases; oral conditions; and congenital 
anomalies 
Source: WHO; 2016l. 
The GDP of Uzbekistan (2015 estimate) is US $187.9 billion, the GDP per capita is 
approximately US $6,100, while the health expenditure of the country is 5.8% of GDP 
(2014 estimate). The distribution of family income (Gini index) is 36.8 (2003 
estimate), unemployment rate as at 2015 estimate was 4.8 below poverty is 17% 
(2011 estimate). Uzbekistan is classified by the World Bank 9% and the population 
living as a lower middle-income country (World Bank, 2015k). 
The following section presents a summary of the health and socioeconomic indicators 
of the selected countries. 
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2.11 SOCIO-DEMOGRAPHIC DIFFERENCES ACROSS THE SELECTED 
COUNTRIES AND THEIR IMPLICATIONS FOR HYPERTENSION 
PREVALENCE    
The following table presents a summary for the health and socioeconomic indicators 
of the selected countries  
Table 2.11: Summary of health and socioeconomic indicators for the selected 
countries 
INDICATORS/ 
COUNTRIES 
Albania Armenia Azerbaijan Egypt Lesotho Maldives Morocco Senegal Ukraine Uzbekistan 
Population 
(million) 
3.0 3.0 9.9 94.7 1.9 0.39 33.6 14.3 44.2 24.5 
Average life 
expectancy 
(years)  
78.3 74.6 72.5 72.7 53 75.6 76.9 61.7 71.8 73.8 
Median age 
(years) 
32.5 34.6 30.9 23.8 24 27.8 28.9 18.7 40.4 28.1 
Birth rate 
(births/1000 
population) 
13.1 13.3 24.7 19.7 47.6 22.9 22.7 50.3 8 18.6 
Date rate 
(deaths/1000 
population) 
6.7 9.4 7.1 4.7 14.9 3.9 4.8 8.3 14.4 5.3 
Infant mortality 
(deaths/1000 
live births) 
12.3 13.1 24.7 19.7 47.6 22.9 22.7 50.3 8.0 18.6 
Maternal 
mortality 
(deaths/100,000 
live births) 
29 25 25 33 487 68 121 315 24 36 
GDP (US$ 
billion) 
32.6  25.3 169.4 1.1* 5.8 5.2 254.4 36.7 339.5 187.9 
Average GDP 
per capita ($) 
11,900 8,500 18,000 11,800 3,000 14,900 7,700 2,500 7,500 6,100 
Gini Index (%) 29
c
 30.3
c
 33.7
b
 30.8
b
 63.2
a
 37.4
b
 40.9
b
 40.3
c
 24.6
c
 36.8
b
 
Health 
expenditure (as 
% of GDP, 2016 
estimate) 
5.9 4.5 6.0 5.6 
 
10.9 13.7 6.4 4.7 7.1 5.8 
% of population 
living in urban 
areas 
57.4 62.7 54.6 43.1 27.3 45.5 59.7 43.7 69.7 36.4 
Population 
living below 
poverty line (%) 
14
c
 32
c
 6.0
c
 25.2
c
 57.1
c
 16.0
b
 15
b
 46.7
c
 69.7
c
 17.0
c
 
Unemployment 
(%) 
17.3
c
 17.8
c
 5.3
c
 12.8
c
 28.1
c
 11.6
c
 9.7
c
 48.0
b
 9.5
c
 4.8
c
 
 
Key: *=trillion, a=1990-2000 estimates, b=2001-2010 estimates, c=2011-2016 estimates 
Source: Central Intelligence Agency, 2016 a-j; World Bank, 2015 b-k 
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From Table 2.1, it can be observed that the population of the countries range from 
390,000 thousand people in Maldives to 94.7 million in Egypt. Hence, Egypt is most 
likely to be densely populated compared to Maldives and the other selected 
countries, so that the resident population of Egypt may be more susceptible to the 
effects of overcrowding, environmental pollution and other environmental risk 
factors of hypertension when compared with the resident population of Maldives and 
the other selected countries (D’Atri & Ostfeld, 1975; Seedat et al., 1982). 
The average life expectancy ranges from 53 years in Lesotho to 78 years in Albania. 
Changes in life expectancy of a country correlate with epidemiological transition, 
which in turn, correlates with hypertension prevalence and other non-communicable 
diseases (Corruccini & Kaul, 1983). Lesotho is at a much earlier stage of 
epidemiological transition, compared to Albania, so it is expected that hypertension 
prevalence would be lower in Lesotho, compared to Albania.  
The median age ranged from 18.7 years in Senegal to 40.4 years in Ukraine. This 
suggests that Ukraine is more likely to have an ageing population, compared to the 
resident population of Senegal. Therefore, hypertension prevalence would likely be 
higher in Ukraine than in Senegal, given the temporal relationship between ageing 
and hypertension (Messerli et al., 1981; Landahl et al., 1986). The population 
pyramids for all the 10 countries demonstrates significant differences in the 
distribution of the populations by age, for instance the percentage of populations 
aged ≥55 years and above were higher in the Eastern European countries (Albania, 
Armenia, Azerbaijan, Ukraine and Uzbekistan) compared to countries in Africa (Egypt, 
Morocco, Senegal, and Lesotho) or the Indian sub-continent (The Maldives). Given 
the relationship between population ageing and hypertension prevalence, these 
differences suggest that variation in unadjusted hypertension rates between the 
countries are to be expected, with prevalence estimates that are more likely to be 
higher among populations resident in the Eastern European countries. 
The average GDP per capita varies from US$2,500 in Senegal to US$18,000 in 
Azerbaijan. There is also a variation in the Gini index which informs us about the level 
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of income inequality existing in these countries. The African countries had the highest 
Gini index (Lesotho 63.2%, Morocco 40.9%, and Senegal 40.3%) compared to 
countries in Eastern Europe suggesting that income inequalities are higher among 
African populations. However, populations living below poverty line are higher in 
Ukraine (69.7%), Lesotho (57.1%), and Senegal (46.7%) compared to other countries 
explored in this research. Hence, the psycho-social burden, and therefore 
hypertension prevalence in these countries that experience such high levels of socio-
economic deprivation are likely to be higher than in countries with lower levels of 
socio-economic deprivation. 
The next chapter will present the methodology and methods of the research. 
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CHAPTER THREE: METHODS 
This chapter is presented in two sections. The first section will describe the methods 
for the systematic review and meta-analysis, and the second section will describe the 
methods for the secondary data analysis. 
3.1 SECTION A 
3.1.1 METHODOLOGY 
A systematic review and meta-analysis was conducted to estimate the pooled 
prevalence of hypertension across low- and middle-income countries. A meta-
analysis was appropriate to provide a more comprehensive, consistent, precise and 
higher-level evidence compared to individual primary studies (Hemingway & 
Brereton, 2009). In combining the different estimates of hypertension prevalence 
from individual primary studies, a systematic review with meta-analysis is more 
robust than a narrative synthesis to make conclusive inferences that aid decision 
making (Higgins & Green, 2011).     
3.1.2 PROTOCOL FOR CONDUCTING THE SYSTEMATIC REVIEW AND 
META-ANALYSIS COMPONENT 
The protocol for this review has been registered in the PROSPERO International 
prospective register of systematic reviews with reference number- PROSPERO 2013: 
CRD42013006162 and has been attached in appendix I.  
3.1.2.1 REVIEW OBJECTIVES 
 To determine the prevalence of hypertension in low-and middle-income 
countries 
 To examine the patterns of hypertension across different socio-demographic 
characteristics (geographical region, age, gender, educational attainment, 
wealth status, place of residence, BMI category, and employment status) 
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3.1.2.2 SEARCH STRATEGY 
A comprehensive literature search of Ovid MEDLINE, EMBASE, SCIELO, electronic databases 
and the World Health Organization Global Cardiovascular Infobase, was conducted from 
inception to August 2015. The search was conducted using medical subject heading (MeSH) 
terms and keywords: “hypertension” OR “blood pressure” OR ‘hypertens*’ AND ‘population-
based’ OR ‘aetiology’ OR ‘etiology’ OR ‘prevalence’ OR ‘epidemiolog*’ AND “low-and middle-
income countries” OR “developing countries” (see appendix II for the complete search 
strategy). Bibliographies of reviews were also scrutinized for additional studies. Reference 
lists of identified studies have been cross-checked for potentially relevant studies. Grey 
literature was sought in order to reduce the risk of reporting bias, and this entailed targeted 
web-based searches (e.g. Google Scholar), contacting authors of unpublished studies 
archived on various online research platforms (e.g. ResearchGate, Academia.eu), and 
databases indexing conference papers and conference proceedings (e.g. Web of Science, 
ProQuest). No restriction was applied on the year of publication.  
3.1.2.3 INCLUSION CRITERIA 
Types of participants/Population 
Adult population (as defined by the authors of the original studies included) living in low-and 
middle-income countries with diagnosed hypertension or on anti-hypertensive medication 
or self-reported hypertension. 
Types of studies 
All population-based studies (cross-sectional studies, cohort studies, randomised controlled 
trials) that reported the prevalence of hypertension will be included. 
Types of outcomes 
Prevalence of hypertension using standard methods of measurements: 
 ≥140/90 mmHg (Systolic/Diastolic blood pressure) or  
 On anti-hypertensive medication or  
 Self-reported health professional diagnosis of hypertension 
 Studies that reported overall prevalence as well as those that reported sex and age-
specific prevalence of hypertension will be included. 
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3.1.2.4 EXCLUSION CRITERIA 
Studies will not be included in the review if they fall into any of the following categories: 
 Studies where standard methods for measurement of hypertension was not clearly 
described 
 Studies in which the definition of hypertension was not ≥140/90 mmHg 
(Systolic/Diastolic blood pressure) 
 Studies where the population or source of population could not be identified 
 Hospital-based studies, policy reports, or expert reviews 
 Studies addressing specific populations, e.g. hypertension in pregnancy, or 
hypertension in adolescents 
 Studies conducted in high-income countries 
A summary of the eligibility criteria can be found in the box below. 
Box 1: Eligibility criteria 
 
 Inclusion Exclusion 
Population Adults (18 years and above) Pregnant women, adolescents, and 
children 
Outcome Hypertension prevalence reported or 
deducible from subgroup estimates 
Hypertension assessed as:  
  BP greater or equal to 140/90mmHg, 
  use of antihypertensive drugs, 
  self-reported physician-diagnosed cases 
Hypertension prevalence not reported 
Pulmonary hypertension   
Hypertension assessed as:       
BP greater or equal to 160/95mmHg, 
other assessment criteria  
 
Study design All population-based studies, regardless of the 
design:  
   cross-sectional studies,  
   cohort studies, 
   randomised controlled trials 
Hospital-based studies 
Policy reports 
Expert reviews 
Study 
location 
Low- and middle-income countries High-income countries 
 
 
Language English Studies published in other languages 
 
 
3.1.2.5 DATA EXTRACTION (SELECTION AND CODING) 
The titles and abstracts of studies retrieved using the search strategy from the 
databases and additional sources were screened independently by the researcher, a 
collaborator (Dr. Nduka), and one of the researcher’s supervisors (Dr. Uthman) to 
identify studies that met the inclusion criteria outlined for the review.  
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Data from the included studies were also extracted independently by Dr. Uthman 
and Dr. Nduka using a standardised protocol and a piloted data-extraction form 
(appendix III), and any discrepancies were resolved by consensus with more senior 
colleagues (Prof Kandala and Prof Stranges). The data extracted included: year of 
publication, country of origin, study design, sample size, sampling strategy, study 
period, place of residence (rural/urban), gender distribution, age group, mean age, 
body mass index (BMI) category, hypertension prevalence, diagnostic criteria for 
hypertension, blood pressure apparatus used, comorbidities of hypertension e.g. 
diabetes, stroke, heart disease. Countries were grouped according to World Bank 
(2015a) regions and country income groups. With the exception of mean age, all 
variables were categorical. Overweight /obesity was defined as BMI≥25kg/m2. 
Hypertension was defined as blood pressure measurement of at least 140/90 mmHg 
or the use of antihypertensive medication or self-reported physician diagnoses. 
Where subgroup estimates of hypertension prevalence were provided, the total 
hypertension prevalence was calculated manually from these estimates.  
3.1.2.6 RISK OF BIAS (QUALITY ASSESSMENT) 
Methodological quality entailed assessing the risk of bias for each study using a 
domain-based tool adapted from the Newcastle-Ottawa Scale (Wells et al., 2014) 
(see appendix IV). The risk of bias in a study was graded as low, moderate, high or 
unclear on the basis of study features including the selection of participants 
(selection bias), sample size justification (selection bias), outcome measurement 
(detection bias), and confounding adjustment. It is worthy to note that non-response 
bias was not assessed in this review and this stems from the limitation of the tool 
used in assessing the risk of bias in our included studies. However, all the studies 
included in the review had high response rates which suggests limiting the likelihood 
of the effect of non-response bias in this review (Groves, 2006). Overall, the risk of 
bias assessment was conducted by myself and Dr. Nduka.  
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3.1.2.7 STATISTICAL ANALYSES 
For the meta-analysis, the raw proportions of participants with hypertension from 
each study were first stabilized using the Freeman-Tukey variant of the arcsine 
square root transformed proportion (Miller, 1978). Due to anticipated differences in 
the prevalence estimates of hypertension across individual studies, the transformed 
proportions were subsequently pooled using the random-effects method, in which 
case, the pooled prevalence of hypertension represents the mean prevalence in a 
random distribution of individual (prevalence) estimates (DerSimonian & Laird, 1986; 
Higgins & Green, 2011). A fixed-effect method, in contrast, assumes that there is one 
true prevalence of hypertension that is common to all the individual studies in a 
fixed-effects meta-analysis, in which case, the pooled prevalence of hypertension is 
an estimate of this true prevalence (Higgins & Green, 2011).    
 Heterogeneity between studies was assessed by inspecting the forest plots and 
using the chi-squared test for heterogeneity with a 10% level of statistical 
significance, and using the I2 statistic where a value of 50% was interpreted as 
representing moderate heterogeneity (Higgins et al. 2002; 2003). 
Subgroup analyses were performed to account for differences in hypertension 
prevalence by geographical region, country income group, place of residence, age 
groups, gender, educational status, employment status, smoking status, drinking 
status and BMI category. Meta-regression analyses were also performed on these 
covariates to identify factors that may be associated with hypertension in LMICs 
(Thompson & Sharp, 1999). In order to ascertain for any secular trends in 
hypertension prevalence in LMICs, meta-regression analysis was performed on the 
year of publication. 
The meta-analysis results were reported as pooled hypertension prevalence with 
95% confidence intervals (CIs). All P values were exact (except where P<0.0001) and 
two-tailed; P<0.05 was considered statistically significant. Analyses were conducted 
using Stata version 12 for Windows (Stata Corp, College Station, Texas) using the 
‘metaprop’ routine (Nyaga et al., 2014). This systematic review and meta-analysis 
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was reported according to the Preferred Reporting Items for Systematic Reviews and 
Meta-analyses (PRISMA) guidelines (Liberati et al., 2009). PRISMA checklist is 
provided in appendix V.  
3.2  SECTION B 
3.2.1 METHODOLOGY 
Secondary data analyses using existing data from the Demographic and Health 
Surveys (DHS) datasets were conducted to map the geographical patterns of 
hypertension prevalence across selected low- and middle-income countries. DHS 
datasets are a well-established source of reliable population-level data in low- and 
middle-income countries, with a substantial focus on health. The DHS datasets also 
provide data for more low- and middle-income countries than other datasets such as 
the WHO Study on global AGEing and adult health (SAGE) and the Prospective Urban 
and Rural Epidemiological study (PURE).     
The Demographic Health Survey program was established in 1984 by the United 
States Agency for International Development (USAID). The Survey was 
conceptualized as a follow-up to two International projects on family planning and 
human fertility viz; the Contraceptive Prevalence Survey and World Fertility Survey 
(Rutstein & Rojas, 2006). Upon commissioning in 1984, the first DHS project was 
awarded to Westinghouse Health Systems (which later became part of OCR Macro) 
and in 2009, ICF International- a venture capital firm also acquired OCR Macro (ICF 
International, 2013). Therefore, the surveys are now conducted by ICF International 
in conjunction with the Ministries of Health of about 89 low-and middle-income 
countries worldwide. 
DHS are nationwide-representative household surveys that provide information on a 
variety of public health issues: anaemia, child health, domestic violence, education, 
environmental health, family planning, female genital cutting, fertility and fertility 
preferences, HIV/AIDS, household and respondent characteristics, infant and child 
mortality, malaria, maternal health, nutrition, maternal mortality, tobacco use, 
Page | 62  
unmet need, wealth, women empowerment and other population health indicators 
(MEASURE DHS, 2013). 
The surveys are conducted in overlapping five-year phases: DHS-I spanned from 
1984 to 1990; DHS-II from 1988 to 1993; and DHS-III from 1992 to 1998 (Rutstein & 
Rojas, 2006). In 1997, DHS was folded into a new multi-project MEASURE 
(Monitoring and Evaluation to Assess and Use Results) program as MEASURE DHS. 
The objectives of the DHS program are:  
 To provide decision makers in participating countries with improved 
information and analyses useful for informed policy choices  
 To improve coordination and partnerships in data collection at the 
international and country levels  
 To develop skills and resources necessary to conduct high-quality 
demographic and health surveys in participating countries  
 To improve data collection and analysis tools and methodology  
 To improve data dissemination and utilization  
Between 1984 and 2006, more than 130 nationally representative household-based 
surveys were conducted and completed under the auspices of DHS project in 70 
countries, at present the project has covered 89 countries with over 260 surveys 
completed (MEASURE DHS, 2013). However, it is imperative to note that the 
countries receiving USAID assistance are the primary participants in the DHS 
program. Several other international donors such as UNICEF, UNFPA or the World 
Bank have funded the DHS program in some countries not supported by USAID 
(Rutstein & Rojas, 2006). 
3.2.2 DHS DATASETS USED IN THE STUDY 
Only ten of the 89 countries with ongoing DHS surveys had data on hypertension 
prevalence (Table 3.1), hence the limited number of datasets examined in this study. 
In addition, the cost implications of translating datasets published in other languages 
further precluded datasets from Latin America/Caribbean, Middle-East, and East-
Asia/Pacific regions.  
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Table 3.1: Summary of DHS datasets with information on number of participants 
included for analysis 
Countries DHS Data Overall Sample Size Sample Included in 
Analysis 
Albania 2008-09 10,597 6,472 
Armenia 2010 7,506 1,813 
Azerbaijan 2006 11,002 11,002 
Egypt 2008 16,527 12,008 
Lesotho 2009 10,941 10,941 
Maldives 2009 11,098 8,546 
Morocco 2003-04 
16,798
A
 
4,716 
Senegal 2010-11 20,617 20,617 
Ukraine 2007 10,019 9,336 
Uzbekistan 2002 7,796 7,796 
Total  122,901 93,247 
A = All Women Sample 
3.2.3 STUDY OUTCOME AND MEASUREMENT 
In all the 10 surveys, the questionnaires issued to the respondents included 
questions to determine if the participants had been diagnosed as hypertensive and if 
they were taking any medication to control raised blood pressure. In some of the 
countries, blood pressure measurements were measured according to established 
protocol using sphygmomanometer and stethoscopes, whereas in other countries, 
automated digital oscillometric BP measuring devices were used.  
On the average, two to four measurements of systolic and diastolic BP in millimetre 
mercury (mmHg) were made with an interval of at least 10-15 minutes between 
measurements. In all the countries, the average of the 2nd and 3rd measurements or 
3rd and 4th measurements were used to classify individuals according to hypertension 
status. The respondents were classified hypertensive if their systolic BP 
measurement ≥140 mmHg or if their diastolic BP measurement was ≥90 mmHg. This 
cut-off is consistent with the definition of hypertension adopted in this study as 
discussed previously (section 1.1) (Chobanian et al., 2003). Participants who used 
anti-hypertensive medication and participants with self-reported physician diagnoses 
of hypertension were also considered to be hypertensive in this study (Chobanian et 
al., 2003). Hence, for this study, a participant was labelled hypertensive if they met 
one or more of these three criteria.  
Page | 64  
3.2.4 OTHER VARIABLES 
All datasets in the selected countries provided information on spatial and non-spatial 
factors that may affect hypertension prevalence in low- and middle-income 
countries. Spatial factors emphasize the importance of geographical location (e.g. 
administrative provinces and districts) and place of residence (urban and rural 
settings). Of note, geographical location can be considered as a proxy for 
unmeasured factors such as availability and access to health services and health-
seeking behavior (Elliot & Wartenberg, 2004; Kandala et al., 2013; Kandala & 
Stranges, 2014). For instance, there are enormous variations in the stages of 
epidemiological transition, socio-economic and demographic indices between and 
within LMICs. For example, rural sub-Saharan Africa is at a much earlier stage of the 
economic and health transition than urban settings (Salomon & Murray, 2002). 
Within countries in sub-Saharan Africa, evidence has shown distinctive spatial 
patterns in hypertension prevalence, beyond the effects of individual-level factors, 
which suggest potential influences of economic disadvantages, availability and 
access to health services, and remoteness of certain communities on hypertension 
prevalence (Kandala et al., 2013).  
Non-spatial factors, on the other hand, include non-geographical variables such as 
age, gender, lifestyle factors (e.g. smoking status and alcohol intake), wealth, 
educational status, and comorbidities of hypertension (e.g. type 2 diabetes, stroke 
and heart disease). In order to identify hot spots of hypertension prevalence in 
LMICs, and to strategically inform national and local policies aimed at the prevention 
and management of highly prevalent conditions such as hypertension in these 
settings, the integration of spatial and non-spatial factors is of paramount 
importance (Elliot & Wartenberg, 2004). 
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3.2.5 DATA ANALYSIS 
This section describes the methods entailed in analysing the DHS datasets. All data 
were analysed using BayesX version 2.9, Stata version 12 for Windows, and 
MapInfo® Professional version 12.0 (a widely-used and reliable mapping and 
geographic analysis software package). All null hypotheses were tested against two-
sided alternative hypotheses at 5% significance level.  
3.2.5.1 DESCRIPTIVE ANALYSIS 
The descriptive statistics entailed exploratory analyses of the characteristics of the 
study population and stratified by hypertension status, age and gender. The means 
of the continuous variables (age, BMI, height, waist circumference) were compared 
between, and where necessary, across strata, using the independent samples t-test 
(Kirkwood & Sterne, 2003). The proportions of the categorical variables (age group, 
gender, lifestyle factors, place of residence, education status, and wealth status) 
were compared between, and where necessary, across strata, using Pearson’s chi-
square (X2) test (Kirkwood & Sterne, 2003). 
Of note, age group was categorised based on 10-year intervals (15-24, 25-34, 35-44, 
45-54, and ≥55). This choice of age distribution is arbitrary as there is no evidence 
that links specific age-intervals with hypertension risk. However, it is clear that there 
is a linear relationship between age and hypertension risk (Landahl et al. 1986; 
Chrysant & Chrysant, 2014), so that a 10-year time-interval may be more robust in 
accounting for the age-related increase in the lifetime risk of hypertension compared 
to wider time-intervals.  
The prevalence of hypertension was also obtained in each of the selected countries 
and stratified by age and gender.  
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3.2.5.2 REGRESSION ANALYSIS 
Univariable logistic regression models were fitted to identify spatial and non-spatial 
predictors of hypertension in LMICs. Each simple regression model included the 
dependent variable (hypertension) and an independent variable (a spatial or a non-
spatial factor). Analyses were presented using odds ratios with 95% confidence 
intervals.  
Multivariable logistic regression models were also fitted while adjusting for potential 
confounders. In this model, the dependent variable (hypertension) was regressed on 
all spatial and non-spatial independent variables. The measure of effect was 
presented as adjusted odds ratios with 95% confidence intervals. 
3.2.5.3 REGRESSION DIAGNOSTICS 
Regression diagnostics were performed and entailed assessing the goodness-of-fit of 
the regression models using the Hosmer-Lemeshow test and the ‘estat gof’ routine 
in Stata (Hosmer & Lemeshow, 1980; Archer & Lemeshow, 2006). The Hosmer-
Lemeshow goodness-of-fit test divides subjects into deciles based on predicted 
probabilities, then computes a X2 from observed and expected parameters. 
Furthermore, a P value is computed from the X2 distribution to test the fit of the 
logistic model. If the Hosmer-Lemeshow goodness-of-fit test statistic is greater than 
0.05, we fail to reject the null hypothesis and conclude that there is no difference 
between observed and model-predicted values, implying that the model's estimates 
fit the data at an acceptable level. In other words, well-fitting models show non-
significance on the goodness-of-fit test, indicating model prediction that is not 
significantly different from observed values. The degree of multicollinearity (linear 
relationship among independent variables) was assessed using the ‘collin’ routine in 
Stata (Long & Freese, 2014). It is imperative to note that only the independent 
variables can be used with the collin routine. Results of the collinearity diagnostics 
usually presents the following; variance inflation factor (VIF), square root VIF, 
tolerance (1/VIF), condition index, and condition number. As a general rule of 
Page | 67  
thumb, VIF values above 10, Mean VIF values above 6, or condition number of 10 
and above suggests high degrees of multicollinearity (Long & Freese, 2014).  
3.2.5.4 MULTIVARIATE BAYESIAN GEO-ADDITIVE ANALYSIS AND DISEASE 
MAPPING 
Multivariate Bayesian geo-additive analysis is used to map the geographical (or 
spatial) distribution of a disease (hypertension in this case), while accounting for 
individual-level (or non-spatial) factors, in order to identify disease hot spots 
(Fahrmeir & Lang, 2001). The Bayesian approach is more appropriate for this 
purpose and preferred to a multivariable logistic regression analysis for several 
reasons.  
First, a multivariable logistic regression approach would assume that the random 
components of a contextual variable such as province or district are mutually 
exclusive, even though, in practice, this assumption may not hold true. Hence, in 
mapping the geographical distribution of a disease at the district level, a 
multivariable regression analysis is likely to result in specification errors. A 
multivariate Bayesian geo-additive model, on the other hand, is robust to such 
specification errors, which is important to account for unmeasured factors as 
opposed to treating these factors as proxies for observed variables (Kandala, 2006).  
Secondly, in predicting the likelihood of a disease, a logistic regression model is more 
likely to be influenced by sample size and less likely to handle missing data as 
effectively as a Bayesian geo-additive model. A multivariate Bayesian geo-additive 
analysis handles missing data more effectively than a logistic regression analysis by 
computing a ‘dummy’ variable and imputing a value that represents the calculated 
probability of having this missing datum (Fahrmeir & Lang, 2001). This is important in 
predicting the likelihood of hypertension because without proper handling of missing 
data, the results obtained from participants with complete data may differ 
significantly from the ones where data is missing. 
Thirdly, the sample design used in the DHS is a stratified multistage cluster sampling 
design, often with over-sampling of smaller domains such as urban areas or certain 
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regions of a country. The complex nature of the sampling employed in these surveys 
means that the derived data are strata-disproportionate and clustered at 
enumeration area. The availability of geographical information system at the level of 
primary sampling unit (PSU) (i.e. enumeration areas) enables the analysis of 
hypertension prevalence within each country using multivariate geo-statistical 
models to account for dependence of prevalence of neighbouring areas. 
Alternatively, depending on the availability of GIS information, the data were 
aggregated at an appropriate administrative boundary to enable lattice spatial 
modelling (Kandala et al., 2013; Kandala & Stranges, 2014).    
The geographical patterns of hypertension and possibly nonlinear effects of other 
factors were explored within a simultaneous, coherent regression framework, using 
a multivariate geo-additive, semi-parametric mixed model that simultaneously 
controls for spatial dependence and complex sampling design (Brezger et al., 2005; 
Kandala et al., 2009). In summary, a logit model for the binary outcome variable yi 
for the individual i in this framework can be written as  
Pr( 1| ) exp( exp() / (1 ))
i i i iy       
with a geo-additive semi-parametric predictor specified as 
'
1 1 2 2
( ) ( ) .. ( ) ( )
i i i p ip spat i i i
f x f x f x f s w        
 
where x refers to continuous covariates (age), w to other discrete variables (such as 
education, urban-rural residence etc.) and s refer to spatial variables that affect the 
outcome. The f functions are nonlinear smoothed effects.  fspat (si)  is the effect of the 
spatial covariate si  {1,...,S} (for example, districts  or provinces). Given the complexity 
of the model specification, Bayesian procedures will be used to estimate the model 
parameters instead of maximum likelihood methods.  P-spline priors will be assigned 
to the functions f1,..,..,fp, while a Markov random field prior will be used for  fspat (si)  
(Brezger et al., 2005; Kandala et al., 2009).   
Bayesian inference is based on posterior distributions and is carried out using 
(Markov chain Monte Carlo) McMC simulation techniques so that samples are drawn 
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j 
from full conditionals of single parameters or block parameters given the estimate. 
Let α denote the vector of all unknown parameters in the model (i.e. x = (f, fspat)) and 
𝜏 represent the vector of all variance components. Then, under usual conditional 
independence assumptions, for the binomial probit model, Bayesian inference can 
be based on the posterior given by the equation: 
    P(α|y) ∝ ∏ 𝐿𝑖𝑛𝑖=1 (𝑦𝑖 , 𝜂𝑖) ∏ {𝑝(𝛽𝑗|𝜏𝑗
2)𝑝(𝜏𝑗
2)}𝑝(𝑓𝑠𝑡𝑟|
𝑝
𝑗=1 𝜏𝑠𝑡𝑟
2 )𝑝(𝑓𝑢𝑛𝑠𝑡𝑟|𝜏𝑢𝑛𝑠𝑡𝑟
2 ) ∏ 𝑝(𝛾𝑗
𝑟
𝑗=1 )𝑝(𝜎
2) 
where βj, j = 1; ..., p, are the vectors of regression coefﬁcients corresponding to the 
functions fj. The full conditionals for the parameter vectors β1,…,..,βp  as well as the 
full conditionals for fstr, funstr and ﬁxed effects parameters y have known distributions. 
For the variance components   𝜏2j, j = 1,..., p, str, unstr, and σ
2 the full conditionals  
are inverse gamma distributions. Thus, a Gibbs sampler can be used for McMC 
simulation, drawing successively from the full conditionals for β1,..,..,βp, fstr, funstr, 𝜏
2
j, 
j= 1; ... ; p; str, unstr, and σ2.  Furthermore, effective sampling from the Gaussian full 
conditionals of nonlinear functions will be guaranteed by using Cholesky 
decompositions for band matrices (Fahrmeir & Lang, 2001; Kandala, 2006). 
This multivariate Bayesian geo-additive regression analysis, which permits Bayesian 
inference based on Markov chain Monte Carlo (McMC) simulation techniques, was 
carried out using BayesX software package version 2.9 (Brezger et al., 2005). The 
standard measure of effect was the posterior odds ratios (POR) with the 
corresponding 95% credible intervals. The estimated posterior ORs, and in essence, 
the maps, were adjusted for age and other variables in the dataset, and reported 
with the corresponding posterior probabilities at 80% and 95% nominal levels. The 
multivariate Bayesian geo-additive regression technique was also used to evaluate 
the significance of the posterior OR for the fixed, nonlinear and spatial effects, 
reflecting the patterns of hypertension prevalence on the maps.  
It is worth noting that Bayesian analyses conducted in this study were limited to the 
countries with the highest prevalence from each region such that Albania, Egypt, and 
Lesotho were selected from countries of Eastern Europe, North Africa, and Sub-
Saharan African regions respectively.  
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Disease mapping explores the geographical distribution of diseases within a 
population (Elliott et al., 2000). There are two distinct characteristics of disease 
mapping. The first one is the geographic distribution of diseases, which makes the 
relative location of events important, enabling the application of geographical 
information systems with a component of spatial statistics.  The second 
characteristic is that disease mapping enables analysis of disease incidence or 
prevalence from geographical information or geo-referenced disease data, such as 
Demographic Health Surveys (Lawson, 2009).  
Maps showing variation of diseases can help in elucidating the aetiology of the 
diseases; they can also be used for understanding the occurrence of diseases in 
small-areas; and they play an important role in monitoring the health of a 
community and in tackling epidemics (Elliott et al., 2000; Lawson & Williams, 2001). 
Disease mapping is employed in this research for examining country- and 
district/province-level geographic variation in hypertension prevalence using DHS 
datasets, as well as examining the potential influence of a wide range of traditional 
and emerging risk factors for hypertension in these countries, including socio-
demographic and major lifestyle factors as well as cardiovascular co-morbidities. 
After conducting the above analyses and geocoding, the results were presented at 
district/province levels using choropeth or shaded area mapping techniques (Lai et 
al., 2009), where the colour red represents districts or provinces with the highest 
posterior ORs and green represents districts or provinces with the lowest posterior 
ORs. Similarly, for the maps with the corresponding posterior probabilities at 80% 
and 95% nominal levels, white indicates a negative spatial effect (associated with 
reduced risk of hypertension), black a positive effect (an increased risk) and grey a 
non-significant effect. 
These maps provide a summary and visual presentation of the findings of this 
research which can be used for surveillance purposes, identification of high risk 
groups, and also for researchers to investigate the relationship between 
hypertension prevalence and explanatory covariates. To reiterate, these maps can be 
used by policy makers towards health resource allocation.  
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3.2.5.5 ETHICAL ISSUES 
No ethical approval was required, as the DHS datasets are publicly available. 
However, permission to use the datasets was sought and obtained from MEASURE 
DHS – an online repository of ready-to-use data for 89 countries from over 260 
surveys.  
It is worth mentioning that ethical approvals for conducting the demographic and 
health surveys were granted by the Health Ministries of all the 10 countries i.e. 
Albania, Armenia, Azerbaijan, Egypt, Lesotho, Maldives, Morocco, Senegal, Ukraine, 
and Uzbekistan. It is also worth emphasizing that written informed consents were 
obtained from the participants in each DHS survey. 
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CHAPTER FOUR: RESULTS 
This chapter presents the results of this research and it is divided into two sections. 
The first section (Section A) presents the results of the systematic review and meta-
analysis. The second section (Section B) presents the results of the secondary data 
analysis. The findings presented in section A have been published: Sarki A., et al. 
(2015) Prevalence of hypertension in low- and middle-income countries: A 
systematic review and meta-analysis. Medicine 94(50): e1959. 
4.1 SECTION A-  S Y S TE MA T I C  R EV I E W AN D  
M E TA - AN AL Y S I S  
4.1.1 STUDY SELECTION 
Figure 4.1 is a PRISMA flow diagram showing study selection. The literature search 
yielded 3226 records from the database search and an additional 89 records from 
grey literature search. Of note, the grey literature search included theses, 
conference abstracts and additional full-text articles. Upon screening, 763 duplicate 
records were removed, and an additional 2148 articles were excluded by their titles 
and abstracts, leaving 404 full-text articles assessed for eligibility. One hundred sixty-
two (162) full-text articles were subsequently excluded for not meeting the eligibility 
criteria, leaving 242 full-text articles that were included in the systematic review and 
meta-analysis.  
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Figure 4.1: PRISMA flow diagram showing study selection  
4.1.2 DESCRIPTIVE CHARACTERISTICS OF THE INCLUDED STUDIES  
The included studies comprised a total of 1,494,609 participants (52% females) from 
45 countries (see Table 4.1). Most of the studies were conducted in India (n=50 
studies; 20.7%), followed by Brazil (n=26; 10.7%), Nigeria (n=17; 11%), and China 
(n=9; 6%).  Although a third of the included studies (n=74; 30.6%) originated from 
sub-Saharan African countries, all six regions, including East Asia and Pacific, Europe 
and Central Asia, Latin America and Caribbean, Middle East and North Africa, South 
Asia, and sub-Saharan Africa were represented in this review. All included studies 
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were observational (predominantly cross-sectional) and population-based. Overall, 
the mean age (± standard deviation) of the study population was 45.9 ± 12.1 years; 
about one in five participants were smokers; 23.1% were current drinkers; about half 
of the total study population were obese or overweight; and more than a quarter 
were non-educated. These characteristics are summarised by region in Table 4.2 and 
Supplementary Tables 1 to 6 in the Appendix.  
Table 4.1: Included countries grouped by World Bank regions 
East Asia and 
Pacific 
 
Europe and 
Central Asia 
 
Latin America 
and Caribbean 
 
Middle East 
and North 
Africa 
 
South Asia 
 
Sub-Saharan 
Africa 
 
China Albania Brazil Egypt India Burkina Faso 
Federated 
States of 
Micronesia 
Armenia Cuba Iran Nepal Cameroon 
Malaysia Azerbaijan Dominican 
Republic 
Morocco Pakistan Ethiopia 
Thailand Romania Haiti Yemen Sri Lanka Ghana 
Vietnam Turkey Mexico Lebanon Bangladesh Kenya 
 Ukraine Panama   Malawi 
 Uzbekistan Peru   Mozambique 
 Kazakhstan Venezuela   Namibia 
     Nigeria 
     Senegal 
     South Africa 
     Sudan 
     Tanzania 
     Uganda 
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Table 4.2: Characteristics of included studies by regions 
 
 
Characteristics 
 
East Asia 
and Pacific 
 
 
Europe and 
Central Asia 
 
 
Latin America 
and 
Caribbean 
 
 
Middle East and 
North Africa 
 
 
South Asia 
 
 
Sub-Saharan 
Africa 
  
Mean age ±SD (y)  
 
 
51.7 ±9.1                  
 
35.7± 11.4                     
 
 
50.5 ± 11.6                                  
 
 
49.3 ± 12.1                     
 
  
42.3 ± 11.0   
 
41.0 ±13.1                                                
Males (%)  
(95% CI) 
 
 
49.1 
(37.2–60.4)   
 
 
37.9  
(38.6–46.5)   
 
 
43.4  
(38.9–47.1)   
 
 
44.0  
(40.0–47.3)   
 
 
48.9  
(40.7–56.1)   
 
 
44.2  
(42.0–46.0)   
 
 
Smokers (%)  
(95% CI)  
 
 
30.8  
(22.0–40.0)  
 
 
20.3 
(7.7–37.0)  
 
 
21.0  
(17.8–24.2)  
 
 
7.0  
(1.4–14.7)  
 
 
27.0  
(15.0–40.3) 
 
 
10.7  
(7.2–15.5)   
 
 
Alcohol users (%) 
(95% CI) 
 
 
26.2  
(21.4–31.0) 
 
 
24.0  
(23.1–25.0) 
 
   
19.8  
(13.0–28.7)   
 
 
2.6  
(2.5–2.9) 
 
 
33.0  
(17.6–48.8)   
 
 
32.8  
(24.5–41.7)   
 
 
Overweight/obese 
(%) (95% CI) 
 
 
29.0  
(18.4–41.0)   
 
 
52.3  
(24.9–79.1)   
 
 
46.8  
(41.0–53.9)   
 
 
56.8  
(40.6–73.2)   
 
 
32.0  
(26.9–38.0)   
 
 
30.4  
(24.2–36.3)   
 
 
Non-educated (%) 
(95% CI)  
 
 
32.1  
(19.0–46.9)  
 
 
15.7  
(14.7–16.7)   
 
 
23.6  
(13.9–37.0)  
 
 
23.2  
(22.8–24.3)   
 
 
38.0  
(31.0–45.2)  
 
 
28.1  
(19.4–36.7)  
 
 
CI=confidence intervals, SD=standard deviation, y=years 
 
4.1.3 RISK OF BIAS OF INCLUDED STUDIES 
The methodological quality of this review entailed assessing the risk of bias for each 
included study using a domain-based tool adapted from the Newcastle-Ottawa scale 
(Wells et al., 2014). The risk of bias in each study was classified as low, moderate, 
high or unclear across the following domains: selection of participants (selection 
bias), sample size justification (selection bias), outcome measurement (detection 
bias), and confounding adjustment. Based on confounding adjustment, 227 studies 
(94%) adjusted for at least one major potential confounder. Summary of risk of bias 
assessment for each study is shown in appendix VII. 
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4.1.4 OVERALL PREVALENCE OF HYPERTENSION IN LOW- AND MIDDLE-
INCOME COUNTRIES 
All 242 studies reported crude prevalence estimates of hypertension and were 
included in the meta-analysis. Overall, the pooled prevalence of hypertension was 
32.3% (95% CI 29.4–35.3), with estimates ranging from 2.5% (95% CI 1.9–3.2) in rural 
India (Gupta & Sharma, 1994) to 90% (95% CI 89.9–90.2) in Vietnam (Thuy et al., 
2010)(See Figure 4.4).  
The overall I2 statistic was 99.9%, indicating a large amount of heterogeneity in the 
prevalence estimates of hypertension across the included studies. As determined by 
meta-regression analysis, the observed heterogeneity was explained by differences 
between studies in mean age, BMI categories, educational status, and employment 
status (P < 0.05 for each) (Figures 4.3 to 4.5). Differences in smoking status 
(P=0.988), alcohol use (P=0.150), gender (P=0.763), place of residence (P=0.338) did 
not account for the observed heterogeneity in the meta-analysis.  
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Figure 4.2: Country-specific hypertension prevalence from the countries included in the 
systematic review and meta-analysis 
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Figure 4.3: Bubble plot showing mean age (in years) accounting for significant heterogeneity 
in hypertension prevalence estimates between studies 
 
 
Figure 4.4: Bubble plot showing combined overweight/obesity accounting for significant 
heterogeneity in hypertension prevalence estimates between studies 
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Figure 4.5: Bubble plot showing educational status accounting for significant heterogeneity 
in hypertension prevalence estimates between studies 
4.1.5 POOLED PREVALENCE OF HYPERTENSION PREVALENCE BY 
GEOGRAPHICAL REGION 
The results of the subgroup analysis of hypertension prevalence by geographical 
region are presented in Figure 4.2 and Supplementary Figures 1 - 5. The region with 
the highest prevalence of hypertension was Latin America and Caribbean (39.1% 
[95% CI 33.1–45.2]), whereas, the Middle East and North Africa region had the 
lowest rate (26.9% [95% CI 19.3–35.3]). 
4.1.6 POOLED PREVALENCE BY COUNTRY INCOME GROUP 
Upper-middle income countries had a higher prevalence of hypertension (37.8% 
[95% CI 35.0–40.6]), compared to lower-middle income (31.1% [95% CI 26.1–36.4]) 
and low-income countries (23.1% [95% CI 20.1–26.2]) (Figure 4.2, Supplementary 
Figures 7–9).  
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4.1.7 POOLED PREVALENCE BY PLACE OF RESIDENCE 
Hypertension prevalence was higher among populations in urban settings (32.7% 
[95% CI 30.4–35. 0]), compared to populations in rural settings (25.2% [95% CI 20.9–
29.8]) (Figure 4.2, Supplementary Figures 10 and 11).  
 
Figure 4.6: Forest plot showing prevalence estimates of hypertension by region, country 
income group, and place of residence 
 
4.1.8 POOLED PREVALENCE OF HYPERTENSION BY PARTICIPANTS’ SOCIO-
DEMOGRAPHIC CHARACTERISTICS 
Patterns of hypertension across different socio-demographic characteristics for each 
region were summarised in Table 4.3. In all regions except the Middle East and North 
Africa region, where no data on hypertension prevalence was reported for the 
elderly (≥ 65 years), the proportion of hypertension was substantially higher among 
.
.
.
Region
Middle East and North Africa
South Asia
Europe and Central Asia
Sub-Saharan Africa
East Asia and Pacific
Latin America and Caribbean
Income
Low-income
Lower middle-income
Upper Middle-income
Residence
Rural
Urban
Subgroup
26.30 (19.20, 34.00)
26.80 (22.90, 30.80)
28.30 (22.60, 34.30)
32.10 (27.70, 36.60)
34.00 (28.70, 39.40)
40.10 (34.00, 46.40)
23.80 (19.90, 27.90)
29.90 (26.70, 33.20)
38.00 (34.50, 41.50)
25.20 (21.70, 28.80)
32.20 (29.90, 34.50)
Prevalence (95% CI)
8
29
11
51
19
34
23
62
67
26
58
studies
Number ofSummary Forest Plot by Region, Income group, and Place of residence
 Prevalence of hypertension (%) 
0 10 20 30 40 50
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adults ≥ 65 years, compared to adults < 65 years. Overall, the prevalence of 
hypertension was high among adults above 65 years, compared to those younger 
than 65 years (66% versus 29%, P < 0.05) 
Although prevalence of hypertension in men overall (33%) was slightly higher 
compared with women (31.2%), this difference was not statistically significant 
overall (P = 0.76). Additionally, no significant sex-deference in hypertension 
prevalence was observed by region. 
There were higher proportions of hypertension among non-smokers compared to 
smokers in Europe and Central Asia, Latin America and Caribbean, and Middle East 
and North Africa regions, whereas the proportions of hypertension were higher 
amongst smokers compared to non-smokers in East Asia and Pacific, South Asia, and 
Sub-Saharan Africa regions. Overall, hypertension prevalence was significantly higher 
among non-smokers, compared to smokers (32% versus 29%, P < 0.05). 
Alcohol use data was not reported in any study originating from countries in the 
Middle East and North Africa or the East Asia and Pacific regions. With the exception 
of the sub-Saharan Africa region, hypertension rates were comparable between non-
drinkers and current drinkers: non-drinkers had a substantially higher proportion of 
hypertension compared to current drinkers in sub-Saharan Africa (32.0% vs 
21.7%). Overall, hypertension prevalence was significantly higher among non-
drinkers, compared to drinkers (30.5% versus 23.5%, P < 0.05).  
Importantly, hypertension rates were consistently higher among overweight/obese 
participants, compared to normal weight persons across all regions, and overall (48% 
vs 27%, P < 0.05). 
With respect to study setting, prevalence estimates of hypertension were higher in 
urban communities, compared to participants in rural settings in the Latin America 
and Caribbean region, East Asia and Pacific, South Asia, and Sub-Saharan Africa. 
Overall, hypertension prevalence was also higher among urban settlers, compared to 
rural settlers (36% versus 32%, P < 0.05). 
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Hypertension rates were generally higher among the non-educated, compared to 
participants with a primary education (50.2% versus 36.3%, P < 0.005) and 
participants with a secondary or tertiary education (50.2% versus 25%, P < 0.05). 
Hypertension rates were also higher among unemployed people, compared to 
employed people (36% versus 31%) (P < 0.05). 
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Table 4.3: Prevalence estimates of hypertension across socio-demographic characteristics by region and overall 
 
 
Characteristics 
   
East Asia and 
Pacific 
 
 
Europe and 
Central Asia 
 
 
Latin America and 
Caribbean 
 
 
Middle East and 
North Africa 
 
 
South Asia                        
 
Sub-Saharan Africa                  
 
Overall 
Region  
 
35.7 (32.2–39.4) 
 
31.5 (25.4–37.9) 
 
39.1 (33.1–45.2) 
 
26.9 (19.3–35.3) 
 
29.4 (22.3–37.0) 
 
31.1 (27.6–34.6) 
 
32.3 (29.4-35.3) 
Age group  
18-64 y 
Elderly (≥65 y) 
23.9 (17.4–30.9)* 
76.5 (61.0–81.0)   
 
39.0 (26.0–52.8)*   
78.6 (71.2–85.1)   
 
30.3 (25.1–35.8)*   
58.9 (52.7–65.0)   
 
32.4 (18.7–47.9)   
- 
 
26.1 (20.3–32.3)*   
53.2 (33.9–72.0)   
 
24.4 (20.0–36.0)*   
61.0 (49.3–72.1) 
 
29.4 (21.2-39.3)* 
65.6 (53.6-75.0) 
Gender   
Male  
Female 
 
35.5 (28.2-43.1)   
30.6 (21.3-40.7)   
 
28.5 (22.8-34.5)   
27.0 (20.6-33.9)   
 
36.3 (31.2-41.7)   
39.6 (34.1-45.2)   
 
28.3 (20.1-37.2)   
27.1 (18.7-36.4)   
 
35.4 (17.9-55.2)   
29.4 (24.3-34.8)   
 
33.8 (28.7-39.2)   
33.4 (27.3-39.7)   
 
33.0 (24.8-41.8) 
31.2 (24.4-38.5) 
Smoker status   
Non-smoker 
Smoker 
 
20.0 (18.1-22.0)*  
32.0 (28.7-35.4)  
 
30.7 (16.4-47.2)* 
20.9 (9.6-35.0) 
 
40.2 (35.0-45.4)  
38.3 (30.5-46.4)  
 
48.0 (7.7-89.9)*  
23.1 (11.3-37.4)  
 
27.7 (15.4-41.9)* 
36.0 (27.8-44.6)   
 
25.7 (22.6-29.0)   
23.9 (18.1-30.3)   
 
32.1 (19.2-45.9)* 
29.0 (21.0-38.2) 
Alcohol use   
Non-drinkers 
Current drinkers 
 
- 
- 
 
28.4 (13.7-45.9)   
29.2 (14.8-46.2)   
 
35.9 (29.5-42.7)   
34.8 (29.9-39.8)   
 
- 
- 
 
28.0 (18.8-38.2)   
32.1 (18.7-47.1)   
 
32.0 (20.9-44.2)*  
21.7 (14.6-29.6)   
 
30.5 (16.6-34.2)* 
23.5 (15.6-27.6) 
Study setting   
Rural 
Urban 
 
47.5 (25.5-70.1)* 
51.2 (32.8-69.5) 
 
29.8 (3.3-68.4)* 
26.4 (4.9-56.9) 
 
42.8 (26.1-60.4 ) * 
51.2 (30.1-72.0)   
 
15.8 (8.2-25.4)   
15.4 (8.3-24.3)   
 
28.0 (19.2-37.8)*   
35.9 (19.1-54.7)   
 
29.9 (22.6-37.9)* 
34.9 (23.0-47.8)   
 
32.3 (17.5-50.0)* 
35.8 (19.7-54.2) 
BMI category   
Normal weight 
Overweight/Obese 
 
21.7 (20.0-23.5)*   
45.8 (37.3-54.4)   
 
18.4 (12.0-25.8)*  
51.8 (32.9-70.5)   
 
28.0 (23.2-32.9)*   
48.8 (44.1-53.4)   
 
46.7 (6.6-89.5)*   
58.3 (20.5-91.2)   
 
23.3 (15.8-31.8)*   
40.4 (31.1-50.1)   
 
22.6 (19.1-26.3)*   
41.1 (35.5-46.9)   
 
26.8 (16.1-38.3)* 
47.7 (33.6-61.1) 
Education   
No education 
Primary 
≥Secondary 
 
65.4 (43.8-84.2)*   
47.8 (21.1-75.2)   
29.5 (17.4-43.3)   
 
57.2 (22.7-88.2)*   
26.1 (7.0-51.8)   
21.4 (17.1-26.0)   
 
50.4 (37.5-63.2)*   
45.2 (37.7-52.8)   
25.7 (23.2-28.3)   
 
48.3 (26.7-70.2)*   
25.7 (16.6-36.1)   
18.6 (13.8-23.9)   
 
31.1 (16.7-47.8)   
39.4 (33.1-45.8)   
27.9 (21.2-35.1)   
 
48.5 (35.2-61.9)*   
33.4 (26.6-40.5)   
27.0 (20.1-34.5) 
50.2 (30.4-69.3)* 
36.3 (23.7-50.4) 
25.0 (18.8-31.9) 
 
Employment  
 
Unemployed 
Employed 
 
44.0 (39.0-49.0)*   
16.0 (11.0-22.0)   
 
29.0 (5.0-63.0)*  
31.0 (25.0-38.0)   
 
47.0 (37.0-57.0)*   
57.0 (33.0-79.0)   
 
23.0 (14.0-34.0)*   
29.0 (27.0-31.0)   
 
32.0 (20.0-45.0)*   
24.0 (18.0-32.0)   
 
43.0 (40.0-46.0)*   
30.0 (25.0-35.0)   
 
36.3 (25.8-49.0)* 
31.2 (23.2-49.5) 
Hypertension prevalence was reported with 95% confidence intervals. * = (P < 0.05). BMI=body mass index, y=year
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4.2 SECTION B –  S E COND AR Y  D A TA  AN AL Y S I S   
4.2.1 DESCRIPTION OF THE SAMPLE POPULATIONS IN THE DATASETS 
A total of 93, 247 participants from 10 countries were included in the analysis. As 
shown in Table 4.3, there were more female participants than male participants in all 
the countries except Morocco where only data for women were provided. This is not 
surprising because the DHS was designed predominantly to target women in order to 
measure their understanding of family planning and fertility issues.  
In each country, the majority of the participants were less than 45 years of age. 
Respondents from the sub-Saharan African countries (Lesotho and Senegal) were 
younger than those from other countries.  
The highest proportions of respondents with formal education were found in the 
Eastern European countries (Albania, Armenia, Azerbaijan, Ukraine, Uzbekistan), 
whereas countries in Africa (Senegal and Morocco) had the highest proportions of 
respondents without formal education.  
Respondents from Eastern European countries were more likely to be living in urban 
settings than in rural settings; whereas, African countries generally had higher 
proportions of rural settlers than urban settlers.  
Apart from Uzbekistan, there was a higher percentage of non-smokers compared to 
smokers in each country. Ukraine, Uzbekistan and Lesotho had higher proportions of 
current drinkers than non-drinkers, whereas Albania had a higher proportion of non-
drinkers compared to drinkers. The other countries not mentioned had no data on 
alcohol consumption. 
Across the 10 countries, respondents from each wealth quintile were fairly 
represented. However, unlike the other countries, respondents from Ukraine and 
Maldives were more likely to be employed than unemployed.  
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Table 4.3: Baseline characteristics of study populations in included countries 
   Eastern Europe    North Africa Sub-Saharan Africa Indian Sub-Continent 
 Albania [n (%)] Armenia [n (%)] Azerbaijan [n (%)] Ukraine [n 
(%)] 
Uzbekistan [n 
(%)] 
Egypt [n (%)] Morocco [n 
(%)] 
Lesotho [n (%)] Senegal [n (%)] Maldives [n (%)] 
Gender            
Female 7,584 (71.6) 5,922 (78.9) 8,444 (76.8) 6,841 (68.3) 5,463 (70.1) 6,578 (54.8) 16,798 7,624 (69.7) 15,688 (76.1) 7,131 (80.5) 
Male 3,013 (28.4) 1,584 (21.1) 2,558 (23.3) 3,178 (31.7) 2,333 (29.9) 5,430 (45.2) - 3,317 (30.3) 4,929 (23.9) 1,727 (19.5) 
Age group            
15-24 3,526 (33.3) 2,434 (32.4) 3,589 (32.6) 2,717 (27.1) 2,930 (37.6) 4,141 (34.5) 6,368 (37.9) 4,865 (44.5) 8,921 (43.3) 1,647 (18.6) 
25-34 2,237 (21.1) 2,233 (29.8) 2,679 (24.4) 2,858 (28.5) 2,220 (28.5) 2,969 (24.7) 4,847 (28.9) 2,995 (27.4) 5,967 (28.9) 3,231 (36.5) 
35-44 3,223 (30.4) 1,735 (23.1) 3,102 (28.2) 2,851 (28.5) 1,814 (23.3) 2,379 (19.8) 3,892 (23.2) 1,905 (17.4) 3,931 (19.1) 2,660 (30.0) 
45-54 1,611 (15.2) 1,104 (14.7) 1,530 (13.9) 1,593 (15.9) 774 (9.9) 1,826 (15.2) 1,691 (10.1) 1,010 (9.2) 1,561 (7.6) 1,134 (12.8) 
≥55 - - 102 (0.93) - 58 (0.7) 693 (5.8) - 166 (1.5) 237 (1.2) 186 (2.1) 
Education            
No Education 52 (0.49) 4 (0.05) 127 (1.2) 4 (0.0) - 2,736 (22.8) 8,917 (53.1) 615 (5.6) 11,898 (57.7) 2,587 (29.7) 
Primary 4,850 (45.8) 542 (7.2) 148 (1.4) 13 (0.1) 4,322 (55.6) 1,653 (13.8) 3,253 (19.4) 5,526 (50.5) 4,392 (21.3) 3,037 (34.8) 
Secondary  4,364 (41.2) 2,867 (38.2) 9,323 (84.7) 4,625 (46.2) 755 (9.7) 5,782 (48.2) 3,821 (22.8) 4,271 (39.0) 4,055 (19.7) 2,812 (32.3) 
Higher 1,331 (12.6) 4,093 (54.5) 1,404 (12.8) 5,377 (53.7) 2,714 (33.76) 1,837 (15.3) 807 (4.8) 529 (4.8) 272 (1.3) 284 (3.3) 
Place of residence            
Rural 5,096 (48.1) 2,477 (33.0) 5,167 (47.0) 3,735 (37.3) 4,366 (56.0) 6,942 (57.8) 7,801 (46.4) 8,228 (75.2) 12,367 (60.0) 7,543 (85.2) 
Urban 5,501 (51.9) 5,029 (67.0) 5,835 (53.0) 6,284 (62.7) 3,430 (44.0) 5,066 (42.2) 8,997 (53.6) 2,713 (24.8) 8,250 (40.0) 1,315 (14.9) 
Currently smoking            
No 9,455 (89.2) 6,467 (86.2) 1,335 (52.2) 7,391 (74.0) 341 (33.2) 9,942 (82.9) - 9,769 (89.6) 19,831 (96.2) 7,884 (89.1) 
Yes 1,142 (10.8) 1,033 (13.8) 1,221 (47.8) 2,594 (26.0) 687 (66.8) 2,054 (17.1) - 1,141 (10.4) 784 (3.8) 962 (10.9) 
Currently drink alcohol           
No 6,311 (59.6) - - 1,408 (14.1) 3,684 (47.3) - - 1,542 (46.5) - - 
Yes 4,286 (40.5) - - 8,576 (85.9) 4,111 (52.7) - - 1,773 (53.5) - - 
Wealth quintile            
Lowest 2,135 (20.2) 1,378 (18.4) 2,276 (20.7) 1,512 (15.1) - 2,326 (19.4) 3,527 (21.0) 2,167 (19.8) 4,911 (23.8) 1,929 (21.8) 
Second 1,812 (17.1) 1,619 (21.6) 2,351 (21.4) 2,494 (24.9) - 2,580 (21.5) 3,512 (20.9) 2,148 (19.6) 4,655 (22.6) 2,263 (25.6) 
Middle 1,899 (17.9) 1,678 (22.4) 2,448 (22.2) 2,052 (20.5) - 2,449 (20.4) 3,299 (19.6) 2,088 (19.1) 4,730 (22.9) 2,420 (27.3) 
Fourth 2,473 (23.3) 1,646 (21.9) 2,150 (19.5) 1,815 (18.1) - 2,190 (18.2) 3,132 (18.7) 2,229 (20.4) 3,571 (17.3) 1,396 (15.8) 
Highest 2,278 (21.5) 1,185 (15.8) 1,777 (16.2) 2,146 (21.4) - 2,463 (20.5) 3,328 (19.8) 2,309 (21.1) 2,750 (13.3) 850 (9.6) 
Marital status            
Never married or living alone 3,950 (37.3) 2,942 (39.2) 6,933 (63.0) 4,492 (44.8) - 4,336 (36.1) 7,947 (47.3) 5,409 (49.4) 7,761 (37.6) 655 (7.4) 
Married or living together 6,647 (62.7) 4,564 (60.8) 4,069 (37.0) 5,527 (55.2) - 7,672 (63.9) 8,851 (52.7) 5,532 (50.6) 12,856 (62.4) 8,203 (92.6) 
Currently working            
No 6,368 (60.1) 4,593 (61.2) 7,713 (70.4) 2,832 (28.3) 4,093 (52.5) 6,675 (97.1) 13,426 (80.0) 5,996 (54.8) 10,951 (53.1) 4,236 (47.9) 
Yes 4,229 (39.9) 2,905 (38.7) 3,248 (29.6) 7,164 (71.7) 3,700 (47.5) 201 (2.9) 3,361 (20.0) 4,943 (45.2) 9,666 (46.9) 4,604 (52.1) 
Diabetes           
Non diabetic - 1,761 (97.2) 10,320 (99.0) - - 11,627 (96.8) - 9,443 (98.1) 20,540 (99.6) 8,399 (96.7) 
Diabetic - 51 (2.81) 106 (1.0) - - 381 (3.2) - 182 (1.9) 77 (0.4) 289 (3.3) 
Heart disease           
No 5,065 (47.8) - 2,653 (91.3) - - 11,903 (99.2) - - 20,478 (99.3) 8,627 (97.5) 
Yes 5,532 (52.2) - 254 (8.7) - - 99 (0.8) - - 139 (0.7) 219 (2.5) 
Stroke           
No 9,455 (89.2) - 2,857 (98.4) - - 11,936 (99.5) - - - 8,658 (98.0) 
Yes 1,142 (10.8) - 46 (1.6) - - 65 (0.5) - - - 175 (2.0) 
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4.2.1.1 PREVALENCE OF HYPERTENSION ACCORDING TO SOCIO-
DEMOGRAPHIC CHARACTERISTICS IN SELECTED COUNTRIES  
As shown in Table 4.4, the prevalence of hypertension was highest in Albania (22.7%) 
but lowest in Morocco (5.4%).  
Prevalence estimates of hypertension were higher among men in Albania, Ukraine, 
Uzbekistan, Lesotho, and the Maldives; whereas women in Armenia, Azerbaijan, 
Egypt, and Senegal had higher proportions of hypertension compared to their male 
counterparts.  
The proportion of hypertension increased significantly with age in all countries except 
Senegal, where hypertension prevalence was relatively low among respondents aged 
55 years and above. It is worth emphasizing that there were only 237 respondents 
(1.2%) aged 55 years and above in Senegal, so that the findings in this small sample 
size may not be generalizable to all adults within this age group in the country.  
In Ukraine, Egypt, Senegal and Maldives, the prevalence of hypertension was highest 
in respondents without formal education; whereas in Lesotho, hypertension 
prevalence was highest among respondents with the highest level of educational 
attainment.  
Respondents living in rural areas in the Eastern European countries were more likely 
to have a higher prevalence of hypertension, compared to respondents who lived in 
urban areas. Conversely, prevalence estimates of hypertension in countries in other 
regions were higher in urban areas than in rural areas.  
Hypertension prevalence was significantly higher among current smokers than non-
smokers in Albania, Azerbaijan and Ukraine. Conversely, non-smokers in Senegal 
reported significantly higher rates of hypertension, compared to smokers. In 
countries with alcohol use data (Albania, Uzbekistan and Lesotho), hypertension rates 
were higher among drinkers than non-drinkers.    
Respondents within the lowest wealth quintiles in Albania, Armenia, and Ukraine 
presented the highest prevalence of hypertension. Whereas respondents within the 
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highest wealth Quintiles in Egypt, Morocco, Lesotho, and the Maldives recorded the 
highest proportions of hypertension. 
The proportion of hypertension was higher among respondents who were employed 
compared to their unemployed counterparts in all the Eastern European countries, 
and in Senegal and Egypt, whereas no significant association between employment 
status and hypertension prevalence was observed in the other countries. 
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Table 4.4: Prevalence of hypertension by socio-demographic characteristics in included countries 
   Eastern Europe    North Africa Sub-Saharan Africa Indian Sub-Continent 
 Albania (%) Armenia (%) Azerbaijan (%) Ukraine (%) Uzbekistan (%) Egypt (%) Morocco (%) Lesotho (%) Senegal (%) Maldives (%) 
Overall prevalence 22.7 17.2 12.3 17.3 9.8 15.7 5.4 12.5 7.2 7.6 
Overall Mean Age (SD) 31.7 (10.9) 31.2 (10.2) 31.7 (10.8) 32.4 (10.0) 29.9 (10.4) 32.4 (12.5) 29.6 (10.0) 28.5 (10.6) 28.3 (10.1) 33.9 (9.3) 
Gender            
Male 26.3
*
 12.8
*
 11.0
*
 17.8 11.2
*
 13.5
*
 - 13.2 1.7
*
 8.6 
Female 19.8 18.0 12.7 17.1 9.2 17.5 5.4 12.2 9.0 7.4 
Age group            
15-24 10.7* 3.0* 3.7* 3.4* 3.5* 6.4* 3.6* 5.9* 3.2* 2.4* 
25-34 18.0 11.1 9.1 10.6 7.2 11.0 5.7 11.8 7.9 3.8 
35-44 30.5 24.4 17.5 25.2 15.6 18.7 5.9 20.7 12.4 9.3 
45-54 38.4 44.6 25.4 39.1 26.2 30.5 10.9 27.6 14.0 18.6 
≥55 - - 40.2 - 29.3 41.7 - 35.5 8.9 30.1 
Education            
No Education 14.3
*
 - 11.0
*
 50.0
* 
- 21.9
*
 5.2 11.4
*
 8.2
*
 14.0
*
 
Primary 27.1 12.2
*
 8.8 16.7 9.1
*
 20.2 5.7 12.5 7.5 6.5 
Secondary  21.5 20.0 12.7 17.8 7.8 12.0 5.6 11.8 4.2 3.5 
Higher 11.8 16.0 10.0 16.8 11.6 13.8 7.0 20.6 4.0 3.5 
Place of residence            
Rural 26.9* 18.9 11.7* 19.4* 9.9 14.7* 4.8* 11.8* 6.3* 7.5 
Urban 19.1 16.3 12.9 16.0 9.7 17.0 6.2 14.7 8.7 8.7 
Currently smoking            
No 20.4* 17.2 9.7* 16.7* 15.8 15.6 - 12.4 7.5* 7.6 
Yes 30.8 16.9 12.4 19.3 15.3 15.9 - 13.7 1.7 8.4 
Currently drink alcohol           
No 18.9* - - - 7.8* - - 11.2* - - 
Yes 27.0 - - - 11.6 - - 14.9 - - 
Wealth quintile            
Lowest 28.9* 23.1* 12.7* 19.6* - 14.4 4.8 10.0* 4.9* 7.8 
Second 24.0 17.3 13.1 18.4 - 15.4 5.1 10.5 6.6 7.7 
Middle 24.9 14.9 13.4 17.9 - 15.6 5.9 12.7 7.8 7.6 
Fourth 22.7 16.4 12.2 16.1 - 15.4 4.5 13.7 9.8 6.8 
Highest 14.9 15.7 9.2 14.9 - 17.5 7.1 15.5 8.2 8.5 
Marital status            
Never married or living alone 13.5* 8.6* 7.0* 13.1* - 10.0* 10.6* 9.6* 3.2* 9.9* 
Married or living together 28.5 20.5 15.4 20.7 - 18.9 5.3 15.4 9.6 7.5 
Currently working            
No 19.1* 15.5* 11.8* 11.8* 8.6* 15.4* 5.2 9.8* 6.7* 7.2 
Yes 27.0 20.3 13.4 19.5 11.2 23.4 6.6 15.8 7.9 8.0 
Diabetes           
Non diabetic - 16.4* 12.0* - - 14.4* - 12.7* 7.2* 6.7* 
Diabetic - 45.1 41.5 - - 56.2 - 36.3 20.8 34.6 
Heart disease           
No 22.0 - 23.5* - - 15.3* - - 7.2* 7.3* 
Yes 23.2 - 33.9 - - 58.6 - - 10.1 20.0 
Stroke           
No 23.0 - 24.5 - - 15.5* - - - 7.5* 
Yes 20.7 - 23.9 - - 41.5 - - - 15.2 
Key: *= p<0.05   
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4.2.1.2 SOCIO-DEMOGRAPHIC PATTERNS OF HYPERTENSION 
PREVALENCE IN PERSONS AGED 15 – 24 YEARS  
Table 4.5 illustrates that the prevalence of hypertension was highest among 15-24 
year olds living in Albania (10.7%) and lowest in the Maldives (2.4%).                                        
Overall, prevalence estimates of hypertension in each country was lower for each 
group, compared to the overall estimates. 
The proportion of hypertension was higher among men in Albania, Azerbaijan, 
Ukraine, Uzbekistan, and Lesotho. 
Respondents with progressively higher levels of education attainment had lower 
hypertension prevalence in Albania, Armenia, Azerbaijan, Ukraine, and Egypt. In 
contrast, respondents with progressively higher levels of education attainment had 
higher prevalence estimates of hypertension in Uzbekistan, Morocco, Maldives, and 
Lesotho.  
Respondents living in rural areas in the Eastern European countries had higher 
prevalence of hypertension, compared to those living in urban areas. However, in 
Morocco, Lesotho, Senegal, and Maldives, respondents living in urban settings had 
slightly higher prevalence estimates of hypertension.  
Hypertension prevalence was higher among current smokers than non-smokers in all 
countries except Uzbekistan, where the reverse was the case. Regarding alcohol 
consumption, the proportion of hypertension was significantly higher among current 
drinkers compared to non-drinkers in all countries with alcohol use data. 
With the exception Morocco, Senegal, and Maldives, respondents within the lowest 
wealth quintiles had the highest prevalence of hypertension. 
There was no pattern of note regarding the prevalence of hypertension according to 
employment status.  
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Table 4.5: Socio-demographic patterns of hypertension prevalence in persons aged 15-24 years in selected countries 
   Eastern Europe    North Africa Sub-Saharan Africa Indian Sub-Continent 
 Albania (%) Armenia (%) Azerbaijan (%) Ukraine (%) Uzbekistan (%) Egypt (%) Morocco (%) Lesotho (%) Senegal (%) Maldives (%) 
Overall prevalence 10.7 3.0 3.7 3.4 3.5 6.4 3.6 5.9 3.2 2.4 
Gender           
    Female 7.7* 3.5 3.6 3.3 3.0* 6.9 3.6 5.9 4.2* 2.4 
    Male 14.1 1.6 4.1 3.8 4.8 5.9 - 6.0 0.2 3.1 
Education            
No Education - - - - - 7.9 3.3 3.0 3.9* 0.0 
Primary 14.6* 2.0 7.4 - 3.1 6.4 3.0 6.0 3.4 2.3 
Secondary  9.2 4.4 3.7 3.6 3.1 6.4 5.0 5.9 2.2 2.5 
Higher 4.3 2.3 3.8 3.3 9.3 5.6 7.1 6.3 6.0 3.1 
Place of residence            
Rural 13.8* 4.0 4.8* 4.2 10.0 6.5 3.1 5.8 3.0 2.2 
Urban 7.7 2.4 2.7 3.0 8.1 6.3 4.2 6.2 3.6 3.9 
Currently smoking            
No 9.6* 2.9 3.3* 3.0* 10.6 6.2 - 5.8 - 2.3 
Yes 18.4 4.3 7.0 5.1 8.3 7.9 - 7.4 - 4.0 
Currently drink alcohol           
No 19.7* - - 1.6* 2.8* - - - - - 
Yes 20.0 - - 4.1 4.6 - - - - - 
Wealth quintile            
Lowest 16.8* 5.1 5.0* 5.2 - 7.9 1.8 6.7 2.6 3.4 
Second 13.0 1.6 3.7 2.6 - 5.6 4.0 5.4 3.0 1.7 
Middle 9.0 2.7 3.8 4.1 - 7.5 3.6 6.0 3.2 2.2 
Fourth 9.2 4.0 4.0 2.4 - 5.1 4.5 6.6 4.0 1.9 
Highest 6.0 2.0 1.8 3.5 - 5.6 5.4 4.6 3.6 4.5 
Marital status            
Never married or living alone 11.0 1.3* 3.0* 2.5* - 5.8* - 5.1* 1.7* 1.1 
Married or living together 7.9 5.2 5.9 7.2 - 8.3 3.7 7.9 6.1 2.5 
Currently working            
No 9.2* 3.3 3.6 2.7* 3.1* 6.3 3.4 5.9 3.2 3.2* 
Yes 16.2 1.2 5.0 4.6 4.7 3.6 5.1 5.9 3.3 1.4 
Diabetes           
Non diabetic - 2.9* - - - 6.3* - 6.0* - 2.3* 
Diabetic - 16.7 - - - 33.3 - 20.0 - 16.7 
Heart disease           
No 11.4 - - - - 6.4* - - 3.2 2.2* 
Yes 10.2 - - - - 23.1 - - 7.9 13.3 
Stroke           
No 10.4 - - - - 6.4 - - - 2.3* 
Yes 12.8 - - - - 11.8 - - - 13.3 
Key: *= p<0.05   
Page | 91  
4.2.1.3 SOCIO-DEMOGRAPHIC PATTERNS OF HYPERTENSION 
PREVALENCE IN PERSONS AGED 25 – 34 YEARS  
As shown in Table 4.6, the prevalence of hypertension was highest among 25-34 year 
olds living in Albania (18.0%) and lowest among respondents from the Maldives 
(3.8%).  
Overall, prevalence estimates of hypertension for each country was lower in this age 
group, compared to the overall estimates. 
The proportion of hypertension was higher among males in Albania, Armenia, 
Ukraine, Uzbekistan, and Lesotho. 
Respondents with no formal education in Azerbaijan and Maldives had the highest 
estimates of hypertension, while respondents with the highest level of education in 
Uzbekistan, Morocco and Lesotho had the highest rates of hypertension. 
Respondents living in rural areas in Albania, Armenia, Azerbaijan, Ukraine, and Egypt 
had higher prevalence estimates of hypertension, compared to those in urban areas. 
Respondents in urban areas in other countries had higher prevalence estimates of 
hypertension than their counterparts in rural areas.  
Non-smokers in Armenia, Azerbaijan, Uzbekistan, Senegal and Maldives had higher 
proportions of hypertension compared to current smokers. With regards to alcohol 
consumption, the proportion of hypertension was significantly higher among current 
drinkers compared to non-drinkers in countries with alcohol use data. 
Respondents within the lowest wealth quintiles in Albania, Armenia, and Ukraine had 
the highest prevalence estimates of hypertension, whereas respondents within the 
highest wealth quintiles in Morocco, Lesotho, and Maldives had the highest 
proportions of hypertension.  
There was no pattern of note regarding hypertension prevalence and employment 
status. 
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Table 4.6: Socio-demographic patterns of hypertension prevalence in persons aged 25-34 years in selected countries 
   Eastern Europe    North Africa Sub-Saharan Africa Indian Sub-Continent 
 Albania (%) Armenia (%) Azerbaijan (%) Ukraine (%) Uzbekistan (%) Egypt (%) Morocco (%) Lesotho (%) Senegal (%) Maldives (%) 
Overall prevalence  18.0 11.1 9.1 10.6 7.2 11.0 5.7 11.8 7.9 3.8 
Gender           
    Female 13.7* 11.0 9.9* 9.0* 3.0* 11.6 5.7 11.6 9.6* 4.4* 
    Male 25.1 12.3 6.2 15.2 4.8 10.3 - 12.3 1.1 1.0 
Education            
No Education 11.1* - 14.3 - - 10.7 5.2 11.7 7.7* 8.3* 
Primary 22.2 9.1 5.6 - 6.9 11.5 6.6 10.5 9.9 4.4 
Secondary  16.1 11.9 9.4 12.0 7.6 11.3 5.2 13.0 5.9 2.8 
Higher 9.9 10.9 7.3 9.6 15.2 10.1 10.6 14.1 1.8 1.9 
Place of residence            
Rural 23.7* 12.2 9.5 12.6* 3.1 11.3 4.7* 11.4 6.8* 3.6 
Urban 14.1 10.6 8.8 9.5 4.1 10.7 6.7 12.6 9.7 5.1 
Currently smoking            
No 16.4* 11.2 7.3 9.4* 10.7 10.8 - 11.7 8.3* 3.9 
Yes 22.8 10.9 5.4 14.0 9.8 11.8 - 11.9 1.4 3.2 
Currently drink alcohol           
No 14.8* - - 7.5 2.8* - - - - - 
Yes 21.5 - - 11.1 4.6 - - - - - 
Wealth quintile            
Lowest 28.0* 16.3 7.9 13.5 - 10.0 4.1 9.4 4.9* 4.5 
Second 17.8 11.6 9.9 11.0 - 13.5 5.7 11.0 7.0 3.8 
Middle 24.7 7.9 8.6 11.2 - 11.7 6.3 12.6 9.2 3.5 
Fourth 17.3 10.0 10.1 10.2 - 9.3 4.7 12.8 11.1 2.8 
Highest 8.6 12.5 9.2 8.1 - 10.4 8.0 12.9 8.5 5.2 
Marital status            
Never married or living alone 18.1 9.7 7.5 12.1 - 8.3* 14.3* 12.2 5.0* 4.7 
Married or living together 18.0 11.4 9.6 9.8 - 11.7 5.5 11.5 8.8 3.8 
Currently working            
No 17.1 11.4 9.5 10.5 3.1* 11.5 5.5 10.0* 9.3* 4.5* 
Yes 18.9 10.7 8.2 10.6 4.7 11.1 6.7 13.2 6.7 3.1 
Diabetes           
Non diabetic - 11.1 8.9 - - 10.9* - 11.5* 7.9 3.5* 
Diabetic - 14.3 23.1 - - 31.3 - 21.2 9.1 23.1 
Heart disease           
No 16.9 - - - - 11.0 - - 8.0 3.7 
Yes 18.9 - - - - 27.3 - - 5.5 8.5 
Stroke           
No 18.6 - - - - 11.0 - - - 3.8 
Yes 14.4 - - - - 27.3 - - - 6.3 
Key: *= p<0.05
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4.2.1.4 SOCIO-DEMOGRAPHIC PATTERNS OF HYPERTENSION 
PREVALENCE IN PERSONS AGED 35 – 44 YEARS 
As shown in Table 4.7, the prevalence of hypertension was highest among 35-44 year 
olds living in Albania (30.5%) and lowest among respondents from Morocco (5.9%).  
Overall, prevalence estimates of hypertension in each country (except Morocco and 
Senegal) was lower for this age group, compared to the overall estimates. Prevalence 
estimates in Morocco and Senegal in this age group were somewhat comparable with 
the overall estimates.   
The prevalence of hypertension was highest among males in Albania, Ukraine, and 
Lesotho. However, in Uzbekistan the prevalence was the same for both sexes 
(15.6%). 
Respondents with no formal education in Albania, Egypt, and Maldives had higher 
hypertension prevalence, compared to those with higher levels of educational 
attainment. Conversely, respondents with the highest levels of educational 
attainment in Uzbekistan and Lesotho had the highest proportions of hypertension. 
Although respondents living in rural areas had higher prevalence estimates of 
hypertension, compared to their counterparts in urban areas, respondents living in 
urban settings in the sub-Saharan African countries had higher hypertension rates, 
compared to those living in rural areas.  
There was no pattern of note with regard to the associations of hypertension with 
lifestyle factors (smoking and drinking) and other socio-economic indicators (wealth 
and employment status). 
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Table 4.7: Socio-demographic patterns of hypertension prevalence in persons aged 35-44 years in selected LMICs 
 
Key: * = P < 0.05 
   Eastern Europe    North Africa Sub-Saharan Africa Indian Sub-Continent 
 Albania (%) Armenia (%) Azerbaijan (%) Ukraine (%) Uzbekistan (%) Egypt (%) Morocco (%) Lesotho (%) Senegal (%) Maldives (%) 
Overall prevalence 30.5 24.4 17.4 25.2 15.6 18.7 5.9 20.7 12.4 9.3 
Gender           
    Female 29.1 24.5 18.8 25.1 15.6 21.5 5.9 20.1 15.1* 10.2* 
    Male 32.5 23.4 12.0* 25.5 15.6 15.2* - 22.4 2.1 5.4 
Education            
No Education 37.5* - 10.0* - - 20.2 6.1 13.1 12.3 10.5 
Primary 35.1 31.3 10.7 - 17.1 18.6 4.9 18.7 12.3 8.5 
Secondary  29.8 27.0 18.5 25.8 13.2 17.4 6.6 24.2 15.9 7.1 
Higher 15.9 22.6 10.9 24.7 28.9 19.0 2.8 30.5 4.6 6.1 
Place of residence            
Rural 35.3* 27.1 18.8 28.2* 17.5 18.7 5.9 19.3 10.1* 9.4 
Urban 26.2 23.4 16.2 23.3 13.3 18.7 5.8 24.6 16.4 9.0 
Currently smoking            
No 28.5* 24.2 10.8 24.9 16.3 19.4 - 20.5 12.9* 9.4 
Yes 36.4 26.3 14.0 26.4 18.8 15.6 - 22.6 2.7 8.5 
Currently drink alcohol           
No 28.2* - - 26.4 14.7 - - - - - 
Yes 32.7 - - 25.2 16.2 - - - - - 
Wealth quintile            
Lowest 38.4* 26.5 18.0* 27.5* - 19.0 7.2 13.3* 7.5* 9.3 
Second 34.1 24.4 20.7 28.5 - 19.7 5.5 16.7 11.7 10.2 
Middle 30.2 26.4 18.7 26.1 - 19.0 6.9 23.5 13.8 9.4 
Fourth 28.9 23.9 16.1 22.6 - 16.0 3.6 20.7 18.3 8.2 
Highest 23.2 19.7 12.0 20.9 - 19.5 5.6 28.1 14.5 8.4 
Marital status            
Never married or living alone 28.2 19.1 7.5 27.5 - 16.8 9.7 19.2 13.0 11.0 
Married or living together 30.7 17.1 9.6 24.3 - 18.9 5.8 21.3 12.4 9.2 
Currently working            
No 30.8 25.3 19.8* 26.9 17.8* 21.3 5.7 17.9* 12.4 9.0 
Yes 30.4 23.4 13.7 24.9 14.2 21.4 6.5 22.7 12.5 9.6 
Diabetes           
Non diabetic - 24.2 17.2 - - 17.9* - 21.1* 12.4 8.4* 
Diabetic - 31.3 38.2 - - 43.1 - 37.1 22.9 27.0 
Heart disease           
No 29.4 - 21.3 - - 18.5* - - 12.4 9.0* 
Yes 31.4 - 26.3 - - 42.9 - - 16.1 18.7 
Stroke           
No 31.2 - 22.0 - - 18.6 - - - 9.3 
Yes 25.3 - 10.5 - - 27.3 - - - 12.3 
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4.2.1.5 SOCIO-DEMOGRAPHIC PATTERNS OF HYPERTENSION 
PREVALENCE IN PERSONS AGED 45 – 54 YEARS 
As shown in Table 4.8, the prevalence of hypertension was highest among 45-54 year 
olds living in Armenia (30.5%) and lowest among respondents from Morocco (10.9%).   
Overall, prevalence estimates of hypertension in each country was higher for this age 
group, compared to the overall estimates. 
The proportion of hypertension was higher among males in Albania, Ukraine, and 
Lesotho. However, in Uzbekistan the prevalence was the same for both sexes 
(15.6%). 
Respondents with no formal education had higher hypertension prevalence than 
their educated counterparts in Azerbaijan and Senegal; whereas, the prevalence was 
highest among respondents with the highest levels of educational attainment in 
Uzbekistan, Egypt and Lesotho. 
Respondents living in rural areas in the Eastern European countries had higher 
prevalence of hypertension; whereas, respondents living in urban settings in the 
African countries (Egypt, Morocco, Senegal, and Lesotho) and the Maldives had 
higher hypertension prevalence than their rural counterparts.  
Non-smokers in Armenia, Uzbekistan, Egypt, Lesotho, Senegal, and Maldives had 
higher proportions of hypertension compared to current smokers in these countries. 
Regarding alcohol consumption, the proportion of hypertension was significantly 
higher among drinkers in Ukraine compared to non-drinkers. There was no difference 
in hypertension prevalence by drinking status in the other countries that had alcohol 
use data. 
Respondents within the lowest wealth quintiles in Armenia had the highest 
prevalence of hypertension, whereas respondents within the highest wealth quintiles 
in the African countries and the Maldives had the highest proportions of 
hypertension.  
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The prevalence of hypertension was higher among unemployed respondents in 
Senegal, Maldives, and all the Eastern European countries, compared to their 
employed counterparts.  
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Table 4.8: Socio-demographic patterns of hypertension prevalence in persons aged 45-54 years in selected LMICs 
Key: *= p<0.05
   Eastern Europe    North Africa Sub-Saharan Africa Indian Sub-Continent 
 Albania (%) Armenia (%) Azerbaijan (%) Ukraine (%) Uzbekistan (%) Egypt (%) Morocco (%) Lesotho (%) Senegal (%) Maldives (%) 
Overall prevalence 38.4 44.6 25.3 39.1 26.2 30.5 10.9 27.6 14.0 18.6 
Gender           
    Female 35.8 45.2 28.3* 40.1 28.2 34.6* 10.9 30.8* 19.9* 20.7* 
    Male 40.9 40.0 19.3 36.3 23.5 25.9 - 22.0 4.5 14.6 
Education            
No Education - - 33.3* - - 30.4 8.2* 11.4* 14.3 18.3 
Primary 43.4* 44.4 14.3 66.7* 25.1 32.2 33.3 25.5 13.8 17.8 
Secondary  36.5 48.7 26.5 43.1 13.9 28.8 25.0 40.8 12.7 26.3 
Higher 26.8 41.6 19.3 35.9 58.2 31.0 0.0 46.2 9.1 18.2 
Place of residence            
Rural 44.0* 52.0 25.7 39.9 29.6* 28.1* 9.0 24.8* 11.8* 18.5 
Urban 34.0 40.6 25.0 38.6 23.2 33.3 14.0 36.9 17.9 19.0 
Currently smoking            
No 37.0 45.2 17.8 39.3 24.6 31.6 - 29.2* 14.7* 20.3* 
Yes 42.0 38.5 20.6 39.1 22.6 26.6 - 17.7 3.3 11.4 
Currently drink alcohol           
No 34.0* - - 40.9 24.0 - - - - - 
Yes 41.9 - - 39.1 27.4 - - - - - 
Wealth quintile            
Lowest 41.0* 68.1* 28.0* 39.3 - 23.8* 16.7* 16.5* 9.0* 15.0 
Second 38.6 42.7 25.7 39.7 - 29.1 0.0 18.9 10.2 18.5 
Middle 45.2 38.3 30.0 38.0 - 29.0 9.1 25.8 17.9 21.9 
Fourth 43.3 35.9 24.9 39.7 - 35.6 13.3 38.9 20.2 20.4 
Highest 25.3 42.6 17.5 38.9 - 33.9 26.7 40.3 19.3 15.1 
Marital status            
Never married or living alone 27.4 40.5 26.8 41.0 - 36.0 22.2 29.9 17.9 22.0 
Married or living together 39.1 45.3 25.0 38.4 - 29.7 10.1 26.5 13.5 18.1 
Currently working            
No 42.0 48.0 29.0* 45.9* 28.2 34.5* 10.3 24.9 17.1 19.0 
Yes 36.5 41.1 21.4 37.7 25.0 50.0 14.3 29.5 12.9 18.2 
Diabetes           
Non diabetic - 42.3* 24.3* - - 27.3* - 26.7* 13.9 16.3* 
Diabetic - 72.7 53.3 - - 62.0 - 65.9 26.1 52.1 
Heart disease           
No 38.0 - 24.2* - - 29.9* - - 14.0 18.1* 
Yes 38.6 - 38.2 - - 67.9 - - 21.4 31.0 
Stroke           
No 39.2 - 25.4 - - 30.2* - - - 18.1* 
Yes 33.6 - 33.3 - - 58.8 - - - 32.3 
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4.2.1.6 SOCIO-DEMOGRAPHIC PATTERNS OF HYPERTENSION 
PREVALENCE IN PERSONS AGED 55 YEARS AND ABOVE 
As shown in Table 4.9, the prevalence of hypertension was highest among 
respondents aged 55 years and above in Egypt (41.7%) and lowest among 
respondents from Senegal (8.9%). It is worth noting that only Egypt had information 
for men and women in this age group. The prevalence of hypertension was 
significantly higher among women than men in Egypt. 
Overall, prevalence estimates of hypertension in each country was higher for this age 
group, compared to the overall estimates. 
Respondents with the highest levels of educational attainment had higher 
hypertension prevalence in Uzbekistan, Egypt, and Lesotho.  
Respondents living in urban areas had higher prevalence of hypertension, compared 
to those in rural areas.  
With exception for Azerbaijan, non-smokers had higher proportions of hypertension, 
compared to current smokers. Regarding alcohol consumption, only Uzbekistan had 
information on drinking status and the proportion of hypertension was higher among 
non-drinkers compared to current drinkers. 
Respondents within the highest wealth quintiles in Egypt, Lesotho, Senegal, and 
Maldives had the highest prevalence estimates of hypertension.  
With exception for Lesotho, the prevalence of hypertension was higher among 
unemployed respondents, compared to their employed counterparts.  
The proportions of hypertension were higher among respondents who suffered a 
comorbidity.   
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Table 4.9: Socio-demographic patterns of hypertension prevalence in persons aged ≥55 years in selected LMICs 
Key: *= p<0.05          
   Eastern Europe    North Africa Sub-Saharan Africa Indian Sub-Continent 
 Albania (%) Armenia (%) Azerbaijan (%) Ukraine (%) Uzbekistan (%) Egypt (%) Morocco (%) Lesotho (%) Senegal (%) Maldives (%) 
Overall prevalence - - 40.2 - 29.3 41.7 - 35.5 8.9 30.1 
Gender           
    Female - - - - - 52.1* - - - - 
    Male - - 40.2 - 29.3 30.9 - 35.5 8.9 30.1 
Education            
No Education - - - - - 42.1 - 21.4* 6.9 28.5 
Primary - - - - 23.5 39.4 - 41.9 11.8 35.7 
Secondary  - - 26.5 - 33.3 42.2 - 33.3 15.8 44.4 
Higher - - 19.3 - 45.8 44.3 - 83.3 - - 
Place of residence            
Rural - - 38.3 - 20.0 36.3* - 32.2* 6.6 26.9* 
Urban - - 41.8 - 34.2 48.1 - 56.5 12.9 50.0 
Currently smoking            
No - - 38.8 - 44.4 44.8* - 38.9 9.6 30.3 
Yes - - 42.3 - 33.3 29.5 - 27.1 3.6 29.6 
Currently drink alcohol           
No - - - - 40.0 - - - - - 
Yes - - - - 28.3 - - - - - 
Wealth quintile            
Lowest - - 35.3* - - 40.4 - 34.6 4.2 25.5 
Second - - 26.3 - - 37.0 - 28.6 13.3 26.1 
Middle - - 67.9 - - 38.5 - 38.5 6.0 23.8 
Fourth - - 31.6 - - 41.5 - 40.0 10.7 38.1 
Highest - - 26.3 - - 49.7 - 40.9 14.3 58.8 
Marital status            
Never married or living alone - - - - - 54.0* - 29.9 - 18.2 
Married or living together - - 41.4 - - 37.9 - 26.5 9.1 30.9 
Currently working            
No - - 50.0 - 33.3 51.7 - 31.9 14.3 45.0 
Yes - - 35.7 - 26.5 41.9 - 37.0 8.1 28.3 
Diabetes           
Non diabetic - - 35.2 - - 37.9* - 35.2 8.7 25.8* 
Diabetic - - 50.0 - - 61.8 - 66.7 16.7 63.2 
Heart disease           
No - - 40.0 - - 39.7* - - 8.9 27.4* 
Yes - - 45.5 - - 52.3 - - - 77.8 
Stroke           
No - - - - - 40.9* - - - 29.6 
Yes - - - - - 68.3 - - - 50.0 
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4.2.1.7 SOCIO-DEMOGRAPHIC PATTERNS OF HYPERTENSION 
PREVALENCE IN MEN 
Stratification by gender was decided a priori, because of the well-known differences 
in hypertension etiology and natural history between men and women (Stranges & 
Guallar, 2012). As shown in Table 4.10, the prevalence of hypertension was highest 
among Albanian men (26.3%) and lowest among Senegalese men (1.7%). In addition, 
Men aged 45 years and above had the highest prevalence of hypertension in all 
countries. 
Men with no education had the highest proportions of hypertension in Albania, 
Azerbaijan, Ukraine, Senegal and Maldives; whereas men with the highest levels of 
educational attainment had the highest proportions of hypertension in Armenia, 
Uzbekistan, and Lesotho. 
Men living in rural areas of Albania, Azerbaijan, and Ukraine recorded the highest 
prevalence of hypertension compared to men living in urban areas in these 
countries. However, in Armenia, Uzbekistan, Lesotho, Senegal and Maldives, men 
living in urban settings had the highest prevalence of hypertension.  
Hypertension prevalence was higher among current smokers than non-smokers in 
Albania, Armenia, Azerbaijan, Ukraine, and Lesotho. Conversely, non-current 
smokers in Senegal and Maldives reported higher proportions of hypertension 
compared to smokers. The proportion of hypertension was significantly higher 
among current drinkers compared to non-drinkers in all countries with alcohol use 
data. 
Men within the lowest wealth quintiles in Albania, Azerbaijan, and Ukraine had the 
highest prevalence of hypertension; whereas men within the highest wealth quintiles 
in Armenia, Lesotho, Senegal, and Maldives the highest proportions of hypertension.  
In all nine countries except the Maldives, men who were employed had higher 
prevalence estimates of hypertension compared to men who were unemployed. 
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Table 4.10: Socio-demographic patterns of hypertension prevalence among the Men in selected countries 
   Eastern Europe    North Africa Sub-Saharan Africa Indian Sub-Continent 
 Albania (%) Armenia (%) Azerbaijan (%) Ukraine (%) Uzbekistan (%) Egypt (%) Morocco# (%) Lesotho (%) Senegal (%) Maldives (%) 
Overall prevalence 26.3 12.8 11.0 17.8 11.2 13.5 - 13.2 1.7 8.6 
Overall Mean Age (SD) 31.8 (11.4) 30.5 (10.1) 33.8 (12.2) 32.1 (10.2) 31.4 (11.5) 32.7 (12.7) - 29.7 (12.2) 29.9 (12.4) 39.5 (11.1) 
Age group            
15-24 14.1* 1.6* 4.1* 3.8* 4.8* 5.9* - 6.0a 0.2a 3.1a 
25-34 25.1 12.3 6.2 15.2 8.0 10.3 - 12.3 1.1 1.0 
35-44 32.5 23.4 12.0 25.5 15.6 15.2 - 22.4 2.1 5.4 
45-54 40.9 40.0 19.3 36.3 23.5 25.9 - 22.0 4.5 14.6 
≥55 - - 40.2 - 29.3 30.9 - 35.5 8.9 30.1 
Education            
No Education 22.2* - 7.7 50.0 - 18.8* - 12.6a 2.0d 14.8a 
Primary 30.5 12.1 11.1 0.0 9.3* 16.2 - 12.3 1.7 4.9 
Secondary  25.2 11.0 11.1 18.3 10.0 10.8 - 12.7 1.2 4.3 
Higher 17.2 14.3 10.8 17.3 10.4 15.7 - 28.0 1.6 5.9 
Place of residence            
Rural 30.3* 8.6 11.5 18.9 9.5* 13.4 - 12.0a 1.4d 8.0c 
Urban 23.1 14.8 10.5 17.2 12.7 13.6 - 17.5 2.1 11.8 
Currently smoking            
No 21.2* 8.7 9.7* 14.2* 15.3 12.3* - 13.2d 1.7d 9.8d 
Yes           32.8 16.1 12.4 21.0 15.3 15.6 - 13.3 1.4 7.2 
Currently drink alcohol           
No 16.9* - - - 7.6* - - 11.2a - - 
Yes 31.3 - - - 12.1 - - 14.9 - - 
Wealth quintile            
Lowest 31.4* 14.0 11.2* 21.7* - 12.3 - 13.6a 1.5d 9.3d 
Second 28.7 8.9 10.8 15.6 - 14.7 - 10.9 1.1 6.5 
Middle 28.6 8.2 14.6 17.2 - 13.0 - 10.3 1.7 8.1 
Fourth 27.2 17.2 9.9 20.6 - 12.3 - 13.5 1.8 9.6 
Highest 18.5 17.8 7.3 15.8 - 15.0 - 18.7 2.8 11.5 
Marital status            
Never married or living alone 16.0* 5.1* 4.5* 14.0* - 6.8* - 9.6a 0.5a 8.1d 
Married or living together 34.4 22.2 14.4 21.6 - 18.1 - 18.3 3.3 8.6 
Currently working            
No 19.0 7.8* 10.2 9.7* 10.2 7.1* - 10.0a 0.9c 14.5c 
Yes 30.4 17.7 11.5 20.2 11.9 24.3 - 15.0 1.9 8.1 
Diabetes           
Non diabetic - 11.8* 10.5* - - 12.7* - 13.7a 1.7d 7.4a 
Diabetic - 40.0 41.7 - - 45.1 - 31.7 6.3 37.5 
Heart disease           
No 23.6* - 20.7 - - 13.1* - - 1.7d 8.1a 
Yes 27.6 - 26.9 - - 56.0 - - 0.0 36.7 
Stroke           
No 26.7 - 21.5 - - 13.3* - - - 8.5d 
Yes 24.2 - 10.5 - - 44.1 - - - 18.2 
Key: *= p<0.05, 
#
= female data only
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4.2.1.8 SOCIO-DEMOGRAPHIC PATTERNS OF HYPERTENSION 
PREVALENCE IN WOMEN 
As shown in Table 4.11, the prevalence of hypertension was highest among Albanian 
women (19.8%) and lowest among Moroccan women (5.4%). Women aged 45 years 
and above had the highest prevalence of hypertension in all countries. 
There were no notable patterns of hypertension prevalence across the different 
levels of educational attainment. 
Women living in rural areas of the Eastern European countries (Albania, Armenia, 
Azerbaijan, Ukraine, and Uzbekistan) had higher prevalence estimates of 
hypertension compared to women living in urban areas in these countries. However, 
in African countries (Egypt, Morocco, Lesotho, Senegal) and the Indian sub-continent 
(Maldives), women living in urban settings had higher prevalence estimates of 
hypertension.  
Hypertension prevalence was higher among current smokers in Armenia, Egypt, 
Lesotho, Senegal, and the Maldives. Conversely, non-smokers in Albania, Ukraine, 
and Uzbekistan had higher proportions of hypertension than smokers. The 
proportion of hypertension was significantly higher among women who were current 
drinkers compared to non-drinkers in all countries with alcohol use data. 
Women within the lowest wealth quintiles in Eastern European had the highest 
prevalence estimates of hypertension; whereas women within the highest wealth 
quintiles in African countries had the highest proportions of hypertension.  
In all 10 countries, the proportion of hypertension was higher among women who 
were employed compared to their unemployed counterparts. 
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Table 4.11: Socio-demographic patterns of hypertension prevalence among women in selected LMICs 
   Eastern Europe    North Africa Sub-Saharan Africa Indian Sub-
Continent 
 Albania (%) Armenia (%) Azerbaijan (%) Ukraine (%) Uzbekistan (%) Egypt (%) Morocco (%) Lesotho (%) Senegal (%) Maldives (%) 
Overall prevalence 19.8 18.0 12.7 17.1 9.2 17.5 5.4 12.2 9.0 7.4 
Overall Mean Age (SD) 31.6 (10.7) 31.4 (10.2) 31.1 (10.3) 32.5 (10.0) 29.3 (9.8) 32.2 (12.2) 29.6 (10.0) 28.1 (9.8) 27.8 (9.2) 32.5 (8.3) 
Age group            
15-24 7.7* 3.5* 3.6* 3.3* 3.0* 6.9* 3.6* 5.9* 4.2* 2.4* 
25-34 13.7 11.0 9.9 9.0 6.8 11.6 5.7 11.6 9.6 4.4 
35-44 29.1 24.5 18.9 25.1 15.6 21.5 5.9 20.1 15.1 10.2 
45-54 35.8 45.2 28.4 40.1 28.2 34.6 10.9 30.8 19.9 20.7 
≥55 - - - - - 52.1 - - - - 
Education            
No Education - - 11.4* 50.0 - 23.0* 5.2 6.1* 9.6* 13.8* 
Primary 24.9* 12.2* 8.5 20.0 9.0* 24.4 5.7 12.6 9.9 6.9 
Secondary  17.8 21.8 13.2 17.6 6.3 13.3 5.6 11.5 5.8 3.3 
Higher 7.7 16.3 9.6 16.7 10.4 11.6 7.0 17.4 6.3 2.8 
Place of residence            
Rural 24.4* 20.7* 13.4 19.6* 10.0* 15.8* 4.8* 11.7* 7.7* 7.3 
Urban 15.6 16.6 12.1 15.6 8.1 19.8 6.2 13.7 10.9 7.9 
Currently smoking            
No 20.1 18.0 - 17.2* 23.8 17.4 - 12.2* 9.0 7.3* 
Yes 14.3 27.3 - 16.7 15.2 28.2 - 40.0 9.5 14.7 
Currently drink alcohol           
No 19.7* - - - 7.8* - - - - - 
Yes 20.0 - - - 12.6 - - - - - 
Wealth quintile            
Lowest 27.3* 25.0* 13.2* 18.7* - 16.0 4.8 8.5* 6.0* 7.5 
Second 20.6 18.6 13.7 19.4 - 15.9 5.1 10.3 8.2 8.0 
Middle 21.9 16.3 13.1 18.1 - 17.9 5.9 14.0 9.8 7.5 
Fourth 19.0 16.2 13.0 14.5 - 18.1 4.5 13.8 12.3 6.1 
Highest 11.7 15.4 9.8 14.5 - 19.6 7.1 14.3 9.8 7.7 
Marital status            
Never married or living alone 11.0* 10.1* 7.7* 12.7* - 13.3 10.6* 9.8* 4.8* 10.1* 
Married or living together 24.5 20.3 15.7 20.5 - 19.4 5.3 14.3 10.9 7.2 
Currently working            
No 19.1 16.6* 12.0* 12.4* 8.1* 17.2 5.2 9.8* 7.3* 7.0 
Yes 21.4 21.0 15.4 19.3 10.8 20.4 6.6 16.4 11.9 8.0 
Diabetes           
Non diabetic - 17.3* 12.5* - - 15.8* - 12.3* 8.9* 6.6* 
Diabetic - 46.3 41.4 - - 62.8 - 38.5 24.6 33.8 
Heart disease           
No 21.2* - 24.7* - - 17.1* - - 9.0 7.2* 
Yes 18.3 - 36.9 - - 61.2 - - 11.7 17.3 
Stroke           
No 20.2* - 25.7 - - 17.4* - - - 7.3* 
Yes 15.7 - 33.3 - - 38.7 - - - 14.8 
Key: *= p<0.05
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4.2.2  RESULTS OF THE UNIVARIABLE LOGISTIC REGRESSION ANALYSIS – 
FACTORS ASSOCIATED WITH HYPERTENSION  
As shown in Table 4.12, the odds of having hypertension were significantly higher 
among men compared to women in Albania and Uzbekistan, whereas the odds of 
having hypertension were significantly higher among women compared to men in 
Armenia, Egypt and Senegal.  
In all ten countries, the odds of having hypertension were highest among 
respondents 45 years of age and above, compared to respondents who were 
progressively younger.  
The odds of hypertension were highest among respondents with the highest levels of 
educational attainment in Uzbekistan and Lesotho, whereas respondents with the 
highest levels of educational attainment had the lowest odds of hypertension in 
Egypt, Maldives and Senegal. Of note, the odds of hypertension in respondents with 
no education were highest in the Maldives. 
Respondents living in urban areas across the Eastern European countries (Albania, 
Azerbaijan and Ukraine) had significantly lower odds of hypertension compared to 
respondents living in the rural areas. However, the odds of developing hypertension 
were significantly higher among respondents living in the urban areas compared to 
rural areas in the African countries (Egypt, Morocco, Lesotho and Senegal).  
The odds of hypertension were significantly higher among current smokers 
compared to non-smokers in Albania, Azerbaijan and Ukraine, whereas respondents 
with hypertension in Senegal were significantly more likely to be non-smokers than 
smokers. Regarding alcohol consumption, the odds of hypertension were also higher 
among current drinkers compared to non-drinkers in countries with alcohol use data.  
In the Eastern European countries (Albania, Armenia, Azerbaijan and Ukraine), the 
odds of developing hypertension were lowest among respondents in the highest 
wealth quintiles; whereas, in African countries (Egypt, Morocco, Lesotho, Senegal), 
the odds of hypertension were highest among respondents in the highest wealth 
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quintiles. The odds of hypertension were significantly higher among employed 
respondents compared to unemployed respondents in all countries except Morocco, 
Lesotho and Maldives, where the associations between hypertension and 
employment status were not statistically significant.   
 
Page | 106  
Table 4.12: Unadjusted odds ratio & 95% Confidence Intervals of the risk of hypertension in all countries 
Eastern Europe North Africa Sub-Saharan Africa Indian Sub-Continent 
 Albania  
OR (95% CI) 
Armenia  
OR (95% CI) 
Azerbaijan  
OR (95% CI) 
Ukraine  
OR (95% CI) 
Uzbekistan  
OR (95% CI) 
Egypt  
OR (95% CI) 
Morocco  
OR (95% CI) 
Lesotho  
OR (95% CI) 
Senegal  
OR (95% CI) 
Maldives  
OR (95% CI) 
Prevalence (%) 22.7 17.2 12.3 17.3 9.8 15.7 5.4 12.5 7.2 7.6 
Gender            
Female 1.00 1.00 1.00 1.00 1.00 1.00 - 1.00 1.00 1.00 
Male 1.44 (1.28, 1.62)*   0.67 (0.46, 0.97)*   0.85 (0.74, 0.98)*   1.05 (0.93, 1.19)   1.24 (1.06, 1.45)*   0.74 (0.67, 0.82)* -   1.09 (0.97, 1.23) 0.17 (0.14, 0.22)*   1.16 (0.96, 1.41) 
Age group            
15-24 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
25-34 1.83 (1.51, 2.22)* 4.02 (2.29, 7.06)* 2.58 (2.08, 3.21)* 3.36 (2.63, 4.30)* 2.12 (1.64, 2.73)* 1.81 (1.53, 2.14)* 1.62 (1.11, 2.37)* 2.12 (1.80, 2.50)* 2.60 (2.23, 3.02)* 1.61 (1.11, 2.32)* 
35-44 3.66 (3.09, 4.33)* 10.4 (6.02, 17.88)* 5.48 (4.51, 6.67)* 9.52 (7.56, 12.00)* 5.07 (4.02, 6.41)* 3.36 (2.86, 3.94)* 1.68 (1.12, 2.52)* 4.16 (3.53, 4.89)* 4.27 (3.67, 4.97)* 4.15 (2.93, 5.88)* 
45-54 5.19 (4.30, 6.25)* 25.86 (14.93, 44.79)* 8.76 (7.12, 10.78)* 18.17 (14.31, 23.05)* 9.76 (7.57, 12.57)* 6.41 (5.47, 7.53)* 3.32 (1.74, 6.35)* 6.09 (5.07, 7.31)* 4.91 (4.08, 5.91)* 9.19 (6.44, 13.12)* 
≥55 - - 17.32 (11.25, 26.69)* - 11.38 (6.25, 20.71)* 10.46 (8.60, 12.72)*   - 8.80 (6.26, 12.35)* 2.92 (1.84, 4.65)* 17.35 (10.98, 27.41)* 
Education            
No Education 1.00 - 1.00 1.00 - 1.00 1.00 1.00 1.00 1.00 
Primary 2.23 (0.77, 6.46) 1.00 0.78 (0.35, 1.72) 0.20 (0.17, 2.39) 1.00 0.90 (0.78, 1.04) 1.11 (0.79, 1.54) 1.11 (0.85, 1.44) 0.91 (0.80, 1.03) 0.43 (0.36, 0.52)* 
Secondary  1.64 (0.57, 4.75) 1.81 (0.98, 3.33) 1.17 (0.67, 2.05) 0.22 (0.30, 1.54) 1.18 (0.97, 1.42) 0.49 (0.43, 0.55)* 1.09 (0.76, 1.55) 1.03 (0.80, 1.36) 0.49 (0.42, 0.58)* 0.22 (0.17, 0.28)* 
Higher 0.80 (0.27, 2.36) 1.38 (0.76, 2.52) 0.89 (0.50, 1.60) 0.20 (0.28, 1.44) 1.52 (1.24, 1.87)* 0.57 (0.48, 0.67)* 1.37 (0.75, 2.52) 2.02 (1.46, 2.80)* 0.47 (0.26, 0.86)* 0.22 (0.19, 0.43)* 
Place of residence            
Rural 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
Urban 0.64 (0.57, 0.71)* 0.84 (0.65, 1.08) 0.89 (0.80, 1.00)* 0.79 (0.71, 0.89)* 0.98 (0.84, 1.14) 1.18 (1.07, 1.30)* 1.31 (1.02, 1.69)* 1.29 (1.14, 1.46)* 1.42 (1.28, 1.58)* 1.19 (0.96, 1.47) 
Currently smoking            
No 1.00 1.00 1.00 1.00 1.00 1.00 - 1.00 1.00 1.00 
Yes 1.74 (1.52, 1.98)* 0.97 (0.64, 1.49) 1.31 (1.02, 1.68)* 1.19 (1.05, 1.34)* 1.04 (0.73, 1.49) 1.01 (0.89, 1.16) - 1.12 (0.93, 1.34) 0.21 (0.12, 0.36)* 1.13 (0.88, 1.45) 
Wealth quintile            
Lowest 1.00 1.00 1.00 1.00 - 1.00 1.00 1.00 1.00 1.00 
Second 0.77 (0.64, 0.93)* 0.69 (0.48, 1.01) 1.03 (0.87, 1.23) 0.92 (0.78, 1.09) - 1.08 (0.93, 1.27) 1.05 (0.72, 1.53) 1.06 (0.87, 1.29) 1.36 (1.15, 1.62)* 0.98 (0.78, 1.23) 
Middle 0.81 (0.68, 0.98)* 0.58 (0.39, 0.85)* 1.07 (0.90, 1.26) 0.89 (0.75, 1.07) - 1.11 (0.94, 1.30) 1.24 (0.85, 1.81) 1.31 (1.08, 1.59)* 1.64 (1.39, 1.94)* 0.97 (0.77, 1.22) 
Fourth 0.72 (0.61, 0.86)* 0.65 (0.45, 0.95)* 0.96 (0.80, 1.14) 0.79 (0.65, 0.95)* - 1.09 (0.92, 1.28) 0.94 (0.60, 1.45) 1.42 (1.18, 1.71)* 2.10 (1.77, 2.49)* 0.85 (0.65, 1.12) 
Highest 0.43 (0.36, 0.52)* 0.62 (0.41, 0.93)* 0.69 (0.57, 0.85)* 0.72 (0.60, 0.86)* - 1.26 (1.08, 1.47)* 1.52 (1.03, 2.24)* 1.64 (1.37, 1.97)* 1.72 (1.42, 2.07)* 1.09 (0.81, 1.47) 
Marital status            
Never married or 
living alone 
1.00 1.00 1.00 1.00 - 1.00 1.00 1.00 1.00 1.00 
Married or living 
together 
2.55 (2.23, 2.92)* 2.74 (1.96, 3.86)* 2.41 (2.10, 2.77)* 1.74 (1.55, 1.94)* - 2.08 (1.85, 2.34)* 0.47 (0.25, 0.87)* 1.70 (1.52, 1.92)* 3.19 (2.78, 3.67)* 0.73 (0.56, 0.97)* 
Currently working            
No 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
Yes 1.57 (1.39, 1.76)* 1.39 (1.08, 1.78)* 1.16 (1.02, 1.31)* 1.81 (1.59, 2.07)* 1.35 (1.16, 1.57)* 1.67 (1.20, 2.33)* 1.29 (0.92, 1.80) 1.72 (1.53, 1.93)* 1.20 (1.08, 1.33)* 1.13 (0.96, 1.32) 
Diabetes           
Non diabetic - 1.00 1.00 - - 1.00 - 1.00 1.00 1.00 
Diabetic - 4.18 (2.37, 7.36)* 5.18 (3.51, 7.67)* - - 7.65 (6.21, 9.42)* - 3.92 (2.88, 5.33)* 3.39 (1.95, 5.90)* 7.36 (5.67, 9.56)* 
Heart disease           
No 1.00 - 1.00 - - 1.00 - - 1.00 1.00 
Yes 1.07 (0.95, 1.21) - 1.66 (1.26, 2.19)* - - 7.82 (5.22, 11.70)* - - 1.44 (0.83, 2.51) 3.16 (2.24, 4.46)* 
Stroke           
No 1.00 - 1.00 - - 1.00 - - - 1.00 
Yes 0.87 (0.72, 1.04) - 0.97 (0.49, 1.92) - - 3.86 (2.35, 6.34)* - - - 2.22 (1.45, 3.39)a 
Key: *=p<0.05           
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4.2.2.1 INTERACTION BETWEEN AGE AND GENDER IN PREDICTING 
HYPERTENSION RISK 
Age and gender remain among the more robust factors in explaining differences in 
cardiovascular disease and mortality (Sacco et al., 1997; Möller-Leimkühler, 2007). 
The potential interaction between age and gender was considered in predicting 
hypertension risk for each selected country, with the exception of Morocco which 
had data for women only.  
As expected, the risk of hypertension increased with increasing age in a non-linear 
pattern in all the countries (Figures 4.7 – 4.15). 
In Albania, the risk of developing hypertension was higher in men compared to 
women across all age groups (Figure 4.7).  However, in Azerbaijan (Figure 4.9), Egypt 
(Figure 4.10), Maldives (Figure 4.12) and Senegal (Figure 4.13), the probability of 
developing hypertension was higher among women and across all age groups. 
In Armenia (Figure 4.8), Lesotho (Figure 4.11), Ukraine (Figure 4.14), and Uzbekistan 
(Figure 4.16) the trends were similar in both men and women. 
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Figure 4.7: Interaction between age and gender predicting the risk of hypertension 
in Albania 
Figure 4.8: Interaction between age and gender predicting the risk of 
hypertension in Armenia 
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Figure 4.9: Interaction between age and gender predicting the risk of hypertension 
in Azerbaijan 
Figure 4.10: Interaction between age and gender predicting the risk of 
hypertension in Egypt 
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Figure 4.11: Interaction between age and gender predicting the risk of hypertension 
in Lesotho 
Figure 4.12: Interaction between age and gender predicting the risk of 
hypertension in Maldives 
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Figure 4.13: Interaction between age and gender predicting the risk of hypertension 
in Senegal 
Figure 4.14: Interaction between age and gender predicting the risk of 
hypertension in Ukraine 
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Figure 4.15: Interaction between age and gender predicting the risk of hypertension 
in Uzbekistan 
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4.2.3  RESULTS OF THE MULTIVARIABLE LOGISTIC REGRESSION ANALYSIS 
As shown in Table 4.13 After adjusting for multiple confounders, the odds of 
developing hypertension were higher among men in Albania and Uzbekistan 
compared to women. The odds of hypertension were lower among men compared to 
women in Armenia, Egypt, and Senegal.  
In all 10 countries, the odds of hypertension remained the highest in respondents 
aged 45 years and above. 
The odds of hypertension also remained the highest among respondents with the 
highest levels of educational attainment in Uzbekistan and Lesotho, and lowest 
among respondents with the highest levels of educational attainment in Egypt, 
Senegal and Maldives.  
Respondents living in urban areas of Albania and Ukraine still had lower odds of 
developing hypertension compared to respondents living in rural areas, and the odds 
of developing hypertension remained higher among respondents living in urban 
areas of Azerbaijan, Egypt, Morocco, Lesotho, and Senegal. 
Current smokers living in Albania and Ukraine had higher odds of developing 
compared to non-smokers. However, the odds were higher in non-smokers 
compared to smokers in Azerbaijan and Senegal.   
Respondents within the highest wealth Quintiles in Armenia had the lowest odds of 
developing hypertension, whereas respondents within the highest wealth quintiles in 
Lesotho had the highest odds of developing hypertension.  
In the sub-Saharan African countries, the odds of developing hypertension remained 
higher among employed respondents compared to unemployed respondents.
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Table 4.13: Covariate adjusted odds ratio & 95% Confidence Interval of the risk of hypertension in all countries 
Eastern Europe North Africa Sub-Saharan Africa Indian Sub-
Continent 
 Albania  
OR (95% CI) 
Armenia  
OR (95% CI) 
Azerbaijan  
OR (95% CI) 
Ukraine  
OR (95% CI) 
Uzbekistan  
OR (95% CI) 
Egypt  
OR (95% CI) 
Morocco  
OR (95% CI) 
Lesotho  
OR (95% CI) 
Senegal  
OR (95% CI) 
Maldives  
OR (95% CI) 
Overall prevalence (%) 22.7 17.2 12.3 17.3 9.8 15.7 5.4 12.5 7.2 7.6 
Overall Mean Age (SD) 31.7 (10.9) 31.2 (10.2) 31.7 (10.8) 32.4 (10.0) 29.9 (10.4) 32.4 (12.5) 29.6 (10.0) 28.5 (10.6) 28.3 (10.1) 33.9 (9.3) 
Gender            
Female 1.00 1.00 - - 1.00 1.00 - - 1.00 - 
Male 1.33 (1.13, 1.57)*   0.91 (0.60, 1.39)   - -   1.10 (0.91, 1.33)   0.70 (0.54, 0.91)* -   - 0.13 (0.10, 0.17)* - 
Age group            
15-24 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
25-34 2.01 (1.58, 2.57)
*
 3.68 (2.05, 6.62)
*
 - 3.49 (2.68, 4.54)
*
 2.14 (1.65, 2.78)
*
 1.68 (1.31, 2.14)
*
 1.60 (1.10, 2.33)
*
 1.84 (1.53, 2.22)
a
 1.93 (1.64, 2.28)
*
 1.34 (0.90, 1.98) 
35-44 3.92 (3.05, 5.06)
*
 9.35 (5.26, 16.61)
*
 - 9.97 (7.75, 12.83)
*
 5.19 (4.07, 6.63)
*
 3.14 (2.44, 4.05)
*
 1.63 (1.08, 2.45)
*
 3.87 (3.20, 4.67)
a
 3.12 (2.63, 3.71)
*
 2.55 (1.69, 3.85)
*
 
45-54 5.70 (4.35, 7.47)* 22.72 (12.72, 40.61)* 1.28 (0.84, 2.00) 19.08 (14.75, 24.67)* 9.90 (7.60, 12.90)* 5.67 (4.35, 7.40)* 3.20 (1.67, 6.14)* 5.85 (4.73, 7.22)a 4.62 (3.75, 5.71)* 5.13 (3.30, 7.97)* 
≥55 - - 2.91 (1.63, 5.21)
*
 - 11.37 (6.09, 21.21)
*
 11.27 (8.31, 15.29)
*
 - 9.48 (6.45, 13.94)
a
 12.85 (7.47, 22.12)
*
 9.22 (5.37, 15.82)
*
 
Education            
No Education - - - - - 1.00 - 1.00 1.00 1.00 
Primary - - - - 1.00 1.11 (0.89, 1.39) - 1.79 (1.31, 2.45)
a
 1.14 (0.99, 1.33) 0.80 (0.64, 1.00)
*
 
Secondary  - - - - 0.81 (0.60, 1.10) 0.99 (0.79, 1.22) - 2.04 (1.46, 2.85)a 1.00 (0.82, 1.22) 0.60 (0.43, 0.83)* 
Higher - - - - 1.18 (0.94, 1.48) 0.72 (0.50, 1.01) - 2.45 (1.64, 3.66)
a
 0.58 (0.31, 1.10) 0.48 (0.24, 0.96)
*
 
Place of residence            
Rural 1.00 - 1.00 1.00 - 1.00 1.00 1.00 1.00 - 
Urban 0.80 (0.65, 0.98)
*
 - 2.03 (1.27, 3.26)
*
 0.86 (0.74, 1.00)
*
 - 1.29 (1.06, 1.58)
*
 1.30 (0.87, 1.93) 1.11 (0.88, 1.40) 1.41 (1.22, 1.62)
*
 - 
Currently smoking            
No 1.00 - 1.00 1.00 - - - - 1.00 - 
Yes 1.22 (1.04, 1.38)* - 0.90 (0.62, 1.31) 1.20 (1.05, 1.37)* - - - - 0.81 (0.45, 1.47) - 
Wealth quintile            
Lowest 1.00 1.00 1.00 1.00 - 1.00 1.00 1.00 1.00 - 
Second 0.76 (0.62, 0.93)* 0.60 (0.40, 0.92)* 1.63 (0.86, 2.99) 0.95 (0.80, 1.14) - 1.04 (0.82, 1.31) 1.00 (0.68, 1.47) 1.02 (0.82, 1.29) 1.21 (1.01, 1.45)* - 
Middle 0.84 (0.67, 1.04) 0.54 (0.36, 0.83)* 1.44 (0.77, 2.71) 0.96 (0.79, 1.17) - 1.10 (0.86, 1.42) 1.06 (0.67, 1.68) 1.31 (1.04, 1.65)* 1.32 (1.09, 1.59)* - 
Fourth 0.91 (0.70, 1.18) 0.56 (0.37, 0.85)* 1.20 (0.60, 2.44) 0.88 (0.70, 1.11) - 1.15 (0.86, 1.53) 0.72 (0.41, 1.28) 1.40 (1.11, 1.78)* 1.39 (1.12, 1.71)* - 
Highest 0.61 (0.46, 0.83) 0.58 (0.37, 0.91)* 0.97 (0.41, 2.32) 0.85 (0.67, 1.06) - 1.07 (0.78, 1.48) 1.14 (0.66, 1.97) 1.34 (1.02, 1.76)* 1.05 (0.82, 1.34) - 
Marital status            
Never married or 
living alone 
1.00 1.00 1.00 1.00 - 1.00 1.00 1.00 1.00 1.00 
Married or living 
together 
0.98 (0.80, 1.21) 1.46 (1.00, 2.15)* 0.88 (0.27, 2.88) 0.92 (0.81, 1.05) - 1.57 (1.20, 2.05) 0.51 (0.28, 0.96)* 1.15 (1.01, 1.32)* 1.86 (1.58, 2.19)* 0.92 (0.68, 1.24) 
Currently working            
No 1.00 1.00 1.00 1.00 1.00 1.00 - 1.00 1.00 - 
Yes 1.01 (0.87, 1.16) 0.90 (0.68, 1.19) 0.70 (0.46, 1.08) 0.97 (0.83, 1.13) 0.92 (0.78, 1.09) 1.23 (0.79, 1.90) - 1.22 (1.07, 1.39)* 1.25 (1.10, 1.40)8 - 
Diabetes           
Non diabetic - 1.00 1.00 - - 1.00 - 1.00 1.00 1.00 
Diabetic - 2.38 (1.27, 4.45)
*
 2.89 (1.26, 6.62) - - 4.06 (2.96, 5.57)
*
 - 2.90 (2.08, 4.04)
*
 1.54 (0.86, 2.76) 5.03 (3.81, 6.64)
*
 
Heart disease           
No - - 1.00 - - 1.00 - - - 1.00 
Yes - - 1.33 (0.72, 2.46) - - 3.47 (1.80, 6.68)* - - - 2.45 (1.63, 3.69)* 
Stroke           
No - - - - - 1.00 - - - 1.00 
Yes - - - - - 2.08 (0.94, 4.62)* - - - 1.16 (0.70, 1.93) 
Key: *= p<0.05 
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4.2.4  RESULTS OF THE BAYESIAN ANALYSIS AND DISEASE MAPPING  
The Bayesian analyses conducted in this study were limited to the countries with the 
highest prevalence of hypertension from each region (Albania, Egypt, and Lesotho). 
All the maps have been produced taking into account age and other covariates as 
potential confounders. Of note, unlike the other covariates included in the Bayesian 
model, the Bayesian analyses do not return the adjusted posterior OR for age, but 
instead return a graph of hypertension prevalence plotted against age (Figures 4.17, 
4.20, and 4.23).       
4.2.4.1 BAYESIAN ANALYSIS OF THE ALBANIA DATASET 
Table 4.14 presents the posterior odds ratios of hypertension across selected study 
characteristics. As shown, after controlling for age (Figure 4.17) and other covariates 
in the Bayesian model, the odds of hypertension were higher among men compared 
to women. There was no significant association between higher educational level 
and hypertension, however, the odds of hypertension among respondents with 
primary education were higher compared to respondents with no education. 
Respondents in each of the upper four quintiles were less likely to have 
hypertension, compared to respondents in the lowest quintile. While there was no 
significant association between smoking status and hypertension, current drinkers 
were more likely to be hypertensive compared to non-drinkers.  
In exploring the relationship between age and hypertension in the Albania dataset, 
Figure 4.20 shows a linear relationship between age and hypertension prevalence in 
the Albania study population. This finding is similar with the results of the 
multivariable logistic regression which also shows increasing odds of hypertension 
with progressively higher age groups.  
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Table 4.14: Posterior odds ratio & 95% Credible Interval of the likelihood of 
hypertension 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Posterior Odds Ratio (POR) (95% Credible Interval) 
Gender   
Male  1.39 (1.20, 1.60) 
Female 1.00 
Education   
No Education 1.00 
Primary 2.48 (1.95, 8.08) 
Secondary  1.99 (0.77, 7.46) 
Higher 1.20 (0.42, 4.44) 
Wealth quintile   
Lowest 1.00 
Second 0.77 (0.67, 0.93) 
Middle 0.82 (0.68, 1.02) 
Fourth 0.84 (0.70, 1.02) 
Highest 0.62 (0.47, 0.82) 
Smoking status   
Noncurrent smoker 1.00 
Current smoker 1.14 (0.95, 1.34) 
Drinking status   
Noncurrent drinker 1.00 
Current drinker 1.21 (1.06, 1.38) 
Stroke   
No 
Yes 
1.00 
1.07 (0.85, 1.35) 
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Figure 4.17: Logit effect of age. Shown are the posterior logit within the 95% and 80% 
pointwise credible intervals 
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Figure 4.18 is a map showing the map of Albania with its districts. 
 
 
Figure 4.18: Map of Albania by districts. 1, Berat. 2, Diber. 3, Durres. 4, Elbasan. 5, Fier. 6, 
Gjirokaster. 7, Korce. 8, Kukes. 9, Lezhe. 10, Shkoder. 11, Tirana. 12, Vlore. 
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Figure 4.18 maps the prevalence of Albania across its 12 districts, where the districts 
with the highest and lowest prevalence of hypertension are denoted by colours red 
and green respectively. Hence, drawing on Figures 4.17 and 4.18, the district with the 
highest prevalence of hypertension in Albania is Tirana, whereas the districts with 
the lowest prevalence estimates of hypertension are Gjirokaster and Vlore. It is 
important to emphasize that age has been into account in producing this map.  
 
 
 
Red = high risk; green = low risk. 
Figure 4.19: Covariate-adjusted residual spatial effects of hypertension at county level in 
Albania 
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4.2.4.2 BAYESIAN ANALYSIS OF THE EGYPT DATASET 
Table 4.15 presents the posterior odds ratios of hypertension across selected study 
characteristics. After controlling for age (Figure 4.20) and other covariates in the 
Bayesian model, the odds of developing hypertension were lower in men, compared 
to women. There was no significant association between educational status and 
hypertension. Only respondents in the fifth wealth quintile had higher odds of 
developing hypertension compared to respondents in the first quintile. Smoking was 
not significantly associated with hypertension. 
  
Table 4.15: Posterior odds ratio & 95% Credible Interval of the likelihood of hypertension 
 Posterior Odds Ratio (POR) (95% Credible Interval) 
Gender   
Male  0.63 (0.55, 0.73) 
Female 1.00 
Education   
No Education 1.00 
Primary 1.04 (0.88, 1.20) 
Secondary  1.03 (0.79, 1.19) 
Higher 0.98 (0.42, 4.44) 
Wealth quintile   
Lowest 1.00 
Second 1.16 (0.98, 1.38) 
Middle 1.20 (0.99, 1.42) 
Fourth 1.18 (0.99, 1.40) 
Highest 1.28 (1.03, 1.57) 
Smoking status   
Noncurrent smoker 1.00 
Current smoker 1.17 (0.99, 1.36) 
Stroke   
No 1.00 
Yes 3.35 (1.77, 5.81) 
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Figure 4.20: Logit effect of age. Shown are the posterior logit within the 95% and 80% 
pointwise credible intervals 
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Figure 4.21 is a map of Egypt with its districts. 
 
Figure 4.21: Map of Egypt by Districts. 1, Aswan. 2, Assiut. 3, Ismailia. 4, Red Sea. 5, Behera. 
6, Dakahlia. 7, Suez. 8, Gharbia. 9, Menoufia. 10, Menya. 11, New Valley. 12, Beni Suef. 13, 
Port Said. 14, South Sainai. 15, Suhag. 16, North Sainai. 17, Qena. 18, Kafr-El-Sheikh. 19, 
Luxor. 20, Matrouh. 21, Cairo. 22, Giza. 23, Damietta. 24, Sharkia. 25, Alexandria. 26, 
Kalyoubia. 27, Fayoum. 
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Figure 4.22 is map of Egypt displaying variations in hypertension prevalence across 
its districts. As shown, the prevalence of hypertension is highest in Sharkia and 
Kalyoubia districts, and lowest in Aswan, Menya and Suhag districts. It is also 
important to reiterate that age was taken into account in producing this map.  
 
 
Red = high risk; green = low risk 
Figure 4.22: Covariate-adjusted residual spatial effects of hypertension at governorate level 
in Egypt 
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4.2.4.3 BAYESIAN ANALYSIS OF THE LESOTHO DATASET 
Table 4.16 presents the posterior odds ratios of hypertension across selected study 
characteristics. 
Table 4.16: Posterior odds ratio & 95% Credible Interval of the likelihood of hypertension 
 Posterior Odds Ratio (POR) (95% Credible Interval) 
Gender   
Male  1.10 (0.97, 1.25) 
Female 1.00 
Education   
No Education 1.00 
Primary 1.75 (1.31, 2.25) 
Secondary  2.03 (1.46, 2.69) 
Higher 2.43 (1.79, 3.35) 
Wealth quintile   
Lowest 1.00 
Second 1.03 (0.84, 1.27) 
Middle 1.28 (1.06, 1.53) 
Fourth 1.38 (1.10, 1.73) 
Highest 1.35 (1.12, 1.63) 
Smoking status   
Noncurrent smoker 1.00 
Current smoker  0.94 (0.75, 1.19) 
After controlling for age (Figure 4.23) and other confounders, there was no 
significant association between gender (POR 1.10, 95% CI 0.97, 1.25) or smoking 
status (POR 0.94, 95% CI 0.75 to 1.19) with hypertension. However, the odds of 
developing hypertension were significantly higher for all levels of formal education, 
compared to no education. Respondents in the third, fourth and fifth quintiles had 
higher odds of hypertension, compared to respondents in the lowest quintile.  
 
Page | 125  
 
Figure 4.23: Logit effect of age. Shown are the posterior logit within the 95% and 80% 
pointwise credible intervals 
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Figure 4.24 is a map of Lesotho with its districts. 
 
 
 
Figure 4.24: Map of Lesotho by districts. 1, Berea. 2, Butha-Buthe. 3, Leribe. 4, Mafeteng. 5, 
Maseru. 6, Mohale’s Hoek. 7, Mokhotlong. 8, Qacha’s Nek. 9, Quthing. 10, Thaba-Tseka. 
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Figure 4.26 is map of Lesotho displaying variations in hypertension prevalence across 
its districts. As shown, the prevalence of hypertension is highest in Quthing and 
Maseru districts, and lowest in Butha-Buthe. It is also important to reiterate that age 
was taken into account in producing this map.  
 
Red = high risk; green = low risk. 
Figure 4.25: Total residual spatial effects of hypertension at district level in Lesotho 
 
The Bayesian framework is a robust technique compared to logistic regression 
modelling and this is why the posterior odds ratios of the Bayesian analysis differ 
from the odds ratios of the logistic regression analysis. The Bayesian analysis takes 
into account the complex nature of the datasets as well as any unobserved spatial 
factors.  
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4.3 KEY FINDINGS FROM TH E RESULTS 
The overall prevalence estimate of hypertension, as observed from the systematic 
review and meta-analysis, was 32.3%, with wide variations between countries 
ranging from 2.5% in rural India (Samuel et al., 2012) to 79.5% in Venezuela (Prince 
et al., 2012). In contrast, the overall prevalence of hypertension across the selected 
ten countries in the secondary data analysis was 12.5%, with prevalence estimates 
ranging from 5% in Morocco to 23% in Albania. However, findings from the 
secondary data analysis comprising ten countries may be less representative of low- 
and middle-income countries, compared to findings from the systematic review and 
meta-analysis comprising 45 countries. Nonetheless, Prince et al. (2012) from the 
systematic review included only participants who were aged 65 years and above, 
which could have explained the extremely high prevalence of hypertension in their 
study. 
The results of the systematic review and meta-analysis suggest that hypertension 
prevalence is highest in the Latin America and Caribbean region. In contrast, findings 
from the secondary data analysis show that the prevalence of hypertension is highest 
in the Eastern European countries. However, it is worth emphasizing that countries in 
the Latin America and Caribbean region were not represented in the secondary data 
analysis because there were no datasets from countries in the region with data on 
hypertension prevalence.  
Overall, men had a slightly higher prevalence of hypertension compared to women in 
the systematic review and meta-analysis (33.0% vs 31.2%); however, the difference 
was not statistically significant. In contrast, men had a significantly higher prevalence 
of hypertension in Albania and Uzbekistan, whereas hypertension prevalence was 
significantly higher in women compared to men in Armenia, Azerbaijan, Egypt and 
Senegal. Across the represented age groups in the secondary data analysis, 
hypertension prevalence was significantly higher in women compared to men in 
Azerbaijan and Senegal. The Morocco dataset included data from women only.  
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In the systematic review and secondary data analysis, hypertension prevalence was 
directly associated with increased age.  
In the systematic review, prevalence of hypertension was significantly higher in 
participants with no education, compared to those with some form of formal 
education in most regions and overall. Similarly, the results of the secondary data 
analysis revealed an inverse association between educational attainment and 
hypertension prevalence in at least one country in each region.  
The findings were also consistent between the systematic review and secondary data 
analysis regarding the association between hypertension prevalence and the place of 
residence. For instance, the systematic review revealed a higher prevalence of 
hypertension among people who lived in urban areas compared to those who lived in 
rural areas in all regions except in Eastern Europe, where the reverse was the case. 
Similarly, the results of the secondary data analysis showed higher prevalence of 
hypertension in the rural areas in Eastern European countries, whereas hypertension 
prevalence was higher in urban areas in the other selected countries representing 
other regions. These findings were not unexpected given that Eastern Europe is likely 
to be further along than other regions in the Epidemiological transition, and this is 
accompanied by changes in health patterns, where residents of urban areas now 
adopt healthier lifestyles than previously known. 
The results of the systematic review were somewhat contradictory to the secondary 
data analysis regarding the association between smoking status and hypertension. 
The systematic review revealed that hypertension prevalence was significantly higher 
among non-smokers compared to smokers in all regions except Asia. In the 
secondary data analysis, hypertension prevalence was only higher among non-
smokers, compared to smokers, in Senegal. In most of the European countries in the 
secondary data analysis, hypertension prevalence was higher among smokers 
compared to non-smokers. The reasons for the difference in the associations 
between smoking and hypertension between the systematic review and secondary 
data analysis are speculative at this point, and may only reside in characteristic 
differences between the study populations.   
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The findings from mapping the distribution of hypertension in Albania show that 
Tirana and Elbasan have a higher burden of hypertension compared to other 
districts. In Egypt, Sharkia and Kalyoubia have a higher burden of hypertension 
compared to other districts. In Lesotho, the burden of hypertension was highest in 
Quthing and Maseru and lowest in Butha-Buthe. 
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CHAPTER FIVE:  DISCUSSION 
In this chapter, the results of the systematic review and secondary data analysis are 
interpreted in the light of known confounders and compared against previous 
evidence. The policy/practice and research implications of the findings are also 
discussed in this chapter.  
5.1 INTERPRETING THE FINDINGS  
5.1.1 INTERPRETATION OF THE FINDINGS OF THE SYSTEMATIC REVIEW 
AND META-ANALYSIS  
The findings suggest that hypertension represents an important public health 
problem in LMICs, with one in three persons affected by the disease. Expectedly, the 
findings also suggest that older age and increased body weight are consistent 
predictors of hypertension across LMICs, irrespective of the different geographical 
regions. These results are consistent with the role of ageing and body fat changes in 
the progressive impairment of endothelial function (Seals et al., 2011). In addition, 
the significant direct association between mean age and hypertension prevalence 
found in the meta-regression analysis, may also explain the unusually high 
prevalence estimates of hypertension (> 70%) observed in a few of the included 
studies (Thuy et al, 2010; Ha et al., 2013; Kiau et al., 2013), given that the sampled 
population in these studies comprised mostly of the elderly. 
Hypertension rates were more likely to be higher in upper-middle income countries 
than in lower-middle income countries, and the latter more likely to be higher 
compared to low-income countries. This finding supports the hypothesis that a 
temporal relationship may exist between increasing levels of affluence and 
urbanization and raised blood pressure. The graded rise in hypertension rates across 
country income groups may be characteristic of the epidemiological transition within 
urban societies in resource-limited settings (Meshram et al., 2012; Samuel et al., 
2012).  The higher prevalence of hypertension in urban settings compared to rural 
settings, as shown in the present review, are also in accordance with this hypothesis.  
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Hypertension prevalence was higher among uneducated and unemployed people, 
compared to their educated and employed counterparts, which suggest that 
hypertension may be associated with socio-economic inequalities in LMICs. Evidence 
of health inequalities associated with hypertension in LMICs are not uncommon 
(Gupta et al., 2012; Jeemon et al., 2012). 
Although there was no significant gender difference in hypertension prevalence 
overall, the slightly higher prevalence observed among men is coherent with the 
male predilection for cardiovascular problems in the middle age, which attenuates in 
older adults as exemplified by an increased risk of cardiovascular diseases among 
post-menopausal women (Gupta et al., 2012; Jeemon et al., 2012).   
The higher proportions of hypertension among non-smokers compared to smokers in 
most regions and overall may be attributed to smokers erroneously self-reporting 
their smoking status as non-smokers in some of the included studies. While this 
argument may account for the higher prevalence of hypertension among non-
drinkers, compared to drinkers, in the sub-Saharan Africa region, it is also important 
to emphasize that non-smokers and non-drinkers alike may engage in other harmful 
behaviours known to increase the risk of hypertension. Obviously, the potential of 
reverse causation in cross-sectional studies cannot be ruled out, as it is possible that 
both non-smokers and non-drinkers may have quit these harmful behaviours due to 
other underlying medical conditions (Gupta et al., 2013). However, it is important to 
state that never smokers and never drinkers could not be separated from former 
smokers and former drinkers in the majority of the included studies.  
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5.1.2 INTERPRETATION OF THE SECONDARY DATA ANALYSIS FINDINGS 
There were differences in the prevalence of hypertension between the countries 
included in the secondary analysis. Generally, countries in Eastern Europe had higher 
estimates of hypertension prevalence compared to other countries. This variation 
may be explained by the fact that Eastern European countries are in the third stage 
of epidemiological transition, which is the age of degenerative and man-made 
diseases, where cardiovascular diseases are more prevalent, compared to the other 
countries in the secondary analysis which are in the first and second stages (Yusuf et 
al. 2001; Kreatsoulas & Anand, 2010).  
There were also between-country differences in the determinants of hypertension, 
which may explain the variations in hypertension prevalence. For instance, smoking 
rates were as high as 67% across the Eastern European countries, and only 17% 
across the other countries represented in the secondary analysis. However, 
variations in other factors, such as social trust, trust in government and violence, 
may be just as likely to explain the differences in hypertension prevalence between 
the selected countries. For instance, Albania had the highest prevalence of the 
hypertension (22.7%) in the analysis and ranks much lower than Morocco (5.4% 
prevalence) in the World Happiness Report score, which is a development indicator 
and measures the perceived trust of a people in government, among other indicators 
of happiness and well-being (Sachs et al., 2016).    
Another possible explanation of the lowest proportion of hypertension in Morocco is 
religion. Moroccans consider themselves to be religious (El Majhad, 2015), and being 
a predominantly Muslim country, societal factors intertwined with religion might 
play a significant role in explaining the low prevalence of hypertension in this 
country. For instance, Moroccans are likely to abide by the doctrines of Islam, which 
encourage abstinence from alcohol, smoking, and other lifestyle habits that are 
predisposing factors of hypertension. In addition, only women were represented in 
the Morocco dataset, and women are less likely to engage in lifestyle practices that 
are risk factors for hypertension.  
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Hypertension prevalence was higher in men compared to women in Albania, 
Ukraine, Uzbekistan, Lesotho and Maldives; whereas hypertension prevalence was 
higher in women compared to men in Armenia, Azerbaijan, Egypt, and Senegal. 
While the higher prevalence of hypertension in men compared to women might be 
expected, given the penchant for high-risk behaviour among the former, the reverse 
may be somewhat unexpected. The high prevalence of cardiovascular disorders in 
post-menopausal women may not account for the higher prevalence of hypertension 
in women than in men, given that respondents aged 55 years and above were grossly 
underrepresented in the secondary data analysis. Nonetheless, it is interesting to 
note that the resident populations of these four countries (Armenia, Azerbaijan, 
Egypt, and Senegal) largely religious, so that issues relating to social and religious 
patriarchy are common and may be at play. For instance, prioritizing the rights of 
men over women in the family restricts the freedom of women to get an education 
and participate in the decision-making process in the family and the society, which 
may potentially bring about social exclusion, emotional distress from being subject to 
domestic and other forms of violence, and eventually, high blood pressure (Joseph, 
1996; Brosschot et al. 2005). This interpretation of the findings is consistent with the 
association between the lack of education and hypertension observed in the results.  
The stratification of hypertension prevalence by age and according to the different 
socio-economic characteristics revealed that hypertension prevalence was lower (or 
at least somewhat comparable) in each country for patients between 15 and 34 
years of age compared to the overall estimates, whereas prevalence estimates were 
higher in each country for patients over 34 years of age compared to the overall 
estimates. These findings are coherent with age as a consistent correlate of 
hypertension in low- and middle-income countries. It is also important to reiterate 
that hypertension prevalence was higher among progressively older age groups, and 
this finding was consistent across all countries except Senegal, where prevalence of 
hypertension in respondents aged 55 years and above was lower than prevalence 
estimates obtained for respondents aged between 35 and 54 years. However, the 
number of respondents aged 55 years and above were markedly smaller (n=237) 
than the numbers of respondents in younger age groups. This small sample size may 
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explain the low prevalence of hypertension in this age group, which may not be 
generalizable to all adults aged 55 years and above in Senegal.  
The observed higher prevalence of hypertension in respondents with no formal 
education compared to respondents with formal education in Ukraine, Egypt, 
Senegal, and Maldives were expected and are consistent with materialist 
explanations underpinning health inequalities associated with hypertension 
(Kreatsoulas & Anand, 2010). In contrast, the contradictory findings observed among 
respondents in Lesotho may be the reduced access to health care among the 
resident population of Lesotho, the majority of whom are literate (UNESCO Institute 
for Statistics Data Centre, 2007).  For instance, with Lesotho spending more than 12% 
of its GDP on education, it is not surprising that about 85% of people aged 14 years 
and above are literate in the country (UNESCO Institute for Statistics Data Centre, 
2007). However, access to medical care is limited by a number of factors, notably the 
low doctor to patient ratio: in 2013, there was one physician for every 20,000 
patients in Lesotho (Doctors without Borders, 2007).   
Similarly, regarding wealth, the higher prevalence of hypertension among people in 
the lowest wealth quintiles, compared to people in upper quintiles, was expected in 
countries in Eastern European, and is in line with the materialist explanations 
underlying health inequalities associated with hypertension. In countries in Africa, 
the higher prevalence of hypertension among people in the upper wealth quintiles 
compared to those in lower wealth quintiles is consistent with the nutritional and 
other lifestyle transition that come with affluence in these countries.  
To reiterate, the higher prevalence of hypertension in the rural areas, compared to 
urban areas in Eastern European countries, and vice versa in the other selected 
countries representing other regions were not unexpected given that Eastern Europe 
is likely to be further along than other regions in the Epidemiological transition, and 
this is accompanied by changes in health patterns, where residents of urban areas 
now adopt healthier lifestyles than previously known (Levenson et al. 2002; Reddy, 
2004; Marmot & Wilkinson, 2006; Joshi et al. 2008). 
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In contrast to other countries in the secondary data analysis, non-smokers had a 
higher prevalence of hypertension compared to smokers in Armenia, Uzbekistan, and 
Senegal. As with the systematic review, this may be attributed to smokers 
erroneously self-reporting their smoking status as non-smokers in these countries.  
The higher prevalence of hypertension among employed respondents, compared to 
their unemployed counterparts in all countries in the Eastern European region, and 
in African countries, such as Senegal and Egypt, explain the nutritional and other 
lifestyle transition that comes with improved socio-economic position. It is also 
consistent with the psychosocial explanations underlying the aetiology of 
hypertension, such as job strain, which is a public health issue in these countries 
(Habibi et al., 2015). It is worthy to note that unemployment was not protective in 
the other selected countries.  
Recall that Bayesian analysis was conducted to assess the spatial distribution of 
hypertension prevalence in Albania, Egypt and Lesotho  countries with the highest 
prevalence of hypertension in each of the represented regions. In Albania, the 
analyses revealed marked variations in hypertension prevalence across the 12 
districts after controlling for age and other confounders. The observed variations 
showed a clear pattern where hypertension prevalence was much higher in districts 
located in the Central region of the country (Tirana and Elbasan), but lower in the 
districts farther away from the Central region. Interestingly, Tirana is the capital of 
Albania, and has the highest urban population in the country; the urban population 
accounts for 88% of the total district. Hence, it stands to reason why Tirana is the 
district with the highest prevalence of hypertension in Albania. Although the 
neighbouring district, Elbasan, is slightly more rural with an urban population 
accounting for 45% of the district population (INSTAT, 2014), the relatively higher 
prevalence of hypertension in this district, compared to other districts in the 
Northern and Southern regions of Albania, may be explained by the close proximity 
which allows for the ease of travel for between these two districts (Tirana and 
Elbasan) for commercial and other reasons.  
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However, the results showed a significantly higher prevalence of hypertension 
among respondents who lived in rural areas in Albania, compared to respondents 
who lived in urban areas. In fact, residence in urban Albania was associated with a 
statistically significant decrease in the risk of hypertension, compared to residence in 
rural Albania. Hence, it may be unlikely that the large urban population in Tirana 
accounts, even though in part, for the geographical variation of hypertension 
prevalence in Albania. Notwithstanding that, it is important to emphasize at this 
point that the city of Tirana suffers from problems related to overpopulation, 
including high levels of air and noise pollution, which have been brought about by a 
substantial increase in the number of cars over the last decades (United Nations 
Environment Programme, 2000). In addition, the increased construction of new 
buildings generates large amounts of inhaled particulate matter (INSTAT, 2014), 
which has been implicated in the aetiology of hypertension (Du et al., 2016). Such 
environmental factors may contribute significantly to the relatively higher prevalence 
of hypertension in Albania compared to other districts, and as such, the observed 
variation in hypertension prevalence in Albania. 
In Egypt, the results also revealed a striking variation in hypertension prevalence 
across its 27 districts. After adjusting for age and other important factors, there was 
a clear pattern where hypertension prevalence where districts with relatively higher 
prevalence of hypertension (Sharkia, Kalyoubia, Kafr-El-Sheikh, Dakahlia, Damietta, 
Cairo, Suez, Matrouh and Behera) are those with higher levels of socio-economic 
inequalities, compared to districts where hypertension prevalence was lower 
(Radwan, 1977; Korayem, 1994; Ibrahim, 1999; Hlasny & Verme, 2013; Ibrahim, 
2013; Verme et al., 2014). 
In Lesotho, the results also showed substantial variation in hypertension prevalence 
across the 10 districts in the country. After adjusting for age and other important 
factors, there was a clear pattern where hypertension prevalence was highest in 
Quthing and Maseru districts. In 2008, unemployment levels in these districts were 
each greater than 50% (Lesotho Bureau of Statistics, 2008). It is also likely that 
unemployment levels in these districts currently drive the unemployment rates in 
Lesotho. Given that results revealed a significant direct association between 
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unemployment level and hypertension prevalence in the sub-Saharan African 
countries, it is possible that unemployment rates may contribute substantially to the 
geographical variation of hypertension prevalence in Lesotho.  
5.2 COMPARISON WITH PREVIOUS EVIDENCE 
5.2.1 COMPARING THE SYSTEMATIC REVIEW AND META-ANALYSIS WITH 
PREVIOUS EVIDENCE 
The results of the review corroborate those of Kearney et al. (2005) where 
hypertension prevalence was the highest among Latin America and Caribbean 
populations, compared to other regions, based on data collected prior to 2001. This 
broadly suggests that hypertension prevalence estimates in the Latin America and 
Caribbean region may have driven prevalence of the disease in the developing world 
for more than a decade. However, participants from countries in this region were not 
the oldest and did not have the highest prevalence estimates of any of the traditional 
risk factors examined in the review. Hence, the reasons for the higher prevalence of 
hypertension in the Latin America and Caribbean region, compared to the other 
regions are largely speculative at this point. 
The higher prevalence of hypertension in urban settings compared to rural settings, 
as shown in our study, is consistent with previous reviews: Addo et al. (2007) in a 
systematic review examining the evidence pertaining to hypertension in sub-Saharan 
Africa found higher prevalence estimates (of hypertension) among people in urban 
areas, compared to those in rural areas, in all ten studies that provided information 
on this comparison. Similarly, Anchala et al. (2014), in a systematic review and meta-
analysis of hypertension prevalence in India, found higher prevalence estimates in 
urban residents, compared to rural residents (33% versus 25%).  
The higher prevalence of hypertension in older people, compared to younger people, 
was also consistent across all included studies reviewed by Addo et al. (2007). 
Although male and female hypertension prevalence estimates were comparable 
overall, the slightly higher prevalence in males, compared to females, observed in 
the results, are also consistent with Addo et al. (2007). 
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The association between combined overweight/obesity and hypertension shown in 
our results exemplify the role of excess body weight in hypertension prevalence, 
which has been long recognised and consistent across numerous observational and 
trial data (Khan et al., 2013; Zaman et al., 2013; Adhikari et al., 2014; Gupta et al., 
2015; Menon et al., 2015). 
The dearth of evidence from systematic reviews and meta-analyses investigating the 
link between socio-economic factors and hypertension in low- and middle-income 
countries precluded comparison of our findings with such previous evidence. 
However, the present findings regarding the association between employment status 
and hypertension differ from the results of a previous retrospective cohort study 
comprising 9,985 participants aged 50 or over across 13 European countries 
(Rumball-Smith et al., 2014).  
 
Overall, the present findings revealed a higher prevalence of hypertension in 
participants who were unemployed, compared to those who were employed. In 
contrast, Rumball-Smith et al. (2014) consistently found no association between 
unemployment and hypertension, irrespective of the metrics used for defining the 
experience of not working. However, this contradictory finding may be explained by 
the different populations between the two studies, where unemployed participants 
in the retrospective cohort study may have been more likely to be out of the 
workforce willingly, given the age demographic (age > 50 years), and may therefore 
be spared the psychosocial effects of being unemployed. In contrast, the 
unemployed participants in the present review were predominantly younger and 
may therefore be less likely to be out of the workforce by choice and less likely to be 
spared the psychosocial effects of unemployment. Psychosocial factors associated 
with hypertension are not uncommon and have been described previously (section 
1.2.3.3).  
 
Again, most of the represented countries in the retrospective cohort study are high-
income, so that the social deprivation and health inequality that comes with 
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unemployment tends to be cushioned by free health and social care systems in these 
countries. More importantly, Rumball-Smith et al. (2014) have cited that the 
possibility of bias may have contributed to the null findings. For instance, 
hypertension was assessed retrospectively based on self-reported physician 
diagnosis, which carried the risk of misclassifying hypertensive participants as 
normotensive, potentially underestimating any association between unemployment 
and hypertension if this bias was equally likely to affect unemployed and employed 
participants (Rumball-Smith et al., 2014).  
The absence of other social risk factors in the studies included in the present review 
(e.g. social stress, job strain) also precluded any comparison with previous evidence 
in this regard. However, the considerable burden of social factors in low- and middle-
income countries and the impact of these factors on hypertension prevalence in 
these countries have previously been acknowledged (section 1.2.3.3). 
5.2.2 COMPARING THE SECONDARY DATA ANALYSIS WITH PREVIOUS 
EVIDENCE 
The analyses of the 2008/09 Albania DHS estimated a 23% prevalence of 
hypertension, which was consistent with estimates obtained from previous analyses 
of the Albania DHS dataset (Harhay et al., 2013; Petrela et al., 2013).  
Zelveian & Podosyan (2011), in a cross-sectional study of 748 participants, found the 
prevalence of hypertension in Armenia to be 27.4% overall, and significantly higher in 
men than in women. While these findings contradict the present analysis, it is worth 
noting that their study was conducted in Yerevan, which is the capital city of 
Armenia, and therefore not likely to provide a nationally representative sample.  
Roberts et al. (2012), in their analysis of a nationally representative household survey 
of 1781 respondents conducted in 2010 found hypertension prevalence in Azerbaijan 
to be 22.7%. While this contradicts the 12.3% prevalence found in the present 
analysis, it is important to recall that the present analysis was of a DHS survey 
conducted in 2006. Hence, it is possible that hypertension prevalence in Azerbaijan 
increased considerably during this four-year period.    
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Similarly, analysis of a nationally representative household survey of 1992 
respondents conducted in 2010 found hypertension prevalence in Ukraine to be 
33.4% (Roberts et al., 2012), which contradicts the 17.3% prevalence observed in the 
present analysis of the 2007 Ukraine DHS dataset. Again, it is possible that 
hypertension prevalence in Ukraine increased considerably during this three-year 
period.    
Harhay et al. (2013), in their analyses of the 2010 DHS datasets for Albania, Armenia, 
Azerbaijan and Ukraine, associated poverty, rural residence and lower educational 
status with increased risk of hypertension, which are consistent with the present 
analyses.  
Mishra et al. (2006), in their analysis of the 2002 Uzbekistan Health Examination 
Survey, found a significant risk of hypertension associated with being employed 
among men in Uzbekistan, but no significant association between employment status 
and hypertension risk was observed among women. Their findings contradict the 
present analysis, which shows a reversal of these associations in men and women, 
where a significant high risk of hypertension was found among working women in 
Uzbekistan, but not among working men. However, the reasons for these contrasting 
findings are not clear, especially considering that there was no indication that data 
on hypertension was collected differently from men and women.  
A 2012 STEPwise survey conducted by the Ministry of Health and Population in 
Egypt, in collaboration with WHO, revealed a 40% prevalence of hypertension among 
adults in the country (WHO, 2016m). This prevalence is a much higher estimate than 
the 15.7% prevalence obtained from the present analysis of the 2008 Egypt DHS 
dataset. It is possible that hypertension prevalence in Egypt increased considerably 
within this four-year gap, especially given that non-communicable diseases account 
for more than 80% of all deaths and more than 60% of premature deaths in Egypt. 
However, it is also important to emphasize that the respondents aged 15–18 years, 
in whom hypertension prevalence is very low, were included the present analyses, 
whereas the STEPwise survey only included adults who were older than this age 
group. In addition, there may have been fundamental differences in the methods for 
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assessing hypertension between the 2008 Egypt DHS survey and the 2012 STEPwise 
survey.   
Analysis of the 2000 National Health Survey in Morocco revealed a 37% prevalence 
of hypertension among Moroccan women (Tazi et al., 2003), which contradicts the 
5.4% female prevalence observed in the present analysis of the 2003/2004 DHS 
dataset. However, a decrease in hypertension prevalence of this magnitude (37% to 
5%) may be unrealistic and inconsistent with current trends in Morocco, where 
cardiovascular disease and other non-communicable diseases account for 75% of all 
deaths (WHO, 2014a). Hence, reasons for this disparity between both surveys may 
rely on other factors such as those highlighted in the preceding paragraph. For 
instance, only respondents aged 20 years and above were surveyed in the 2000 
National Health Survey in Morocco, which might explain the higher prevalence of 
hypertension obtained from this survey; the present DHS survey was more inclusive 
by providing data for respondents aged 15 years and above. Again, there may have 
been fundamental differences in the methods for assessing hypertension between 
the 2000 National Survey and the 2003/2004 DHS survey. 
Nair et al. (1994) attributed the variation in hypertension prevalence in Lesotho to 
nutritional transition between rural and urban populations, which is somewhat 
consistent with the significantly higher prevalence of hypertension in urban 
populations, compared to rural populations in Lesotho.  
Aboobakar et al. (2010), in a cross-sectional survey of 2028 participants in the 
Maldives, found a significantly higher risk of hypertension among participants with 
no formal education, compared to participants who were educated. Their finding 
was consistent with the present analyses of the 2009 Maldives DHS survey, which 
showed significantly higher prevalence of hypertension among uneducated people 
compared to those who are educated.  
In a recent cross-sectional survey, Macia et al. (2016) found a prevalence of 
hypertension of 24.7%. While this estimate contradicts the 7.6% prevalence found in 
the present analysis of the 2010/2011 Senegal DHS dataset, it may also suggest that 
hypertension prevalence may have increased about three-folds in the past six years. 
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In addition, the association between a lack of education and hypertension is also 
consistent with the present analysis.  
5.3 LIMITATIONS AND STRENGTHS 
5.3.1 LIMITATIONS AND STRENGTHS OF THE SYSTEMATIC REVIEW AND 
META-ANALYSIS 
It is acknowledged that the overall quality of the included studies was moderate at 
best, especially given that more than a third of the studies (39%) were assessed as 
having high risk of sampling bias. However, as shown using meta-regression analysis, 
the high rates of sampling bias had no undue impact on the overall hypertension 
prevalence. A salient limitation in light of the risk of bias is that non-response bias 
was not assessed in the included studies, and this stems from the fact the adopted 
tool (Newcastle-Ottawa Scale) does not offer a provision of non-response bias to be 
assessed. 
High amounts of heterogeneity across the included studies was another limitation of 
our study. Prevalence estimates from different regions were pooled in this meta-
analysis, and as expected, high heterogeneity between studies was found in the 
meta-analyses. A substantial amount of the heterogeneity across studies was 
explained by such factors as differences in population characteristics and study 
methodologies. Nonetheless, as affirmed by previous evidence, meta-analyses are 
the preferred options to narrative syntheses for interpreting the results in a review, 
even in spite of the presence of a considerable amount of heterogeneity (Ranasinghe 
et al., 2015). Heterogeneity appeared to be the norm rather than exception in 
published meta-analyses of observational studies, in which case, it should be 
expected and quantified appropriately (Rahman et al., 2015).  
Only studies from 45 countries were included in the meta-analysis, whereas the 
World Bank (2015) and International Monetary Fund (2009) recognize 156 
developing countries. Hence, majority of the low- and middle-income countries were 
not represented in the systematic review, potentially increasing the risk of selection 
bias and threatening the external validity of the findings. Nonetheless, coverage of 
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evidence for all geographic regions might be reasonable, potentially allowing for 
generalisability of the results across geographic regions. 
In addition, there is a possibility that non-smokers and non-drinkers may potentially 
be at risk of hypertension due to other health-damaging behaviours; this study 
therefore highlights the importance of expatiating on other lifestyle variables as 
potential correlates of hypertension and other cardiovascular conditions. For 
example, the potential impact of differential dietary patterns and dietary salt intake 
on the observed variations in hypertension prevalence across countries were not 
examined and it is likely that differences in average dietary salt intake at the 
population level may contribute to some of the observed variations in hypertension 
prevalence across countries and world regions (Edwards et al., 2000; Amoah, 2003; 
Bhansali et al., 2015).  
In spite of the aforementioned limitations, the review’s strengths are important. In 
addition to providing the most comprehensive evidence of the status of hypertension 
in low- and middle-income countries, comprehensive searches of databases were 
conducted to ensure that all relevant publications were identified. Potential bias was 
also reduced during the conduct of this review by having the authors independently 
scan through the search output and extract the data.  
5.3.2 LIMITATIONS AND STRENGTHS OF THE SECONDARY DATA ANALYSIS 
The cross-sectional nature of the secondary data analysis does not allow for 
temporal or causal interpretations of the observed associations between socio-
demographic risk factors and hypertension.  
With only 10 countries included in the analysis, including the all-women data for 
Morocco, the surveys were not representative of low- and middle-income countries, 
potentially introducing a high risk of selection bias in the secondary analyses and 
threatening the external validity of the findings. In addition, absence of datasets 
from East Asia/Pacific and Latin America/Caribbean regions also limit the 
generalizability of the findings to low- and middle-income countries in these regions.   
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Data on most variables were collected on a self-report basis, increasing the likelihood 
of information (recall) bias, which may affect the observed associations between 
socio-demographic factors and hypertension risk.   
There were missing data for some variables in the analyses. For example, the 
Armenia and Uzbekistan datasets provided no information on people with no 
education, so that it was not possible to examine the associations of hypertension 
across all levels of educational attainment in these countries. It is unclear from the 
datasets if the reason for missing data is because Armenia and Uzbekistan have 
attained a certain minimum of educational attainment where it is unlikely to have 
persons aged 15 years and above to be without formal education.  
Due to ongoing epidemiological transition in the 10 countries explored (Yusuf et al., 
2001), it is speculated that the observed prevalence of hypertension in each country 
may have been underestimated, given that the datasets are not recent. 
The potential variations in the access to anti-hypertensive medications could not be 
examined because the data were not available, potentially precluding any 
assessment of its impact on hypertension prevalence in low- and middle-income 
countries.  
Across all the 10 datasets, there was hardly any information on other important 
social factors that may be associated with hypertension prevalence in low- and 
middle-income countries such as social stress, job strain, overcrowding, physical 
activity, dietary habits, sleep patterns etc. Data on these variables would have 
provided more robust information about the social determinants and other risk 
factors of hypertension in the selected countries.  
Besides the above limitations, it is important to acknowledge that the secondary 
analyses have also provided novel information on the spatial distribution of socio-
demographic factors associated with hypertension in low- and middle-income 
settings. 
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5.4 IMPLICATIONS OF THE RESULTS 
5.4.1  IMPLICATIONS FOR PRACTICE AND POLICY  
The elderly, overweight/obese, non-educated and urban settlers present 
opportunities for targeted health promotion and preventive interventions in LMICs. 
Given the high burden of infectious diseases in these countries, it might be 
economically justified to implement intervention programs for hypertension in 
higher-risk populations alone. However, the occurrence of hypertension in the 
general population remains unacceptably high, which poses an ethical dilemma to 
relying on high-risk strategies only in these settings; countries in the Middle East and 
North Africa region may even not have sufficient evidence to implement public 
health interventions in certain high-risk populations such as the elderly.  
Health inequalities associated with hypertension have been recognized as an 
important public health issue in low- and middle-income countries (Cappuccio et al., 
2004; Gupta et al., 2012; Jeemon et al., 2012). Addressing the wider social 
determinants of the disease is therefore crucial to its control in these countries. 
Failure to address these issues portends additional threats to the sustainability of 
public health infrastructure, especially alongside the prevailing effects of infectious 
disease epidemics. For instance, in countries such as Egypt, Senegal and Maldives, 
where education is protective against hypertension, resources, though limited, can 
be deployed more effectively to achieve a significant reduction in the proportions of 
adolescents and adults without formal education.    
In countries where being employed was associated with hypertension (such as 
Albania, Armenia, Azerbaijan Ukraine, Uzbekistan, Egypt and Senegal), country-wide 
policies that ensure that employers of labour conform to international ethical 
standards in dealing with their employees must be enforced as a matter of public 
health in order to prevent job strain or other stressors that may be associated with 
hypertension and its complications.    
The geographical variations of hypertension observed in Albania, Egypt and Lesotho 
will provide policy makers with information on how to allocate resources so that the 
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amount of attention given to the districts within these countries is directly 
proportional to the district prevalence of hypertension and the magnitudes of its 
associations with spatial and non-spatial factors. Policy makers and public health 
planners in LMICs may adopt the WHO global action plan targets (see Box 2) as a 
guide to tackling health disparities associated with hypertension at the district level. 
This is especially important within the contexts of other low- and middle-income 
countries where hypertension constitutes considerable economic burden (WHO, 
2014b). Although, by definition, LMICs have a low GDP, which consequently reduces 
spending on health expenditure, however, considering that hypertension is 
associated with a much larger disability adjusted life years in LMICs, compared to 
high income countries, the cost-effective solution would be to prioritize government 
spending on health care over sectors of the economy that do not require urgent 
reforms. Interventions that could be useful for preventing hypertension in districts 
considered hotspots for hypertension are summarized in Table 5.1.  
Population-wide strategies such as reduction in dietary salt intake from processed 
foods are warranted in these low-resource settings, because they have been proven 
to be cost-effective means to shift blood pressure distribution at the population 
level, thus reducing the burden of cardiovascular disease associated with the 
epidemic of hypertension (Agyemang et al., 2006; Duda et al., 2007; Erhun et al., 
2005; Kamadjeu et al., 2006; Kenge et al., 2007; Niakara et al., 2007). Specifically, 
population-wide salt reduction through legislation, voluntary agreements with food 
industries and mass media campaigns are evidence-based cost-effective strategies 
for reducing hypertension prevalence in low- and middle-income countries, 
potentially preventing millions of years lost to the disease as a result of ill-health, 
disability or premature death (Omuemu et al. 2007).  
Overall, the findings could be useful for the design of screening and treatment 
programs for hypertension in low- and middle-income countries. Early screening and 
initial management in primary care centers is key to tackling the burden of 
hypertension in low- and middle-income countries. Given that doctor to patient 
ratios tend to be low in these countries, building the capacity of non-physician health 
workers (such as community health extension workers) on basic screening 
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procedures, initial management and timely referral to secondary or tertiary health 
facilities where necessary could be useful. 
The use of home blood pressure monitors should be encouraged and taught to 
patients at first contact in primary care centers. Home-based blood pressure 
monitoring is considered to be as accurate a blood pressure measurement as 
ambulatory blood pressure monitoring (National Institute for Health and Care 
Excellence, 2011). Given the relatively high costs in low- and middle-income 
countries, home blood pressure monitors could be subsidized by the governments of 
these countries, or by international donor agencies.  
 
Box 2: Voluntary targets of the WHO Global Action Plan. 
a. 25% reduction in the prevalence of hypertension 
b. A 25% relative reduction in risk of premature mortality from cardiovascular 
diseases, cancer, diabetes, or chronic respiratory diseases. 
c. At least 10%relative reduction in the harmful use of alcohol, as appropriate, 
within the national context. 
d. A 10% relative reduction in prevalence of insufficient physical activity. 
e. A 30% relative reduction in mean population intake of salt/sodium. 
 
f. A 30% relative reduction in prevalence of current tobacco use in persons aged 
15+ years. 
 
g. A 25% relative reduction in the prevalence of raised blood pressure or contain the 
prevalence of raised blood pressure, according to national circumstances.  Halt 
the rise in diabetes and obesity. 
 
h. At least 50% of eligible people receive drug therapy and counselling (including 
glycaemic control) to prevent heart attacks and strokes. 
 
i. An 80% availability of the affordable basic technologies and essential medicines, 
including generics, required to treat major non-communicable diseases in both 
public and private facilities. 
Source: WHO, 2013e. 
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Table 5.1: Interventions for prevention of hypertension in LMICs 
 
Risk factor for hypertension 
 
Preventive measure 
Unhealthy diet and physical activity  Creating enabling environments for population-
based salt reduction strategies 
 Implementing salt reduction and iodine 
fortification strategies 
 Formulating strategies for monitoring and 
evaluating population sodium consumption and 
sources of sodium in diets 
 Replacing trans-fat with polyunsaturated fat in 
diets 
 Creating awareness among the population 
about the benefits of healthy diet and increased 
physical activity 
 
Tobacco use  Increasing taxes on tobacco 
 Banning tobacco advertisements, promotion, 
and sponsorships 
 Smoke free legislation for public and work 
places should be enforced 
 Disseminating information about the harmful 
effects of tobacco through health warnings on 
tobacco products 
 
Harmful alcohol use  Increasing taxes on alcohol 
 Restricting retail access to alcohol and alcoholic 
beverages 
 Banning alcohol advertisements, promotion, 
and sponsorships 
 
5.4.2  IMPLICATIONS FOR FUTURE RESEARCH 
This research has provided a valuable platform to plan further investigations around 
the epidemiology and management of hypertension in low-and middle-income 
countries by laying a foundation for intensifying prevention efforts in those districts 
where hypertension is most burdensome, and investigating local drivers of 
hypertension within high-risk populations in these hotspots. 
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As highlighted in the limitations above, there was a paucity of information on other 
important variables such as social stress, job stain, physical activities, dietary 
patterns, sleep problems and medication adherence. Therefore, there is a need for 
more comprehensive country-specific data on hypertension and its determinants in 
low-and middle-income countries to account for the impact of these non-spatial 
factors on hypertension prevalence in low- and middle-income settings. Of note, the 
dearth of evidence on the social epidemiology of hypertension in low- and middle-
income countries cannot be overemphasized. For instance, variations in social trust 
and violence and how they might drive hypertension prevalence within low- and 
middle-income countries remain largely unknown, even though these factors are 
highly pertinent in these countries.  
In none of the studies or the datasets was ambulatory blood pressure measurement 
used to assess hypertension, even though ABPM represents the gold standard 
method for measuring blood pressure and diagnosing hypertension. More studies 
assessing hypertension using ABPM) are needed in low -and middle-income countries 
in order to ascertain the true prevalence of hypertension within study samples.  
Finally, there is a need for studies to accurately predict future trends of hypertension 
prevalence estimates in low- and middle-income countries. For instance, national 
point prevalence surveys could provide a cost-effective approach for monitoring 
trends of hypertension prevalence in these countries. 
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CHAPTER SIX:  CONCLUSIONS 
This chapter summarises the important findings, while taking into account future 
plans for dissemination as well as reflection on the entire process involved with 
producing the thesis.    
6.1 CONCLUSION 
The systematic review and meta-analysis conducted to determine the prevalence of 
hypertension in low- and middle-income countries is among the first of its kind, 
including 242 epidemiological studies with more than one million participants from 
45 countries classified as low- and middle-income by the World Bank (2015). The 
findings show that one out of three adults over the age of 18 years suffer from 
hypertension in the developing world. The findings of the systematic review also 
suggest that the prevalence of hypertension across the developing regions of the 
world may be influenced by high illiteracy and unemployment rates.  
The secondary analyses of DHS datasets were conducted to identify potential 
correlates of hypertension in countries that provided data on hypertension 
prevalence from nationwide surveys. These surveys, comprising over 90,000 
respondents, were conducted in 10 countries including Albania, Armenia, Azerbaijan, 
Ukraine, Uzbekistan, Egypt, Morocco, Lesotho, Senegal and Maldives. The findings 
revealed variations in hypertension prevalence between these countries, ranging 
from 5.4% in Morocco to 22.7% in Albania. There were also variations in potential 
correlates of hypertension between countries, with age being the most consistent 
factor directly associated with hypertension prevalence. Hypertension prevalence 
was also influenced by unemployment rates; however, this was only true for all 
Eastern European countries. Education was protective in Egypt, Senegal and 
Maldives, but may be a strong determinant in Lesotho given the extremely high 
literacy rates in the country.  
Secondary analyses of the DHS datasets were also conducted to map the distribution 
of hypertension in countries with the highest prevalence of the disease in the 
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represented regions (Albania, Egypt and Lesotho). These analyses revealed that the 
districts closest to the capital cities of these countries were hotspots for 
hypertension, and may warrant prioritized resource allocation over other districts in 
addressing this disparity. 
Overall, the findings provide contemporary and up-to-date estimates that reflect the 
significant burden of hypertension in low- and middle-income countries and 
evidence that hypertension remains a major public health issue in these settings. The 
findings also suggest that addressing the wider social determinants of hypertension, 
such as illiteracy and unemployment, may reduce overall prevalence of the disease in 
low- and middle-income countries.  
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FUTURE DIRECTIONS AND REFLECTIONS 
FUTURE DIRECTION 
Considering the fact that the findings of this research have generated novel 
information about the countries explored, especially in Albania, Egypt, and Lesotho, 
these findings are aimed for publication in high-ranking international journals in the 
area of CVD research, epidemiology or public health (e.g., International Journal of 
Health Geographics, Hypertension, International Journal of Epidemiology, and 
Medicine). There is also a plan to write a review/implication article in a policy-
oriented journal. It is expected that findings from this research will further 
emphasize the importance of collecting hypertension and blood pressure data in the 
on-going Demographic and Health Surveys conducted across 89 low-and middle-
income countries, given the socioeconomic burden associated with the disease. 
There is an on-going discussion to formulate a proposal for grant application to 
further expand the scope of this research, particularly towards generating country-
specific data on hypertension in some selected low-and middle-income countries 
across Africa, through collaborations between Division of Health Sciences of Warwick 
Medical School and South African Medical Research Council. It is anticipated that the 
findings from the research will be used by local governments to start or change 
policy towards improving the prevention and management of hypertension and its 
related illnesses in the selected countries and Africa at large. There is also a plan to 
present the findings in workshops for various stakeholders in low- and middle-
income countries, such as health professionals, government departments, non-
governmental organizations, academics and journalists.  
REFLECTIONS AND LESSONS LEARNT 
My original background is Microbiology, but due to my passion and sheer 
commitment to make an impact on major public health issues in communities, 
particularly in low-and middle-income countries, I got into public health. Prior to 
embarking on my PhD journey, I established a non-governmental organisation 
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[Family and Youth Health Initiative (FAYOHI)] in my home state of Jigawa in Nigeria 
with the view of impacting on rural areas that have not been impacted upon by on-
going health interventions and reforms taking place in the state and the country. I 
chose this topic because as shown by WHO and previous literature, hypertension is 
the number one risk factor for mortality and the third leading cause of disability-
adjusted life years in developing regions of the world. On a personal note, I was not 
happy that there was no data on hypertension in Nigerian DHS surveys. However, 
this has posed a challenge to me and informed my decision to be part of the frontier 
of hypertension and cardiovascular research in Nigeria and other developing regions 
of the world. I would also like to state that our organisation (FAYOHI) has now 
entered into partnership with the Jigawa State Ministry of Health to conduct the 
largest ever NCDs Survey in the state and we are presently holding stakeholder 
engagement meetings to discuss possible cost effective approaches from the 3 
Critical Pathway Analysis I developed. 
Overall, conducting this research stimulated me intellectually, because of the 
proficiency required to conduct a systematic review and robust statistical analyses of 
huge datasets using novel techniques (Bayesian geospatial mapping).  
Time and unavailability of data were also limiting factors, otherwise I would have 
liked to analyse recent primary data from the 10 countries explored (Albania, 
Armenia, Azerbaijan, Egypt, Lesotho, Maldives, Morocco, Senegal, Ukraine, and 
Uzbekistan) and do a more comparative analysis of the findings to observe the 
change in trends and patterns of hypertension within districts over time (e.g. From 
1995-2015). Nonetheless, this study has broadened my horizons towards acquiring 
research skills necessary for independently conducting a research project on 
hypertension and other cardiovascular risk factors. 
The most fascinating part of this Thesis however, is that it enabled me to apply all the 
knowledge I gained throughout the course of my PhD journey ranging from; Practical 
Project Management 1 and 2, Understanding Research & Critical Appraisal in Health 
Care, Practice of Public Health, SPSS (Overview for Complete Beginners & Elementary 
Statistical Methods) all from the University of Warwick, Introduction to Regression 
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Analyses from University College London Institute for Child Health, and Stata (Data 
management, manipulation, and analyses) from University of Oxford IT Services. 
There will have not been a better opportunity to bring all of these knowledge 
together. 
If I was to do a similar research study again, I will make sure I manage my time more 
effectively so as to analyse as much data as I can possibly lay my hands on despite 
the short time frame provided (3 years). 
Finally, I am confident to state that the information provided by this research will 
promote the understanding of hypertension across low-and middle-income 
countries, and also inform public health planners, decision makers, and major 
stakeholders on the need for adequate attention to the disease in the developing 
regions of the world. I am also optimistic that this research will inform and 
encourage policy makers to make concerted efforts towards effectively reducing the 
burden of hypertension and its related illnesses in low-and middle-income countries. 
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APPENDICES 
APPENDIX I: PROSPERO REGISTRATION 
PROSPERO International prospective register of systematic reviews 
Prevalence of hypertension in low-and middle-income countries: a systematic 
review 
and meta-analysis 
Ahmed Mohammed Sarki, Olalekan Uthman, Ngianga-Bakwin Kandala, Saverio Stranges, Chidozie Nduka 
Citation 
Ahmed Mohammed Sarki, Olalekan Uthman, Ngianga-Bakwin Kandala, Saverio Stranges, Chidozie Nduka. 
Prevalence of hypertension in low-and middle-income countries: a systematic review and meta-analysis. 
PROSPERO 2013:CRD42013006162 Available from 
http://www.crd.york.ac.uk/PROSPERO_REBRANDING/display_record.asp?ID=CRD42013006162 
Review question(s) 
To determine the prevalence of hypertension in low-and middle-income countries 
To examine the pattern of hypertension across different socio-demographic characteristics (age, gender, 
educational 
attainment, wealth status, place of residence, and employment status) 
Searches 
A literature search of MEDLINE, EMBASE, Scopus, and Web of Knowledge will be conducted using the 
following subject terms "hypertension", "blood pressure", "low-and middle-income countries", "developing 
countries". The World Health Organization Global Cardiovascular Infobase and bibliographies of reviews and 
study articles will also be scrutinized for additional studies. No language or publication period restriction will 
be applied. 
Types of study to be included 
We will include all study designs in the review. 
Condition or domain being studied 
Hypertension. 
Participants/ population 
Adult population (as defined by the authors of the original studies included) living in low-and middle-income 
countries. 
Intervention(s), exposure(s) 
Not Applicable. 
Comparator(s)/ control 
Not Applicable. 
Context 
Inclusion criteria: 
Studies will be included in the review if they meet the following criteria 
- Population-based studies that reported the prevalence of hypertension 
- Standard methods for the measurement of hypertension was described 
- The definition of hypertension was equal to or above140/90 mmHg (Systolic/Diastolic blood pressure) or on 
anti- hypertensive medication, or self-reported health professional diagnosis of hypertension 
- Sex and age-specific prevalence of hypertension was reported 
Exclusion criteria: 
Studies will not be included in the review if they fall into any of the following categories 
- Studies where standard methods for measurement of hypertension was not clearly described 
- Studies in which the definition of hypertension is not equal to or above 140/90 mmHg (Systolic/Diastolic 
blood 
pressure) 
- Studies where the population or source of population could not be identified 
- Hospital-based studies 
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Outcome(s) 
Primary outcomes 
Hypertension, defined as equal to or above 140/90 mmHg (Systolic/Diastolic blood pressure) or on anti-
hypertensive medication, or self-reported health professional diagnosis. 
Secondary outcomes 
Not Applicable. 
Data extraction, (selection and coding) 
The titles and abstracts of studies retrieved using the search strategy from the databases and additional 
sources will be screened independently by two authors of the review to identify studies that meet the 
inclusion criteria outlined for the review. 
Data from the included studies will be extracted using a standardised protocol and a data-extraction form by 
two authors of the review. Whenever the data of a particular article differ between the team members, the 
discrepancy will be resolved either by consensus, seeking additional information from the author(s) of the 
study or consulting another member of the review team. 
The data will be extracted based on the following: 
i. Methodological information; year of publication, geographic origin of publication, study setting 
(rural/urban), target population and their selection criteria, sample size, analysis, main findings, and reliability 
of outcome data. 
ii. Case definition; criteria used for diagnosis and methods employed for hypertension measurement. 
iii. Medication history; number of participants on antihypertensive medication. 
iv. Risk factors of hypertension and other comorbidities. 
v. Population-based study outcomes; incidence, prevalence disability-adjusted life years, mortality rate and 
prevalence of antihypertensive drugs within the study settings. 
Risk of bias (quality) assessment 
The reporting and methodological qualities of the included studies will be assessed using a standardised 
appraisal checklist and some selected items from the STROBE (Strengthening the Reporting of Observational 
Studies in Epidemiology) statement respectively. 
Strategy for data synthesis 
Study results will be narratively described and where appropriate, we will pool the data using random effects 
meta- analyses. 
Analysis of subgroups or subsets 
Differences between studies with regards to the pattern of hypertension across different socio-demographic 
characteristics (age, gender, educational attainment, wealth status, place of residence, and employment 
status) will be explored using subgroup analyses. 
Dissemination plans 
The review will be disseminated via publication in a high-impact journal. 
Contact details for further information 
Ahmed Mohammed Sarki 
Warwick Medical School, 
University of Warwick, 
Coventry, UK 
CV4 7AL 
a.m.sarki@warwick.ac.uk 
Organisational affiliation of the review 
Warwick Medical School, University of Warwick, Coventry, UK CV4 7ES 
http://www2.warwick.ac.uk/fac/med/ 
Review team 
Mr Ahmed Mohammed Sarki, Warwick Medical School, University of Warwick 
Dr Olalekan Uthman, Warwick Medical School, University of Warwick 
Dr Ngianga-Bakwin Kandala, Warwick Medical School, University of Warwick 
Dr Saverio Stranges, Warwick Medical School, University of Warwick 
Dr Chidozie Nduka, Warwick Medical School, University of Warwick 
Anticipated or actual start date 
01 November 2013 
Anticipated completion date 
30 November 2014 
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Funding sources/sponsors 
No funding 
Conflicts of interest 
None known 
Language 
English 
Country 
England 
Subject index terms status 
Subject indexing assigned by CRD Subject index terms 
Developing Countries; Humans; Hypertension; Prevalence 
Stage of review 
Completed but not published 
Date of registration in PROSPERO 
05 November 2013 
Date of publication of this revision 
19 February 2015 
Stage of review at time of this submission Started Completed 
Preliminary searches Yes Yes 
Piloting of the study selection process Yes Yes 
Formal screening of search results against eligibility criteria Yes Yes 
Data extraction Yes Yes 
Risk of bias (quality) assessment Yes Yes 
Data analysis Yes Yes 
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APPENDIX II: REVIEW SEARCH STRATEGY 
 
 
 
 
 
 
 
#1 ‘hypertension’ or ‘blood pressure’ or ‘hypertens*’ 
#2 ‘population based’ or ‘aetiology’ or etiology’ or ‘prevalence’ ‘epidemiolog*’ 
#3 ‘low-and middle-income countries’ or ‘developing countries’ or ‘Afghanistan ’or 
‘Albania’ or ‘Algeria ’or ‘American Samoa’ or ‘Angola’ or ‘Antigua and Barbuda’ or 
‘Argentina’ or ‘Armenia or ‘Azerbaijan’ or ‘Bangladesh’ or ‘Belarus’ or ‘Belize’ or  
‘Benin’ or ‘Bhutan’ or ‘Bolivia’ or ‘Bosnia and Herzegovina’ or ‘Botswana’ or ‘Brazil’ 
or ‘Bulgaria’ or ‘Burkina Faso’ or ‘Burundi’ or ‘Cambodia’ or ‘Cameroon’ or ‘Cape 
Verde ’or ‘Central African Republic’ or  ‘Chad’ or ‘China’ or ‘Colombia’ or  
‘Comoros’ or ‘Congo Democratic Republic’ or ’Congo’ or ‘Costa Rica’ or ‘Cote 
d'Ivoire’ (Ivory Coast) or ‘Cuba’ or ‘Djibouti’ or ‘Dominica’ or ‘Dominican Republic’ 
or ‘ Egypt’ or ‘El Salvador’ or ‘Eritrea’ or ‘Ethiopia’ or ‘Fiji’ or ‘Gabon’ or ‘Gambia’ or 
‘Georgia’ or ‘Ghana’ or ‘Grenada’ or ‘Guatemala’ or ‘Guinea’ or ‘Guinea-Bissau’ or 
‘Guyana’ or ‘Haiti’ or ‘Honduras’ or ‘India’ or ‘Indonesia’ or ‘Iran Islamic Republic’ 
or ‘Iraq’ or ‘Jamaica’ or ‘Jordan’ or ‘Kazakhstan’ or ‘Kenya’ or ‘Kiribati’ or ‘Korea 
Democratic Republic’ or ‘Kosovo’ or ‘Kyrgyz Republic’ or ‘Lao Peoples Democratic 
Republic’ or ‘Lebanon’ or ‘Lesotho’ or ‘Liberia’ or ‘Libya’ or ‘Macedonia’ or 
‘Madagascar’ or ‘Malawi’ or ‘Malaysia’ or ‘Maldives’ or ‘Mali’ or ‘Marshall Islands’ 
or ‘Mauritania’ or ‘Mauritius’ or ‘Mayotte’ or ‘Mexico’ or ‘Federated States of 
Micronesia’ or ‘Moldova’ or ‘Mongolia’ or ‘Montenegro’ or ‘Morocco’ or 
‘Mozambique’ or ‘Myanmar’ or ‘Namibia’ or ‘Nepal’ or ‘Nicaragua’ or ‘Niger’ or 
‘Nigeria’ or ‘Pakistan’ or ‘Palau’ or ‘Panama’ or ‘Papua New Guinea’ or ‘Paraguay’ 
or ‘Peru’ or ‘Philippines’ or ‘Romania’ or ‘Rwanda’ or ‘Samoa’ or ‘Sao Tome and 
Principe’ or ‘Senegal’ or ‘Serbia’ or ‘Seychelles’ or ‘Sierra Leone’ or ‘Solomon 
Islands’ or ‘Somalia’ or ‘South Africa’ or ‘Sri Lanka’ or ‘Saint Lucia’ or ‘Saint Vincent 
and the Grenadines’ or ‘Sudan’ or ‘Suriname’ or ‘Swaziland’ or ‘Syrian Arab 
Republic’ or ‘Tajikistan’ or ‘Tanzania’ or ‘Thailand’ or ‘Timor-Leste’ or ‘Togo’ or 
‘Tonga’ or ‘Tunisia’ or ‘Turkey’ or ‘Turkmenistan’ or ‘Tuvalu’ or ‘Uganda’ or 
‘Ukraine’ or ‘Uzbekistan’ or ‘Vanuatu’ or ‘Venezuela’ or ‘Vietnam’ or ‘West Bank 
and Gaza’ or ‘Yemen Republic’ or ‘Zambia’ or ‘Zimbabwe’. 
#4 #1 and #2 and #3 
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APPENDIX III: DATA EXTRACTION FORM 
Prevalence of Hypertension in Low-and Middle-Income Countries- Data Extraction Form 
 
Primary Reviewer: ……………………………                    Second Reviewer: ……………………………… 
 
Endnote Study ID: ……………………………                      Date of Extraction: ……………………………             
 
Study Characteristics: 
Aim/objectives of the study: 
………………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………………… 
Study Design: ……………………………………………………………………………………………………………………….   
Study Inclusion and Exclusion Criteria: 
………………………………………………………………………………………………………………………………………………
………………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………………… 
Recruitment/Sampling Procedures used: 
………………………………………………………………………………………………………………………………………………
………………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………………… 
 
Participant Characteristics: 
Age: …………………………………. 
Gender: …………………………… 
Ethnicity: ………………….…….. 
Socio-economic status: ……………………………………………………………………………….. 
Disease characteristics: ……………………………………………………………………………….. 
Potential confounders: Did the authors consider the following potential confounders (tick all 
that apply) 
Age           
Sex 
Smoking 
Alcohol  
Education status  
 
 
 
 
Page | 222  
Co-morbidity 
BMI 
Recall bias                                          ...............………………………………………………… 
Other (specify)                                           ..........……………………………………………………… 
 
Number of participants in each characteristic category for intervention and control group(s) 
or mean/median characteristic values (record whether it is the number eligible, enrolled, or 
randomised that is reported in the study): 
………………………………………………………………………………………………………………………………………………
………………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………………… 
Intervention and Setting: 
Setting in which the intervention is delivered: 
…………………………………………………………………………………… 
Description of the intervention(s) and control(s) (e.g. dose, route of administration, number 
of cycles, duration of cycle, care provider, how the intervention was developed, theoretical 
basis (where relevant)): 
………………………………………………………………………………………………………………………………………………
………………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………………… 
Description of co-interventions: ………………………………………………………………………………………….. 
Outcome Measurement: 
Unit of assessment/analysis: …………………………………………………………………………………………….. 
Definition of hypertension used in study: ………………………………………………………………………….. 
Measurement tool or method used for measuring hypertension: …………………………………….. 
…………………………………………………………………………………………………………………………………………… 
Criteria used for diagnosis of hypertension: 
………………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………………… 
Unit of measurement (if appropriate): ………………………………..………………………………………………. 
Length of follow-up, number and/or times of follow-up measurements: 
…………………………………………………………………………………………………………………………………………….. 
For all intervention group(s) and control group(s): 
Number of participants enrolled: ………………………………………………………………………………………. 
Number of participants included in analysis: …………………………………………………………………….. 
Number of withdrawals, exclusions, lost to follow-up: ………..……………………………………………. 
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Type of analysis used in study (e.g. intention to treat, per protocol): ………………………………..  
…………………………………………………………………………………………………………………………………………….                          
Results of study analysis (e.g. dichotomous: odds ratio, risk ratio and confidence intervals, p-
value) or (continuous: mean difference, confidence intervals): ………………………....................... 
……………………………………………………………………………………………………………………………………………….          
Other Information: 
Description as stated in report/paper 
Key conclusions of 
study authors 
      
References to other 
relevant studies 
      
Correspondence 
required for further 
study information 
(from whom, what 
and when) 
      
Notes:         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page | 224  
APPENDIX IV: NEWCASTLE- OTTAWA SCALE 
 
 
 
 
 
 
 
 
 
 
 
Risk of bias assessment tool (Newcastle-Ottawa scale) 
Domain (source of bias) Assessment                                                               Risk of bias 
 
Selection (representativeness of 
the sample) 
All subjects or random sampling (A)                       Low 
 Non-random sampling (B)                                         Moderate 
 Selected group of users (C)                                       High 
 No description of sampling strategy (D)                 Unclear/High 
  
Selection (sample size) Justified and satisfactory (A)                                     Low 
 Not justified (B)                                                           High 
  
Detection (outcome 
measurement) 
Validated measurement tool (A)                              Low                     
 Tool described but non-validated (B)                      High 
 Tool not described (C)                                                Unclear/High 
  
Confounding Adjusted for confounders (A)                                    Low 
 No adjustment for confounders (B)                         High 
  
(Detection) Outcome assessment Independent blind assessment (A)                             - 
 Record linkage (B)                                                          -                                                   
 Self-report (C)                                                                 -                                                               
 No description (D)                                                          - 
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APPENDIX V: PRISMA CHECKLIST 
Section/topic  # Checklist item  
TITLE  
Title  1 Identify the report as a systematic review, meta-analysis, or both.  
Prevalence of Hypertension in Low- and Middle-income Countries: A Systematic Review and Meta-analysis 
ABSTRACT  
Structured 
summary  
2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility 
criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions 
and implications of key findings; systematic review registration number.  
Background: Low-and middle-income countries (LMICs) bear a high burden of hypertension. However, no 
previous systematic review has assessed the prevalence of hypertension and its determinants across all 
developing regions of the world. We aimed to obtain overall and regional estimates of hypertension prevalence 
and examine the pattern of the disease condition across different socio-demographic characteristics in LMICs. 
Methods and Findings: We searched electronic databases for articles published between 1948 and November 
2014. We included population-based studies that reported hypertension prevalence using the current definition 
of blood pressure ≥140/90 mmHg or self-reported use of anti-hypertensive medication. We used random-effects 
meta-analyses to pool prevalence estimates of hypertension, overall, by World Bank region and country income 
group. Subgroup and meta-regression analyses were performed on socio-demographic variables. One hundred 
fifty two (152) studies, comprising 613,074 adults from 41 countries, met our inclusion criteria. The overall 
prevalence of hypertension was 32.4% (95% confidence interval [CI] 30.2–34.7) with the Latin America and 
Caribbean region reporting the highest prevalence (40%, 95% CI 34.0–46.0). Prevalence was also highest in upper-
middle income countries (38.0%, 95% CI 35.0–42.0) and lowest in low-income countries (24.0%, 95% CI 20.0–
28.0). Prevalence among adults ≥65 years was substantially higher than adults <65 years; however, we found no 
significant sex-difference overall (31.9% vs 30.8%, p=0.6). Prevalence was generally higher among the non-
educated compared to educated people (49.0% vs. 24.9%, p<0.00001), among overweight/obese persons 
compared to normal weight (46.4% vs. 26.3%, p<0.00001), and among urban settlers compared to rural (32% vs 
25%, p=0.0005).  Meta-regression showed that combined overweight/obesity (p=0.001) and being uneducated 
(p=0.049) significantly accounted for between-study heterogeneity in hypertension rates. 
Conclusion: Hypertension remains a major public health issue in the developing world despite regional variations. 
Notwithstanding the social determinants of the disease, population-wide strategies remain pivotal to its effective 
prevention and control in LMICs.  
PROSPERO Registration ID: CRD42013006162 
INTRODUCTION  
Rationale  3 Describe the rationale for the review in the context of what is already known.  
Hypertension drives the global burden of cardiovascular disease being widely acknowledged as the most common 
cardiovascular disorder and number one risk factor for mortality.1-3 The occurrence of hypertension is increasing 
globally, with projections estimating a 30% increase in prevalence by the year 2025.4 However, owing to several 
factors such as the ongoing nutritional transition, increasing trends in sedentary lifestyle and other modifiable risk 
factors, and inadequate health care systems, populations in low- and middle-income countries (LMICs) may bear a 
higher burden of the disease, compared to the global average. Projections estimate that three-quarters of the 
world’s hypertensive population will reside in LMICs within the next decade.4  However, no systematic review has 
been conducted to quantify the occurrence of the disease condition and its determinants across developing 
regions of the world: systematic reviews have hitherto been country-specific5 or focussed on the African region.6,7  
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS).  
Our study, therefore, aimed to provide overall and regional estimates of hypertension prevalence for the 
developing world, as well as to examine the pattern of this disease across different socio-demographic 
characteristics.  
METHODS  
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Protocol and 
registration  
5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, 
provide registration information including registration number.  
This systematic review rational and methods were specified in advance and documented in a protocol which was 
published in the PROSPERO register (CRD42013006162) 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, 
language, publication status) used as criteria for eligibility, giving rationale.  
 Inclusion Exclusion 
Population Adults (18 years and above) Adolescents and children 
 
Outcome Hypertension prevalence reported or deducible  
from subgroup estimates 
Hypertension assessed as:  
    BP greater or equal to 140/90mmHg, 
    use of antihypertensive drugs, 
    self-reported physician-diagnosed cases 
Hypertension prevalence not 
reported 
Pulmonary hypertension   
Hypertension assessed as:       
    BP greater or equal to                        
160/95mmHg,  
    other assessment criteria  
 
Study design All population-based studies, regardless of the 
design:  
   cross-sectional studies,  
   cohort studies, 
   randomised controlled trials 
Hospital-based studies 
Policy reports 
Expert reviews 
 
 
Study 
location 
Low- and middle-income countries High-income countries 
 
Information 
sources  
7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched.  
We searched the following electronic databases from inception to November 2014: EMBASE, Ovid MEDLINE and 
the WHO Global Cardiovascular Infobase for relevant articles.  
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could be 
repeated.  
The search was conducted using medical subject heading (MeSH) terms and keywords: “hypertension” OR “blood 
pressure” OR ‘hypertens*’ AND ‘population-based’ OR ‘aetiology’ OR ‘etiology’ OR ‘prevalence’ OR ‘epidemiolog*’ 
AND “low-and middle-income countries” OR “developing countries”. 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if 
applicable, included in the meta-analysis).  
Three reviewers (AMS, CN, and OU) independently evaluated the eligibility of the studies obtained from the 
literature searches. All articles yielded by the database search were initially screened by their titles and abstracts 
to obtain studies that met our inclusion criteria. In cases of discrepancies, agreement was reached by consensus 
and by discussion with a fourth reviewer (SS).  
Data collection 
process  
10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from investigators.  
Three reviewers (AMS, CN, and OU) independently evaluated the methodological quality of each included study 
and extracted data using a piloted form; discrepancies were resolved by discussion with a fourth reviewer (SS).  
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and 
simplifications made. 
Data extracted included year of publication, country of origin, study design, sample size, sampling strategy, study 
period, setting (rural/urban), gender distribution, age group, mean age, body mass index (BMI) category, 
hypertension prevalence, diagnostic criteria for hypertension, blood pressure apparatus used, confounders and 
comorbidities. Countries were grouped by region and income according to World Bank9 development indicators. 
Age group, gender, BMI category, smoker status, alcohol use, and study setting were coded as dichotomous 
variables. We defined overweight/obesity as BMI≥25kg/m2. Total prevalence estimates of hypertension were 
calculated from studies providing only subgroup estimates. The total mean age was also obtained from studies 
only reporting this variable measure within subgroups. 
Risk of bias in 
individual studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this 
was done at the study or outcome level), and how this information is to be used in any data synthesis.  
Methodological quality entailed assessing the risk of bias for each study using a domain-based tool adapted from 
the Newcastle-Ottawa Scale (see Appendix 2).10   The risk of bias in a study was graded as low, moderate, high or 
unclear on the basis of study features including the selection of participants (selection bias), sample size 
justification (selection bias), outcome measurement (detection bias), and confounding adjustment.  
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Summary 
measures  
13 State the principal summary measures (e.g., risk ratio, difference in means).  
Prevalence estimates 
Synthesis of 
results  
14 Describe the methods of handling data and combining results of studies, if done, including measures of 
consistency (e.g., I2) for each meta-analysis. 
We conducted meta-analyses the DerSimonian-Laird random effects model12 due to anticipated variations in 
study population, methodologies, and stage of epidemic transition. We assessed heterogeneity among studies by 
inspecting forest plots and using the I2 statistic where we interpret a value of 50% as representing moderate 
heterogeneity. 
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APPENDIX VI: SUPPLEMENTARY TABLES 1-6 SHOWING INCLUDED STUDIES BY GEOGRAPHICAL REGION 
Table 1: Characteristics of included studies for the East Asia and Pacific region 
 
First author, year 
 
Year of data 
collection 
 
Country 
 
Setting 
 
Age 
(years) 
 
Mean age ± SD 
(years) 
 
Sample 
size 
 
 
% Males 
 
Hypertension 
prevalence 
(male/female) 
 
BP cut-off  
(mmHg) 
 
Country income 
group 
 
Shmulewitz, 2001 
 
1994  
 
FS Micronesia 
 
rural 
 
>20 
 
42.0±14.0 
 
2188 
 
42.0 
 
17.0 
 
 
140/90 
 
lower-middle 
Wu, 2001 2001 China urban ≥60 67.9±5.8 2272 41.5 59.8 140/90 upper-middle 
Gu, 2002 2000-01 China urban and rural 35-74 NR 13198 47.8 27.2(28.6/25.8) 140/90 upper-middle 
Lim, 2004 1996 Malaysia urban and rural ≥30 NR 21391 47.0 33.0(31.9/33.9) 140/90 upper-middle 
Minh, 2006 2002 Vietnam rural 25-64 NR 1996 50.1 14.1(18.1/10.1) 140/90 lower-middle 
Rampal, 2008 2004 Malaysia urban and rural ≥15 NR 16440 42.4 27.8(29.6/26.0) 140/90 upper-middle 
Sun, 2008 2004-06 China urban ≥35 51.2±11.8 45390 49.6 39.5(37.0/38.6) 140/90 upper-middle 
Zhang, 2009 2006 China urban ≥60 69.7±6.7 4141 35.3 48.5(48.4/48.6) 140/90 upper-middle 
Lee, 2010 2002-06 China urban 40-74 52.5±8.9 39252 100 25.1 140/90 upper-middle 
Swaddiwudhipong, 2010 2009 Thailand rural ≥15 52.8±11.9 5273 44.9 29.8(29.8/29.7) 140/90 upper-middle 
Thuy, 2010 2005  Vietnam urban 25-64 41.3±1.0 910 100 35.2 140/90 lower-middle 
Wu, 2010 2010 China urban ≥60 71.7±6.6 2074 41 70.4 140/90 upper-middle 
Prince, 2012 2003-06 China urban and rural ≥65 73.2±6.1 2157 43.7 60.4 140/90 upper-middle 
Ha, 2013 2011 Vietnam urban and rural ≥25 45.0 2368 43.5 23.3(30.0/19.0) 140/90 lower-middle 
Kiau, 2013 2006 Malaysia urban and rural ≥18 NR 4933 46.3 74.0(70.1/77.4) 140/90 upper-middle 
Amiri, 2014 2012 Malyasia urban ≥18 41.5±14.9 1096 43.7 39.3 140/90 upper-middle 
Fan, 2014 2010 China urban and rural 15-74 38.2±15.1 18772 40.4 24.9 140/90 upper-middle 
Feng, 2014 2011-12 China urban and rural ≥45 NR 13707 46.7 38.6 140/90 upper-middle 
Lloyd-Sherlock, 2014 2007-10 China urban and rural ≥50 NR 13348 49.8 59.5(58.8/60.1) 140/90 upper-middle 
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BP=blood pressure, FS Micronesia=Federal States of Micronesia, SD=standard deviation, mmHg=millimetre mercury, NR=not reported in original paper. Country   income   
group is classified according to World Bank indicators  
 
 
  
First author, year Year of data 
collection 
Country Setting Age 
(years) 
Mean age ± SD 
(years) 
Sample 
size 
 
% Males Hypertension 
prevalence 
(male/female) 
BP cut-off  
(mmHg) 
Country income 
group 
Nguyen, 2014 2012 Vietnam urban and rural 34-65 47.4±8 3779 43.3 12.3(28.3/14.6) 140/90 upper-middle 
Wang, 2014 2003-10 China urban ≥18 45.2±13.9 37141 60.7 32.1(33.7/19.3) 140/90 upper-middle 
Zhao, 2015 2008-12 China rural 18-60 53.4±10.3 6324 100 48.8 140/90 upper-middle 
Hou, 2015 2008-12 China urban and rural ≥45 NR 3797 47.7 46.2 140/90 upper-middle 
Chen, 2015 2012 
 
China rural ≥50 NR 2208 43.1 38.5 140/90 upper-middle 
Li, 2015 
 
2015 China urban and rural ≥18 45.1±3.6 58985 43.2 37.4 140/90 upper-middle 
 
Wang, 201543 2009 China urban and rural 18-87 41.2±15.5 15172 45.7 42 140/90 upper-middle 
Guo, 201544 1991-2011 China urban and rural ≥18 NR 24410 - 28.6 140/90 upper-middle 
Li, 201545 2015 China urban  ≥18 NR 2026 - 26.9 140/90 upper-middle 
Gu, 201546 2002 China urban and rural 35-70 NR 7137 - 40.9 140/90 upper-middle 
Lu, 201547 2013 China urban ≥18 45 4675 - 31.6 140/90 upper-middle 
Ke, 201548 2012 China urban 18-93 NR 1410 45.2 34 140/90 upper-middle 
Wei, 201549 2015 China urban ≥18 NR 3778 47.3 41 140/90 upper-middle 
Do, 201550 2005 Vietnam urban and rural 25-64 NR 17199 - 20.7 140/90 lower-middle 
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 Table 2: Characteristics of included studies for the Europe and Central Asia region 
 
BP=blood pressure, SD=standard deviation, mmHg=millimetre mercury, NR=not reported in original paper. Country income   group is classified according to World Bank 
Indicators 
 
First author, Year 
 
Year of data 
collection 
 
Country 
 
Setting 
 
Age 
(years) 
 
Mean age ± SD 
(years) 
 
Sample  
Size 
 
 
% Male 
 
Hypertension prevalence 
(male/female) 
 
BP cut-off   
(mmHg) 
 
Country  
income group 
 
Shapo, 2003 
 
2001 
 
Albania 
 
urban 
 
≥25 
 
NR 
 
1120 
 
47.8 
 
31.8(36.6/27.4) 
 
140/90 
 
upper-middle  
Onal, 2004 2002 Turkey urban ≥25 NR 423 - 35.5 140/90 upper-middle  
Mishra, 2006 2002 Uzbekistan urban and rural 15-59 NR 7796 29.9 13.6(17.0/12.0) 140/90 lower-middle  
Erem, 2008 2005 Turkey urban and rural 20-70+ 40.6±14.5 4809 45.9 44.0(41.6/46.1) 140/90 upper-middle  
Dorobantu, 2010 2005 Romania urban and rural ≥18 NR 2017 42.0 44.9(50.2/41.1) 140/90 upper-middle  
Altun, 2012 NR Turkey urban and rural >18 40.5±16.3 10748 44.3 32.7(29.4/35.9) 140/90 upper-middle  
Dogan, 2012 2005-06 Turkey urban and rural 18-70+ 47.8±13.1 2035 41.3 24.2(14.1/31.3) 140/90 upper-middle  
Harhay, 2013 2008-09 Albania urban and rural 15-49 31.9±11.0 6472 44.0 23.3(27.6/20.0) 140/90 upper-middle  
Harhay, 2013 2005 Armenia urban and rural 15-49 31.3±10.6 7552 16.0 22.6(27.3/21.7) 140/90 lower-middle  
Harhay, 2013 2006 Azerbaijan urban and rural 15-59 31.7±10.8 10958 23.0 16.4(16.6/16.4) 140/90 upper-middle  
Harhay, 2013 2007 Ukraine urban and rural 15-49 32.3±10.0 10802 47.0 28.0(31.9/24.5) 140/90 lower-middle  
Supiyev, 2015 2012-13 Kazakhstan urban 50-75 29.7±5.0 497 46.9 70.0 140/90 upper-middle 
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Table 3: Characteristics of included studies for the Latin America and Caribbean region 
 
 
First author, year 
 
Year of 
data 
collection 
 
Country 
 
Setting 
 
Age 
(years) 
 
Mean age ± SD 
(years) 
 
Sample 
size 
 
 
% Male 
 
Hypertension 
prevalence 
(Male/Female) 
 
BP cut-off  
(mmHg) 
 
Country 
income group 
 
Ordunez-Garcia, 1998 
 
1994 
 
Cuba 
 
urban 
 
>15 
 
NR 
 
1633 
 
45.6 
 
43.5(45.9/41.5) 
 
140/90 
 
upper-middle 
Barreto, 2001 1997 Brazil urban and rural ≥18 NR 2314 40.9 24.8(22.0/26.9) 140/90 upper-middle 
Freitas, 2001 1998 Brazil urban ≥18 NR 688 41.6 31.5(33.9/29.9) 140/90 upper-middle 
Lorenzo, 2002 1987-96 Mexico urban 35-64 47.3±0.3 2282 41.2 18.8(18.7/18.9) 140/90 upper-middle 
Matos, 2003 2003 Brazil rural ≥19 46.6±19.7 126 43.7 36.5 140/90 upper-middle 
Gus, 2004 1999-2000 Brazil urban and rural >20 44±15.6 1063 48.2 33.7(33.3/34.1) 140/90 upper-middle 
Ordunez, 2005 2001-02 Cuba urban 15-74 NR 1667 23.4 24.1(22.8/25.2) 140/90 upper-middle 
Almeida-Pitito, 2006 2005 Brazil urban ≥30 NR 1751f 0 33.0 140/90 upper-middle 
Jean-Baptiste, 2006 2002-03 Haiti urban 20≥65 NR 1113 29.7 47.1(48.7/46.5) 140/90 lower-middle 
Lessa, 2006 1999-2000 Brazil urban and rural ≥20 41.1±14.4 1439 42.3 29.9(27.4/31.7) 140/90 upper-middle 
Jardim, 2007 2002 Brazil urban >18 39.7±15.6 1739 34.6 36.4(41.8/31.8) 140/90 upper-middle 
Medina-Lezama, 2007 2006 Peru urban ≥20 49.1±17.2 1878 46.2 15.7(16.1/15.6) 140/90 upper-middle 
Capilheira, 2008 2002-03 Brazil urban ≥20 43.2±16.1 3100 43.3 23.4(18.2/27.4) ** upper-middle 
Ordunez, 2008 2001-02 Cuba urban and rural 25-74 NR 1475 44.3 21.4(29.4/26.3) 140/90 upper-middle 
Sparrenberger, 2008 2005-07 Brazil urban 18-60 48.8±19.3 1484 41.4 40.4 140/90 upper-middle 
Longo, 2009 2007 Brazil urban 20-59 31.0±11.6 2022 47.7 33.7(31.1/38.1) 140/90 upper-middle 
Reichert, 2009 2003 Brazil urban ≥40 NR 1696 42.6 34.4(27.3/39.6) ** upper-middle 
Rodrigues, 2009 1999-01 Brazil urban 25-64 45.0±11.0 1655 45.9 42.6(47.5/38.3) 140/90 upper-middle 
Rosario, 2009 2006 Brazil urban and rural ≥18 42.6±15.4 1003 51.3 30.1 140/90 upper-middle 
Diaz, 2009 2000-01 Cuba urban and rural ≥20 NR 19519  61 140/90 upper-middle 
Cipullo, 2010 2004-05 Brazil urban ≥18 55.0±14.7 1717 48.8 44.4(23.8/26.8) 140/90 upper-middle 
Nascente, 2010 2002 Brazil rural >18 43.2±14.9 1168 36.8 32.7(35.8/30.9) 140/90 upper-middle 
Hofelmann, 2012 2009 Brazil urban 20-59 38.1±0.5 1702 44.5 40.0(51.6/30.5) 140/90 upper-middle 
Kerkhoff, 2012 2007-08 Brazil urban 18-90 NR 1858 42.0 34.2(32.4/52.3) 140/90 upper-middle 
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First author, year 
 
Year of 
data 
collection 
 
Country 
 
Setting 
 
Age 
(years) 
 
Mean age ± SD 
(years) 
 
Sample 
size 
 
 
% Male 
 
Hypertension 
prevalence 
(Male/Female) 
 
BP cut-off  
(mmHg) 
 
Country 
income group 
Lyra, 2012 2008-09 Brazil urban 31-90 57.4 198 34.3 64.2(51.5/70.8) 140/90 upper-middle 
Prince, 2012 2003-06 Cuba urban and rural ≥65 75.1±7.0 2944 35.0 73.9 140/90 upper-middle 
Prince, 2012 2003-06 Dominican 
Republic 
urban and rural ≥65 75.3±7.5 2011 34.1 76.9 140/90 upper-middle 
Prince, 2012 2003-06 Venezuela urban and rural ≥65 72.3±6.9 1965 36.5 79.5 140/90 upper-middle 
Prince, 2012 2003-06 Peru urban and rural ≥65 74.6±7.4 1929 38.8 49.8 140/90 upper-middle 
Prince, 2012 2003-06 Mexico urban and rural ≥65 74.3±6.7 2003 36.7 62.9 140/90 upper-middle 
Mendes, 2013 2003 Brazil urban ≥60 70.2 872 48.1 45.3(38.0/52.0) ** upper-middle 
Selem, 2013 2008 Brazil urban >20 NR 535 36.8 43.4 140/90 upper-middle 
Silva, 2013 2009-10 Brazil urban 20-59 37.9±11.5 1790 44.2 40.4(51.6/30.5) 140/90 upper-middle 
Lloyd-Sherlock, 2014 2007-10 Mexico urban and rural ≥50 NR 2281 46.8 58.2(55.2/60.9) 140/90 upper-middle 
Posso, 2014 2011 Panama urban and rural ≥18 NR 3406 30.4 29.6(33.5/20.7) 140/90 upper-middle 
 
Bernabe-Ortiz, 2015 2010 Peru rural ≥35 45.3 3238 48.3 16 140/90 upper-middle 
Bresan, 2015 2010 Brazil rural ≥20 NR 355 43.9 46.2 140/90 upper-middle 
de Souza, 2015 2007 Brazil urban and rural ≥18 NR 1729 91.7 25 140/90 upper-middle 
Unger, 2015 2003 Brazil urban ≥18 NR 5649 - 21 140/90 upper-middle 
Vieira, 2015 2008-09 Brazil urban ≥18 NR 491 - 22.6 140/90 upper-middle 
Almeida, 2015 2013 Brazil urban and rural 35-80 NR 1410 - 53.2 140/90 upper-middle 
** = Self-reported only, BP=blood pressure, f= Female only sample, SD=standard deviation, mmHg=millimetre mercury, NR=not reported in original paper. Country income 
group is classified according to World Bank indicators   
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Table 4: Characteristics of included studies for the Middle East and North Africa region 
 
BP=blood pressure, SD=standard deviation, mmHg=millimetre mercury, NR=not reported in original paper. Country income   group is classified according to World Bank 
Indicators 
 
First author, year  
 
Year of data 
collection 
 
Country 
 
Setting 
 
Age 
(years) 
 
Mean age ± SD 
(years) 
 
Sample 
size 
 
 
% male 
 
Hypertension 
prevalence 
(male/female) 
 
BP cut-off  
(mmHg) 
 
Country income 
group 
 
Ibrahim, 1995 
 
1986-90 
 
Egypt 
 
urban and rural 
 
≥25 
 
NR 
 
6733 
 
43.5 
 
26.3(26.9/25.7) 
 
140/90 
 
lower-middle 
Bahrami, 2006 2002-05 Iran urban and rural 35-81 52.8±9.4 8998 42.1 32.5(29.8/34.5) 140/90 upper-middle  
Azimi-Nezhad, 2009 2005 Iran urban and rural 15-65 NR 4519 51.3 24.2(27.7/20.5) 140/90 upper-middle  
Ramezani, 2009 2006 Iran urban and rural 15-65 NR 3760 50.0 20.7(20.5/21.0) 140/90 upper-middle  
Ebrahimi, 2010 2006 Iran urban and rural 15-64 NR 29971 50.6 17.4(18.5/16.2) 140/90 upper-middle  
Berraho, 2012 2006 Morocco urban and rural <50-60+ NR 525 31.3 70.4(67.7/72.0 140/90 lower-middle  
Modesti, 2013 2008 Yemen urban and rural 15-69 NR 10242 49.4 7.7(6.7/8.6) 140/90 lower-middle  
Veghari, 2013 2013 Iran urban 15-65 39.5±14.3 3497 49.8 21.2(19.8/22.6) 140/90 upper-middle  
Khalifeh, 2015 2014 Lebanon urban and rural ≥18 59.5±12.1 672 40.2 33.3 140/90 upper-middle 
Matar, 2015 2012-13 Lebanon urban and rural ≥21 42.9±15.8 1697 - 36.9 140/90 upper-middle 
Sepanlou, 2015 2004-08 Iran urban and rural 40-75 51.6±8.8 46674 42.5 40.1 140/90 upper-middle 
Yazdanpanah, 2015 2015 Iran urban and rural ≥20 NR 944 45.8 17.6 140/90 upper-middle 
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Table 5: Characteristics of included studies for the South Asia region 
 
First author, year Year of data 
collection 
Country Setting Age 
(years) 
Mean age ± SD 
(years) 
Sample 
size 
% Male Hypertension prevalence 
(male/female) 
BP cut-off  
(mmHg) 
Country income 
Group 
 
Gupta, 1994 1994 India rural ≥20 NR 3148 63.0 21.4(24.0/17.0) 140/90 lower-middle 
Gupta, 1995 - India urban ≥20 NR 2122 66.7 32.4(30.0/33.0) 140/90 lower-middle 
Goel, 1996 1996 India rural ≥30 NR 1572 - 7.2(5.6/8.8) 140/90 lower-middle 
Singh, 1998 1997 India urban 25-64 NR 3212ᶠ - 25.6 140/90 lower-middle 
Malhotra, 1999 1994-95 India rural 16-70 NR 2559 - 4.5 140/90 lower-middle 
Gurav, 2001 - India urban ≥18 NR 767 53.6 13.9(9.5/19.0) 140/90 lower-middle 
Swami, 2002 1998-99 India urban and rural ≥65 NR 362 42.3 58.0(52.3/62.2) 140/90 lower-middle 
Hazarika, 2002 - India urban ≥30 45.1±11.0 1015 50.4 60.8 140/90 lower-middle 
Reddy, 2002 - India urban ≥18 43.1±9.5 3307 88.0 28.0 140/90 lower-middle 
Gupta, 2002 1990 India urban ≥20 NR 1123 49.0 37.0(36.4/37.5) 140/90 lower-middle 
Bharucha, 2003 2002 India urban ≥20 NR 2415 45.5 36.4(32.8/39.4) 140/90 lower-middle 
Deepa, 2003 2001-02 India urban and rural ≥20 47.0±14.5 1262 44.1 22.1(23.9/19.9) 140/90 lower-middle 
Hazarika, 2003 2003 India urban ≥60 NR 888 56.3 63.6(64.2/62.9) 140/90 lower-middle 
Shanthirani, 2003 2001-02 India urban and rural ≥20 NR 1262 44.1 21.1(22.8/19.7) 140/90 lower -middle 
Gupta, 2004 - India urban and rural ≥35 NR 88653 40.0 48.0(47.5/48.4) 140/90 lower -middle 
Hazarika, 2004 - India rural ≥30 NR 3180 45.3 33.3 140/90 lower -middle 
Ahmad, 2005 1990-94 Pakistan urban and rural ≥18 NR 8432 46.6 35.6(29.0/41.3) 140/90 lower-middle 
Das, 2005 2001 India urban ≥18 NR 1609 53.9 24.9 140/90 lower-middle 
Siddiqui, 2005 2005 Pakistan urban ≥15 34.0±15.1 327 50.5 15.0(17.5/14.0) 140/90 lower-middle 
Prabhakaran, 2005 - India urban 20-59 42.0 2122 100 30.0 140/90 lower-middle 
 
Thankappan, 2006 - India rural ≥30 50.0 4955  36.7(36.0/37.2) 140/90 lower-middle 
Mohan, 2007 2001-02 India urban and rural ≥20 43.0±12.5 2350 49.5 20.0(23.2/17.1) 140/90 lower-middle 
Vaidya, 2007 2004-05 Nepal rural ≥35 NR 1000 100 22.7 140/90 low 
Wijewardene, 2007 2004 Sri Lanka urban and rural 30-65 46.5±9.2 6047 44.5 19.1(18.8/19.3) 140/90 lower-middle 
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Reddy, 2007 - India - - 39.8±11.9 19973 59.6 33.8 140/90 lower-middle 
 
First author, year  Year of data 
collection 
Country Setting Age 
(years) 
Mean age ± SD 
(years) 
Sample 
size 
% Male Hypertension prevalence 
(male/female) 
BP cut-off  
(mmHg) 
Country income 
group 
Gupta, 2007 - India urban ≥20 NR 1127 49.3 52.4(54.3/57.9) 140/90 lower-middle 
Chaturvedi, 2007 - India urban ≥20 NR 2318  44.8 140/90 lower-middle 
Agrawal, 2008 2005 India rural ≥30 NR 406 53.7 33.5(35.3/31.4) 140/90 lower-middle 
 
Yadav, 2008 - India urban ≥60 NR 294 40.5 39.5(41.0/38.0) 140/90 lower-middle 
Kusuma, 2009 2006 India urban ≥20 NR 453 48.8 18.3(20.8/15.9) 140/90 lower-middle 
Pednekar, 2009 1991-97 India urban ≥35 NR 148173 59 46.2(47.3/45.7) 140/90 lower-middle 
Pednekar, 2009 - India urban ≥35 NR 146827 59.6 90 140/90 lower-middle 
Midha, 2009 2009 India urban and rural ≥20 NR 800 44.4 23.6 140/90 lower-middle 
Bhardwaj, 2010 2009 India rural ≥18 NR 1092 46.4 35.9(39.8/33.2) 140/90 lower-middle 
Jonas, 2010 2007-08 India rural ≥30 49.5±13.4 4711 46.5 22.1(22.5/21.7) 140/90 lower-middle 
Kinra, 2010 2005-07 India rural 20-69 NR 1983 69.3 20.2(20.0/22.0) 140/90 lower-middle 
Kar, 2010 2004-05 India urban and rural ≥30 NR 400 - 35.7 140/90 lower-middle 
Chataut, 2011 2011 Nepal rural ≥18 NR 527 40.6 22.4(32.7/15.3) 140/90 low 
Norboo, 2011 2007-11 India urban and rural ≥20 53.8±15.0 2800 44.3 37.0 140/90 lower-middle 
Manimunda, 2011 2007-09 India rural ≥18 NR 975 43.5 50.5(50.7/50.3) 140/90 lower-middle 
Thrift, 2011 - India rural ≥18 39.7 1479 46.2 11.4 140/90 lower-middle 
Bansal, 2012 2010 India rural ≥15 NR 968 70.0 32.3(30.9/27.8) 140/90 lower-middle 
Bharati, 2012 2009 India urban and rural ≥30 NR 856 37.4 27.6(26.9/28.0) 140/90 lower-middle 
Dutta, 2012 2007-11 India rural ≥18 43.0 1186ᶠ 0 24.7 140/90 lower-middle 
Esam, 2012 2011-12 India rural ≥15 NR 504 57.0 27.4(26.3/28.8) 140/90 lower-middle 
Prasad, 2012 2011 India urban ≥20 47.5±12.9 1178 50.0 36.6(38.5/34.7) 140/90 lower-middle 
Prince, 2012 2003-06 India urban and rural ≥65 72.0±6.0 1977 44.3 57.3 140/90 lower-middle 
Vaidya, 2012 1980 Nepal rural ≥21 NR 1218 43.3 33.8(38.3/30.8) 140/90 low 
Vaidya, 2012 2009 Nepal rural ≥35 NR 641 NR 17.5 140/90 low 
Meshram, 2012 1998-99 India rural ≥18 NR 4192 45.1 40.0(44.8/35.8) 140/90 lower-middle 
Samuel, 2012 1998-2002 India rural 26-32 28.3±1.1 2218 52.3 2.5 140/90 lower-middle 
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First author, year Year of data 
collection 
Country Setting Age 
(years) 
Mean age ± SD 
(years) 
Sample 
size 
% Male Hypertension prevalence 
(male/female) 
BP cut-off  
(mmHg) 
Country income 
group 
Kaur, 2012 - India urban and rural 40-70 NR 600 - 18 140/90 lower-middle 
Jeemon, 2012 2003-06 India urban ≥18 40.9±11.0 10543 - 33.8 140/90 lower-middle 
Gupta, 2012 2009-10 India urban 20-59  739 61.0 33.6(39.5/24.6) 140/90 lower-middle 
Gupta, 2012 - India urban and rural 35-70 NR 4608 - 39.2 140/90 lower-middle 
Chinnakali, 2012 - India rural - NR 211 - 40.5(39.2/40.8) 140/90 lower-middle 
Kokiwar, 2012 - India rural ≥30 NR 924 - 19.0(23.4/14.4) 140/90 lower-middle 
 
Borah, 2012 2012 India urban and rural ≥18 NR 916 50.8 44.4 140/90 lower-middle 
 
Bhagyalaxmi, 2013 2008 India urban and rural 15-64 37.7±1.4 3489 51.2 25.8(27.6/23.9) 140/90 lower-middle 
Gupta, 2013 2006-10 India urban 20-75 NR 6106 55.2 42.8(43.8/41.5) 140/90 lower-middle 
Khan, 2013 1994-97 Nepal rural ≥16 34.2 1679ᶠ 0 3.3 140/90 low 
Adhikari, 2014 2013 Nepal urban and rural 15-64 NR 1240 53.6 22.3(24.8/19.3) 140/90 low 
Lloyd-Sherlock, 2014 2007-10 India urban and rural ≥50 NR 7238 51.1 32.3(30.3/35.0) 140/90 lower-middle 
Zaman, 2015 2013 Bangladesh urban and rural ≥25 NR 4073 44.5 23.1 140/90 Lower-middle 
Gupta, 2015 2005-09 India urban 20-75 NR 6198 55.8 31.6 140/90 lower-middle 
Menon, 2015 2014 India rural ≥18 NR 84456 51.4 11.5 140/90 lower-middle 
Ranasinghe, 2015 2005-06 Sri Lanka urban and rural ≥18 46.1±15.1 4482 39.5 26.5 140/90 lower-middle 
Rahman, 2015 2011 Bangladesh urban and rural ≥35 NR 7876  24.4 140/90 low 
Bhansali, 2015 - India urban and rural ≥20 NR 14059 - 26.3 140/90 upper-middle 
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Table 6: Characteristics of included studies for the sub-Saharan Africa region  
First author, year Year of data 
collection 
Country Setting Age 
(years) 
Mean age ± SD 
(years) 
Sample  
size 
 
% Males Hypertension 
prevalence 
(male/female) 
BP cut-off  
(mmHg) 
Country income 
group 
Edwards, 2000 1996-97 Tanzania urban and rural ≥15 43.0±11.0 1695 43.1 30.6(30.0/30.2) 140/90 low 
Amoah, 2003 2003 Ghana urban ≥25 NR 4733 40.0 28.3 140/90 lower-middle 
Cappuccio, 2004 2001-02 Ghana urban and rural 40-75 54.7±11.3 1013 38.0 28.7(29.9/28.0) 140/90 lower-middle 
Erhun, 2004 2004 Nigeria urban ≥18 NR 1000 66.5 21.0(23.3/16.4) 140/90 lower-middle 
Agyemang, 2006 2004 Ghana urban and rural 16 ≥50 NR 1431 45.0 29.4(31.0/28.0) 140/90 lower-middle 
Kamadjeu, 2006 2003 Cameroon urban and rural ≥15 NR 10011 40.0 24.1(25.6/23.1) 140/90 lower-middle 
Duda, 2007 2000 Ghana urban ≥18 46.8±18.0 1321ᶠ - 23.7 140/90 lower-middle 
Kengme, 2007 2004 Cameroon urban 15-99 NR 2559 40.3 34.9 140/90 lower-middle 
Niakara, 200 2004 Burkina Faso urban ≥35 NR 2044 46.8 40.2(38.9/40.1) 140/90 low 
Omuemu, 2007 2007 Nigeria rural ≥15 30.7±14.6 590 60.2 20.2(24.8/13.2) 140/90 lower-middle 
Thorogood, 2007 2002 South Africa rural ≥35 NR 402 24.0 43.0(44.0/42.0) 140/90 upper-middle 
Damasceno, 2009 2005 Mozambique urban/rural 25-64 NR 3323 36.5 33.1(35.7/31.2) 140/90 low 
Grimsrud, 2009 2002-04 South Africa urban and rural ≥18 37.0 4351 46.3 16.7(10.7/23.6) 140/90 upper-middle 
 
Tesfaye, 2009 2006 Ethiopia urban 25-64 NR 3713 41.4 30.0(31.5/28.9) 140/90 low 
Wamala, 2009 2006 Uganda rural ≥20 39.6±15.8 842 51.0 30.4(25.4/34.0) 140/90 low 
Ekwunife, 2010 2009 Nigeria urban ≥18 34.9±13.9 756 48.1 21.1(40.3/24.7) 140/90 lower-middle 
Oladapo, 2010 2002-05 Nigeria rural 18-64 42.1±21.6 2000 43.7 20.8(21.1/20.5) 140/90 lower-middle 
Sani, 2010 2006 Nigeria urban 18-75 37.6±10.6 300 43.0 25.7(27.9/24.0) 140/90 lower-middle 
Ulasi, 2010 2010 Nigeria urban 25-64 NR 1458 48.6 32.8 140/90 lower-middle 
Maher, 2011 2008-09 Uganda rural ≥18 32.8±18.0 6678 56.6 22.0(22.5/22.6) 140/90 low 
Ulasi, 2011 2010 Nigeria urban ≥18 38.0±13.3 688 51.5 42.2(46.3/37.7) 140/90 lower-middle 
Wokoma, 2011 2011 Nigeria rural ≥15 48.9±14.8 152 40.0 27.9 140/90 lower-middle 
Awoke, 2012 2012 Ethiopia urban ≥35 51.5±14.4 679 47.6 28.3(26.0/30.3) 140/90 low 
Dzudie, 2012 2011 Nigeria urban ≥18 NR 2120 52.7 47.5(50.1/44.6) 140/90 lower-middle 
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Hendriks, 2012 2009-11 Nigeria rural ≥18 45.3±18.3 2678 46.6 21.0 140/90 lower-middle 
 
 
 
First author, year Year of data 
collection 
Country Setting Age 
(years) 
Mean age ± SD 
(years) 
Sample  
size 
 
% Males Hypertension 
prevalence 
(male/female) 
BP cut-off  
(mmHg) 
Country income 
group 
Hendriks, 2012 2009-11 Kenya rural ≥18 40.9±16.2 2111 40.1 20.2 140/90 low 
Hendriks, 2012 2009-11 Tanzania urban ≥18 36.8±11.2 1046 40.4 19.0 140/90 low 
Hendriks, 2012 2009-11 Namibia urban ≥18 36.9±13.4 1733 44.5 32.0 140/90 upper-middle 
Macia, 2012 2009 Senegal urban and rural 50-59 NR 500 52.6 65.4(63.9/67.1) 140/90 lower-middle 
Mayega, 2012 2011 Uganda rural 35-60 NR 1656 48.6 20.5(20.7/20.3) 140/90 low 
Msyamboza, 2012 2009 Malawi urban and rural 25-64 NR 3727 31.8 33.2(36.9/29.9) 140/90 low 
Adebayo, 2013 2013 Nigeria rural 15-90 32.3±14.7 1000 48.6 26.4(27.3/25.4) 140/90 lower-middle 
Asekun-Olarinmoye, 2013 2011 Nigeria rural ≥18 49.7±1.6 259 38.6 13.2(15.0/11.9) 140/90 lower-middle 
Ekanem, 2013 2013 Nigeria urban 16-65 31.7±7.6 442 51.6 47.0 140/90 lower-middle 
Kandala, 2013 1998 South Africa urban and rural ≥15 41.8±16 13596 41.8 30.4(27.4/32.6) 140/90 upper-middle 
Musinguzi, 2013 2012 Uganda urban and rural ≥15 NR 4563 35.6 21.8(21.7/22.3) 140/90 low 
Ogah, 2013 2012 Nigeria urban and rural ≥15 41.7±18.5 2928 47.8 31.0(33.5/30.5) 140/90 lower-middle 
Ogunmola, 2013 2013 Nigeria rural ≥40 66.8±12.1 104 31.7 66.4 140/90 lower-middle 
Okpechi, 2013 2011-12 Nigeria urban and rural ≥18 41.7±0.3 2983 47.9 31.4(34.9/28.1) 140/90 lower-middle 
Peer, 2013 2008-09 South Africa urban 25-64 NR 1099 35.7 38.9 140/90 upper-middle 
Peltzer, 2013 2008 South Africa urban and rural ≥50 NR 3840 42.7 77.3(74.4/79.6) 140/90 upper-middle 
Pessinaba, 2013 2010 Senegal urban ≥15 53.6±15.8 1424 31.0 46.0(41.7/47.9) 140/90 lower-middle 
Awosan, 2014 2012 Nigeria urban 20-69 35.4±8.3 390 53.0 29.1(26.2/32.4) 140/90 lower-middle 
Awuah, 2014 2010-11 Ghana urban 15-59 31.0±10.6 714 46.1 28.3(31.0/25.6) 140/90 lower-middle 
Doulougou, 2014 2012 Burkina Faso urban and rural ≥18 NR 1481 51.7 9.4(7.6/8.0) 140/90 low 
Doulougou, 2014 2010 Burkina Faso urban ≥18 NR 2041 44.3 18.6 140/90 low 
Duboz, 2014 2009 Senegal urban NR NR 600 - 27.5 140/90 lower-middle 
Helelo, 2014 2013 Ethiopia rural ≥31 47.4±12.2 518 44.2 22.4(26.2/19.4) 140/90 low 
Lloyd-Sherlock, 2014 2007-10 Ghana urban and rural ≥50 NR 4716 49.7 57.1(54.6/59.9) 140/90 lower-middle 
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Lloyd-Sherlock, 2014 2007-10 South Africa urban and rural ≥50 NR 3820 44.0 77.9(74.7/80.3) 140/90 upper-middle 
Moges, 2014 2005 Ethiopia urban ≥18 38.8±10.7 68 42.6 13.3(17.2/10.3) 140/90 low 
Minicuci, 2014 2007/08 Ghana urban and rural ≥50 NR 4724 49.7 51.1 140/90 lower-middle 
Oladimeji, 2014 2012 Nigeria urban ≥18 43.0±9.0 801 62.0 29 140/90 lower-middle 
Oluyombo, 2015 2015 Nigeria urban and rural ≥18 61.7±18.5 750 29.5 47.2 140/90 lower-middle 
Abebe, 2015 2012 Ethiopia urban and rural ≥35 47.0±12.4 2200 46.3 27.9 140/90 low 
First author, year Year of data 
collection 
Country Setting Age 
(years) 
Mean age ± SD 
(years) 
Sample  
size 
 
% Males Hypertension 
prevalence 
(male/female) 
BP cut-off  
(mmHg) 
Country income 
group 
Akpan, 2015 - Nigeria urban and rural ≥18 NR 1565 - 38 140/90 lower-middle 
Angaw, 2015 2014 Ethiopia urban ≥48 39.0±10.4 655 44.4 27.3(28.3/26.2) 140/90 low 
Anteneh, 2015 2014 Ethiopia urban ≥30 NR 678 45.6 25.1 140/90 low 
Asiki, 2015 2011 Uganda rural ≥18 NR 7741 43.7 12.3 140/90 low 
Isara, 2015 2013 Nigeria rural ≥18 NR 845 31.1 37.6(43.7/35.1) 140/90 lower-middle 
Musinguzi, 2015 - Uganda urban and rural ≥15 34.5±15.5 4432 36.3 20.2 140/90 low 
Oguoma, 2015 2014 Nigeria urban and rural ≥18 40.6±20.6 422 35.3 35.7 140/90 lower-middle 
Wandera, 2015 2010 Uganda urban and rural ≥50 NR 2382 16.4 16.0(10.8/20.3) 140/90 low  
Sowemimo, 2015 2015 Nigeria urban 18-90 38.8±15.6 806 - 33.1(36.8/31.1) 140/90 lower-middle 
Kingue, 2015 - Cameroon urban and rural ≥16 NR 15470 - 29.7 140/90 lower-middle 
Bushara, 2015 2015 Sudan rural 18-90 39.6±15.9 1099 41.9 38.2(36.7/39.3) 140/90 lower-middle 
Seck, 2015 2015 Senegal rural ≥18 40.9±17.2 627 40.1 23.4(24.9/22.4) 140/90 lower-middle 
Ezeala-Adekaibe, 2015 2015 Nigeria urban ≥20 NR 774 - 52.5(55.4/50.8) 140/90 lower-middle 
Ibekwe, 2015 2012 Nigeria rural ≥18 NR 272 - 21 140/90 lower-middle 
Ugwuja, 2015 2015 Nigeria rural ≥18 NR 267 - 23.2 140/90 lower-middle 
Botha, 2015 2010 South Africa urban and rural ≥18 NR 429 - 44.5 140/90 upper-middle 
Sander, 2015 2007-10 Uganda rural  - NR 426 - 8.0 140/90 low 
 
BP=blood pressure, f=female, SD=standard deviation, mmHg=millimetre mercury, NR=not reported in original paper. Country income group is classified according to World 
Bank indicators
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APPENDIX VII: RISK OF BIAS ASSESSMENT FOR EACH STUDY 
Publication year First Author Country Selection 
(sampling) 
Selection 
(sample size) 
Detection 
(outcome 
exposure) 
Control 
confounders 
Detection 
(outcome 
assessment) 
1994 Gupta India D A C A D 
1995 Gupta India A A A A D 
1995 Ibrahim Egypt A B A A D 
1996 Kaufman Nigeria A A A A D 
1996 Goel India B B A A D 
1998 Singh India A B A A D 
1998 Ordunez-Garcia Cuba D B A A C 
1999 Malhotra India A A A A D 
2000 Edwards Tanzania A B C A D 
2001 Barreto Brazil B A A A D 
2001 Gurav India A A A A D 
2001 
Shmulewitz 
Federated 
States of 
Micronesia 
A A A A D 
2001 Freitas Brazil A B A A D 
2001 Wu China A A B A C 
2002 Swami India A B A A D 
2002 Hazarika India D B A A D 
2002 Reddy  India B B B A C 
2002 Lorenzo Mexico B A D B D 
2002 Gupta India B A A A D 
2002 Gu China B B A A D 
2003 Shapo Albania B A A A D 
2003 Amoah Ghana C B A A D 
2003 Matos Brazil A A C A D 
2003 Bharucha India A A A A D 
2003 Shanthirani India A A A A D 
2003 Deepa India B A A A D 
2003 Hazarika India D B A A D 
2004 Onal Turkey A B A A D 
2004 Cappuccio Ghana A B A A D 
2004 Gus Brazil B B A A D 
2004 Lim Malaysia A A A A D 
2004 Gupta India C B A A D 
2004 Hazarika India D B A A D 
2005 Erhun Nigeria B B A A D 
2005 Ordunez Cuba B B A A D 
2005 Ahmad Pakistan B A C A C 
2005 Siddiqui Pakistan A A A A D 
2005 Das India A B A A D 
2005 Prabhakaran India B B A A D 
2006 Bahrami Iran A A A A D 
2006 Agyemang Ghana B B A A D 
2006 Lessa Brazil A A A A D 
2006 Jean-Baptiste Haiti D B A A D 
2006 Kamadjeu Cameroon A A A A D 
2006 Minh Vietnam A A A A D 
2006 Almeida-Pititto Brazil A A A A D 
2006 Mishra Uzbekistan A A A A D 
2006 Thankappan India A A A A D 
2007 Jardim Brazil B B C A C 
2007 Niakara Burkina Faso B B A A D 
2007 Medina-Lezama Peru C B A A D 
2007 Duda Ghana A A A A D 
2007 Kengme Cameroon B B A A D 
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2007 Thorogood South Africa D A A A D 
2007 Omuemu Nigeria A B A A D 
2007 Vaidya Nepal B A A A D 
2007 Mohan India A A A A D 
2007 Wijewardene SriLanka B A A A D 
2007 Reddyet India B A A A D 
2007 Gupta India D B A A D 
2007 Chaturvedi India A B B A D 
2008 Rampal Malaysia D B A A D 
2008 Ordunez Cuba C B B A D 
2008 Capilheira Brazil A B A A D 
2008 Sun China A A A A D 
2008 Sparrenberger Brazil A A A A D 
2008 Erem Turkey A A A A D 
2008 Agrawal India D B A A D 
2008 Yadav India D B A A D 
2009 Azimi-Nezhad Iran A A A A D 
2009 Ramezani Iran D B C A D 
2009 Longo Brazil D B A A D 
2009 Rosario Brazil B A A A D 
2009 Zhang China A B B A D 
2009 Rodrigues Brazil B B B A C 
2009 Reichert Brazil B B B A C 
2009 Diaz Cuba B B B A C 
2009 Grimsrud South Africa B B B A C 
2009 Wamala Uganda B B B A C 
2009 Tesfaye Ethiopia B B B A C 
2009 Damasceno Mozambique B B B A C 
2009 Kusuma India B B B A C 
2009 Pednekar India A B A A D 
2009 Pednekar India B A A A D 
2009 Midha India A B A A D 
2010 Ebrahimi Iran B B A A D 
2010 Cipullo Brazil A B C A D 
2010 Nascente Brazil B B A A D 
2010 Lee China B B A A D 
2010 Swaddiwudhipong Thailand D B C A D 
2010 Thuy Vietnam B B A A D 
2010 Wu China D B A A D 
2010 Dorobantu Romania D B A A D 
2010 Ulasi Nigeria B A C A D 
2010 Ekwunife Nigeria B B A A D 
2010 Oladapo Nigeria B B A A D 
2010 Sani Nigeria A B A A D 
2010 Bhardwaj India D B A A D 
2010 Jonas India A A C A D 
2010 Kinra India A B A A D 
2010 Kar India A B A A D 
2011 Maher Uganda A B A A D 
2011 Ulasi Nigeria A B A A D 
2011 Wokoma Nigeria B B C A D 
2011 Chataut Nepal D B A A D 
2011 Norboo India D B C A D 
2011 Manimunda India B B A A D 
2011 Thrift India A B A A D 
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2012 Berraho Morocco B B A A D 
2012 Hofelmann Brazil A B A A D 
2012 Kerkhoff Brazil A A A A D 
2012 Altun Turkey A A A A D 
2012 Prince Cuba D B A A D 
2012 Dogan Turkey C B A A D 
2012 Prince 
Dominican 
Republic 
A A C A D 
2012 Prince Peru A B A A D 
2012 Prince Venezuela A B A A D 
2012 Prince Mexico A B A A D 
2012 Prince China A B A A D 
2012 Macia Senegal A B A A D 
2012 Awoke Ethiopia B A A A D 
2012 Mayega Uganda B B A A D 
2012 Msyamboza Malawi A B C A D 
2012 Hendriks Nigeria B B A A D 
2012 Hendriks Kenya D A A A D 
2012 Hendriks Tanzania D B A A D 
2012 Hendriks Namibia D B A A D 
2012 Dzudie Cameroon B B C A D 
2012 Oladimeji Nigeria A A A A D 
2012 Bharati India D B A A D 
2012 Bansal India A A A A D 
2012 Vaidya Nepal D B A A D 
2012 Vaidya Nepal A A A A D 
2012 Esam India D B A A D 
2012 Dutta India D A A B D 
2012 Prasad India D B A A D 
2012 Prince India D B C B D 
2012 Meshram India A B A B D 
2012 Samuel India A B C A D 
2012 Kaur India D B A A D 
2012 Jeemon  India A B A A D 
2012 Gupta India D A A A D 
2012 Gupta India A A A B D 
2012 Chinnakali India B B A B D 
2012 Kokiwar India A B A A D 
2012 Borah India A B A B D 
2012 Kaur India B B A B D 
2013 Modesti Yemen A B A A D 
2013 Harhay Albania B B A A D 
2013 Harhay Armenia A B A B D 
2013 Harhay Azerbaijan A B A A D 
2013 Mendes Brazil B B A A D 
2013 Selem Brazil A A C A D 
2013 Ha Vietnam A B A A D 
2013 Kiau Malaysia A B A A D 
2013 Silva Brazil A B A A D 
2013 Harhay Ukraine A B A A D 
2013 Ogah Nigeria A B A A D 
2013 Pessinaba Senegal B A A A D 
2013 Peltzer South Africa B B A A D 
2013 Kandala South Africa A B C A D 
2013 Asekun-Olarinmoye Nigeria B B A A D 
2013 Okpechi Nigeria D A A A D 
2013 Veghari Iran 
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2013 Ogunmola Nigeria D B A A D 
2013 Ekanem Nigeria B B C A D 
2013 Adebayo Nigeria A A A A D 
2013 Peer South Africa D B A A D 
2013 Musinguzi Uganda A A A A D 
2013 Bhagyalaxmi India D B A A D 
2013 Gupta India A A A A D 
2013 Khan Nepal D B A A D 
2014 Wang  China D A A B D 
2014 Feng China D B A A D 
2014 Lloyd-Sherlock China D B C B D 
2014 Fan China A B A B D 
2014 Posso Panama A B C A D 
2014 Awosan Nigeria D B A A D 
2014 Lloyd-Sherlock Ghana A B A A D 
2014 Lloyd-Sherlock South Africa D A A A D 
2014 Helelo Ethiopia A A A B D 
2014 Moges Ethiopia B B A B D 
2014 Duboz Senegal A B A A D 
2014 Doulougou Burkina Faso A B A B D 
2014 Awuah Ghana B B A B D 
2014 Doulougou Burkina Faso A B A A D 
2014 Oluyombo Nigeria B B A A D 
2014 Nguyen Vietnam A B A B D 
2014 Lloyd-Sherlock Mexico A B A A D 
2014 Amiri Malaysia B B A A D 
2014 Zhao China A A C A D 
2014 Adhikari Nepal A B A A D 
2014 Lloyd-Sherlock India A B A A D 
2014 Zaman Bangladesh A B A A D 
2015 Abebe Ethiopia A B A A D 
2015 Akpan Nigeria A B A A D 
2015 Angaw Ethiopia B A A A D 
2015 Bernabe Ortiz Peru B B A A D 
2015 Bresan Brazil A B C A D 
2015 De Souza Brazil B B A A D 
2015 Anteneh Ethiopia D A A A D 
2015 Asiki Uganda D B A A D 
2015 Isara Nigeria D B A A D 
2015 Muusinguzi Uganda B B C A D 
2015 Khalifeh Lebanon A A A A D 
2015 Matar Lebanon D B A A D 
2015 Minicuci Ghana A A A A D 
2015 Sepanlou Iran D B A A D 
2015 Supiyev Kazakhstan A A A A D 
2015 Oguoma Nigeria D B A A D 
2015 Wandera Uganda D A A B D 
2015 Hou China D B A A D 
2015 Chen China D B C B D 
2015 Lim China A B A B D 
2015 Iazdanpanah Iran A B C A D 
2015 Wang  China D B A A D 
2015 Sowemimo Nigeria A B A A D 
2015 Guo China D A A A D 
2015 Kingue Cameroon A A A B D 
2015 Bushara Sudan 
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2015 Seck Senegal A B A A D 
2015 Ezeala-Adekaibe Nigeria A B A B D 
2015 Li  China B B A B D 
2015 Unger Brazil A B A A D 
2015 Ibekwe Nigeria B B A A D 
2015 Ugwuja Nigeria A B A A D 
2015 Botha South Africa A A A A D 
2015 Vieira Brazil A A A A D 
2015 Gu China A A A A D 
2015 Almeida Brazil D B A A D 
2015 Sander Uganda D B A A D 
2015 Lu China A A A A D 
2015 Ke China D B C A D 
2015 Wei China D B A A D 
2015 Do Vietnam B A A A D 
2015 Gupta India A B B A D 
2015 Menon India B B B A C 
2015 Ranasighe Sri Lanka B B B A C 
2015 Rahman Bangladesh B B B A C 
2015 Bhansali India B B B A C 
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APPENDIX VIII: SUPPLEMENTARY FIGURES 1-11 SHOWING SUBGROUP 
ANALYSIS 
Figure 1: Prevalence estimate of hypertension in the Latin America and Caribbean region 
Pooled estimate of hypertension prevalence (39.1%) is displayed in forest plot. I2 is greater 
than 75%, suggesting considerable heterogeneity across included studies. However, 
prevalence estimates were pooled using random effects meta-analysis. ES=effect size. 
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Figure 2: Prevalence estimate of hypertension in the Middle East and North Africa region 
Pooled estimate of hypertension prevalence (26.9%) is displayed in forest plot. I2 is greater 
than 75%, suggesting considerable heterogeneity across included studies.  
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Figure 3: Prevalence estimate of hypertension in the East Asia and Pacific region 
Pooled estimate of hypertension prevalence (35.8%) is displayed in forest plot. I2 greater than 
75% suggesting considerable heterogeneity across included studies.  
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Figure 4: Prevalence estimate of hypertension in the Sub-Saharan Africa region 
Pooled estimate of hypertension prevalence (31.0%) is displayed in forest plot. I2 greater than 
75% suggesting considerable heterogeneity across included studies.  
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Figure 5: Prevalence estimate of hypertension in the Europe and Central Asia region 
Pooled estimate of hypertension prevalence (31.5%) is displayed in forest plot. I2 greater than 
75% suggesting considerable heterogeneity across included studies.  
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Figure 6: Prevalence estimate of hypertension in the South Asia region 
Pooled estimate of hypertension prevalence (29.4%) is displayed in forest plot. I2 greater than 
75% suggesting considerable heterogeneity across included studies.  
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Figure 7: Prevalence estimate of hypertension in upper-middle income countries 
Pooled estimate of hypertension prevalence (37.8%) is displayed in forest plot. I2 greater than 
75% suggesting considerable heterogeneity across included studies.  
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Figure 8: Prevalence estimate of hypertension in lower-middle income countries 
Pooled estimate of hypertension prevalence (31.1%) is displayed in forest plot. I2 greater than 
75% suggesting considerable heterogeneity across included studies.  
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Figure 9: Prevalence estimate of hypertension in low-income countries 
Pooled estimate of hypertension prevalence (23.1%) is displayed in forest plot. I2 greater than 
75% suggesting considerable heterogeneity across included studies.  
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Figure 10: Prevalence of hypertension in urban settings 
Pooled estimate of hypertension prevalence in urban settings (32.7%) is displayed in forest 
plot. I2 greater than 75% suggesting considerable heterogeneity across included studies.  
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Figure 11: Prevalence of hypertension in rural settings 
Pooled estimate of hypertension prevalence in rural settings (25.2%) is displayed in forest 
plot. I2 greater than 75% suggesting considerable heterogeneity across included studies.  
 
 
 
 
 
 
 
 
 
